#Sample Identifier	Patient Identifier	Cancer Type	Sample Type	Sample Class	Metastatic Site	Primary Tumor Site	Cancer Type Detailed	Gene Panel	SO comments	Sample coverage	Tumor Purity	Oncotree Code	MSI Comment	MSI Score	MSI Type	Institute Source	Somatic Status	Age at Which Sequencing was Reported (Days)	Archer Panel	Impact TMB Percentile (Across All Tumor Types)	Impact TMB Score	Impact TMB Percentile (Within Tumor Type)	MSK Pathology Slide Available	MSK Slide ID
#A unique sample identifier.	Identifier to uniquely specify a patient.	Cancer Type	The type of sample (i.e., normal, primary, met, recurrence).	The sample classification (i.e., tumor, cellline, xenograph).	The anatomic location to which the cancer has spread.	Text term to describe the organ sub-division in an individual with cancer.	Cancer Type Detailed	Gene panel.	Sign-out comments	Sample coverage	Tumor Purity	Oncotree Code	MSI Comment	MSI Score	MSI Type	Institute Source	Somatic Status	Age (in days) at which sequencing was reported	Archer Panel	Percentile for the TMB within the MSK-IMAPCT cohort	Calculated TMB score	Percentile for the TMB within the Tumor type cohort (at least 10 cases are needed in that tumor type to have a result for this)	Indicates the existence of a MSK Pathology slide.	MSK Slide ID
#STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	NUMBER	STRING	STRING	NUMBER	STRING	STRING	STRING	NUMBER	STRING	NUMBER	NUMBER	NUMBER	STRING	STRING
#0	0	1	1	0	0	0	1	1	0	1	1	0	0	1	1	1	1	0	0	0	1	0	0	0
SAMPLE_ID	PATIENT_ID	CANCER_TYPE	SAMPLE_TYPE	SAMPLE_CLASS	METASTATIC_SITE	PRIMARY_SITE	CANCER_TYPE_DETAILED	GENE_PANEL	SO_COMMENTS	SAMPLE_COVERAGE	TUMOR_PURITY	ONCOTREE_CODE	MSI_COMMENT	MSI_SCORE	MSI_TYPE	INSTITUTE	SOMATIC_STATUS	AGE_AT_SEQ_REPORT	ARCHER	CVR_TMB_COHORT_PERCENTILE	CVR_TMB_SCORE	CVR_TMB_TT_COHORT_PERCENTILE	PATH_SLIDE_EXISTS	MSK_SLIDE_ID
P-0000197-T01-IM3	P-0000197	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341		1188	30	PRAD	Not Available	0.09	Stable	MSKCC	Matched	82	NO	44.1	3.3	69.1	YES	744282
P-0000318-T01-IM3	P-0000318	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341		782	60	PRAD	Not Available	1.67	Stable	MSKCC	Matched	68	NO	44.1	3.3	69.1	NO	NA
P-0000373-T01-IM3	P-0000373	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		708	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	57	NO	17.3	1.1	28.8	YES	472020
P-0000377-T03-IM3	P-0000377	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		805	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.73	Stable	MSKCC	Matched	63	NO	86.6	10.0	96.4	YES	739720
P-0000391-T01-IM3	P-0000391	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		704	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	47	NO	17.3	1.1	28.8	YES	471972
P-0000401-T01-IM3	P-0000401	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		552	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.27	Stable	MSKCC	Matched	86	NO				YES	473464
P-0000431-T01-IM3	P-0000431	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		530	60	PRAD	Not Available	0.34	Stable	MSKCC	Matched	59	NO	17.3	1.1	28.8	YES	473451
P-0000441-T01-IM3	P-0000441	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		734	70	PRAD	Not Available	1.18	Stable	MSKCC	Matched	72	NO	74.4	6.7	94	NO	NA
P-0000442-T01-IM3	P-0000442	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		922	50	PRAD	Not Available	0.18	Stable	MSKCC	Matched	69	NO	17.3	1.1	28.8	YES	474027
P-0000449-T01-IM3	P-0000449	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341		919	20	PRAD	Not Available	4.76	Indeterminate	MSKCC	Matched	71	NO	93.6	17.8	97.6	YES	473398
P-0000479-T01-IM3	P-0000479	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		537	60	PRAD	Not Available	0.00	Stable	MSKCC	Matched	73	NO				YES	473430
P-0000484-T01-IM3	P-0000484	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		571	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO	29.9	2.2	49.5	YES	473429
P-0000504-T01-IM3	P-0000504	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		655	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.34	Stable	MSKCC	Matched	52	NO				YES	478143
P-0000505-T02-IM6	P-0000505	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome.	667	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.44	Stable	MSKCC	Matched	71	NO	73.7	6.1	93.5	NO	NA
P-0000509-T02-IM5	P-0000509	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410		1022	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.56	Stable	MSKCC	Matched	68	NO	37.9	3	60	NO	NA
P-0000521-T01-IM3	P-0000521	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341		919	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.39	Stable	MSKCC	Matched	74	NO				YES	744422
P-0000541-T01-IM3	P-0000541	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		515	60	PRAD	Not Available	0.36	Stable	MSKCC	Matched	59	NO	44.1	3.3	69.1	YES	744573
P-0000560-T01-IM3	P-0000560	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		560	80	PRAD	Not Available	0.27	Stable	MSKCC	Matched	68	NO	44.1	3.3	69.1	YES	478082
P-0000600-T01-IM3	P-0000600	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341		814	50	PRAD	Not Available	0.10	Stable	MSKCC	Matched	67	NO	29.9	2.2	49.5	YES	472002
P-0000603-T01-IM3	P-0000603	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		729	75	PRAD	Not Available	0.08	Stable	MSKCC	Matched	66	NO				YES	471061
P-0000610-T01-IM3	P-0000610	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		308	70	PRAD	Not Available	0.56	Stable	MSKCC	Matched	50	NO	44.1	3.3	69.1	YES	473470
P-0000615-T01-IM3	P-0000615	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		796	40	PRAD	Not Available	0.18	Stable	MSKCC	Matched	60	NO	17.3	1.1	28.8	YES	478117
P-0000640-T03-IM5	P-0000640	Prostate Cancer	Metastasis	Tumor	Spine	Prostate	Prostate Adenocarcinoma	IMPACT410		404	70	PRAD	Not Available	0.16	Stable	MSKCC	Matched	63	NO	25.2	2	41.8	NO	NA
P-0000647-T01-IM3	P-0000647	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		805	60	PRAD	Not Available	0.00	Stable	MSKCC	Matched	73	NO	17.3	1.1	28.8	YES	472148
P-0000655-T01-IM3	P-0000655	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT341		614	70	PRAD	Not Available	0.52	Stable	MSKCC	Matched	72	NO	68	5.6	90.3	YES	471282
P-0000659-T01-IM3	P-0000659	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		1267	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.84	Stable	MSKCC	Matched	72	NO	58.6	4.5	83.5	YES	472152
P-0000672-T01-IM3	P-0000672	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		603	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.24	Stable	MSKCC	Matched	60	NO	17.3	1.1	28.8	YES	470749
P-0000675-T01-IM3	P-0000675	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		616	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	56	NO	29.9	2.2	49.5	YES	470755
P-0000683-T01-IM3	P-0000683	Prostate Cancer	Metastasis	Tumor	Urethra	Prostate	Prostate Adenocarcinoma	IMPACT341		256	30	PRAD	Not Available	3.91	Indeterminate	MSKCC	Matched	68	NO	74.4	6.7	94	YES	470792
P-0000691-T01-IM3	P-0000691	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		92	60	PRAD	Not Available	4.88	Indeterminate	MSKCC	Matched	67	NO	17.3	1.1	28.8	YES	470576
P-0000725-T01-IM3	P-0000725	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		586	65	PRAD	Not Available	0.34	Stable	MSKCC	Matched	69	NO	44.1	3.3	69.1	YES	470584
P-0000828-T02-IM3	P-0000828	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		482	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.69	Stable	MSKCC	Matched	70	NO	44.1	3.3	69.1	YES	745191
P-0000842-T02-IM5	P-0000842	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 13q13-13q14, 15q13-15q21, 16q23-16q24 and  17p12-17p13	395	20	PRAD	Not Available	0.40	Stable	MSKCC	Matched	66	NO	13.1	1	20.7	NO	NA
P-0000847-T01-IM3	P-0000847	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		585	50	PRAD	Not Available	0.32	Stable	MSKCC	Matched	61	NO	17.3	1.1	28.8	YES	478816
P-0000909-T03-IM3	P-0000909	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		461	NA	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	49	NO	29.2	2.2	47.7	NO	NA
P-0000912-T01-IM3	P-0000912	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		523	70	PRAD	Not Available	0.08	Stable	MSKCC	Matched	66	NO	29.9	2.2	49.5	YES	479502
P-0000931-T01-IM3	P-0000931	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		589	50	PRAD	Not Available	0.09	Stable	MSKCC	Matched	79	NO	17.3	1.1	28.8	YES	482108
P-0000935-T01-IM3	P-0000935	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341		578	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.37	Stable	MSKCC	Unmatched	82	NO	17.3	1.1	28.8	YES	482106
P-0000964-T01-IM3	P-0000964	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		618	70	PRAD	Not Available	0.59	Stable	MSKCC	Matched	52	NO	68	5.6	90.3	YES	478689
P-0000966-T02-IM3	P-0000966	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT341		537	30	PRAD	Not Available	0.17	Stable	MSKCC	Matched	68	NO	88.7	11.2	97	YES	746433
P-0000990-T02-IM3	P-0000990	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		457	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO				NO	NA
P-0001021-T01-IM3	P-0001021	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		1072	80	PRAD	Not Available	1.08	Stable	MSKCC	Matched	88	NO	68	5.6	90.3	YES	471407
P-0001092-T01-IM3	P-0001092	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		1068	50	PRAD	Not Available	1.28	Stable	MSKCC	Matched	55	NO	74.4	6.7	94	YES	744665
P-0001108-T01-IM3	P-0001108	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		737	50	PRAD	Not Available	0.38	Stable	MSKCC	Matched	56	NO	29.9	2.2	49.5	YES	744739
P-0001128-T01-IM3	P-0001128	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		373	35	PRAD	Not Available	0.17	Stable	MSKCC	Matched	64	NO	78.6	7.8	95.4	YES	500923
P-0001141-T01-IM3	P-0001141	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341		730	40	PRAD	Not Available	1.23	Stable	MSKCC	Matched	74	NO	44.1	3.3	69.1	YES	745278
P-0001153-T01-IM3	P-0001153	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		619	25	PRAD	Not Available	0.00	Stable	MSKCC	Matched	73	NO	58.6	4.5	83.5	YES	482713
P-0001187-T01-IM3	P-0001187	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		453	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.66	Stable	MSKCC	Matched	61	NO				YES	744904
P-0001202-T01-IM3	P-0001202	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		572	60	PRAD	Not Available	0.00	Stable	MSKCC	Matched	72	NO	44.1	3.3	69.1	YES	745602
P-0001204-T03-IM5	P-0001204	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT410		827	70	PRAD	Not Available	1.65	Stable	MSKCC	Matched	60	NO	37.9	3	60	YES	418296
P-0001206-T01-IM3	P-0001206	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		849	25	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.93	Stable	MSKCC	Matched	63	NO				YES	745727
P-0001221-T02-IM5	P-0001221	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q.	883	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.70	Stable	MSKCC	Matched	60	NO	13.1	1	20.7	YES	398114
P-0001230-T01-IM3	P-0001230	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341		515	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	MSKCC	Matched	65	NO	44.1	3.3	69.1	YES	482641
P-0001242-T02-IM3	P-0001242	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341		357	60	PRAD	Not Available	0.09	Stable	MSKCC	Matched	46	NO	29.9	2.2	49.5	YES	745871
P-0001244-T03-IM6	P-0001244	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		665	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.17	Stable	MSKCC	Matched	71	NO	25.2	1.8	41.8	YES	702597
P-0001247-T01-IM3	P-0001247	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341		566	60	PRAD	Not Available	1.12	Stable	MSKCC	Matched	50	NO	58.6	4.5	83.5	YES	745826
P-0001262-T01-IM3	P-0001262	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		443	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	57	NO	17.3	1.1	28.8	YES	745852
P-0001274-T01-IM3	P-0001274	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		731	30	PRAD	Not Available	0.26	Stable	MSKCC	Matched	68	NO	44.1	3.3	69.1	YES	745918
P-0001297-T01-IM3	P-0001297	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		597	40	PRAD	Not Available	0.19	Stable	MSKCC	Matched	71	NO	58.6	4.5	83.5	YES	745534
P-0001319-T05-IM5	P-0001319	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410		1206	80	PRAD	Not Available	2.39	Stable	MSKCC	Matched	52	NO	49.7	3.9	75.2	YES	397995
P-0001329-T01-IM3	P-0001329	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		153	40	PRAD	Not Available	0.74	Stable	MSKCC	Matched	73	NO	29.9	2.2	49.5	YES	745507
P-0001332-T02-IM3	P-0001332	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		550	50	PRAD	Not Available	0.30	Stable	MSKCC	Matched	51	NO	29.9	2.2	49.5	YES	741420
P-0001337-T01-IM3	P-0001337	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		441	35	PRAD	Not Available	0.26	Stable	MSKCC	Matched	52	NO	17.3	1.1	28.8	YES	741456
P-0001382-T01-IM3	P-0001382	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT341		619	15	PRAD	Not Available	0.00	Stable	MSKCC	Matched	73	NO	44.1	3.3	69.1	NO	NA
P-0001407-T01-IM3	P-0001407	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		461	15	PRAD	Not Available	1.35	Stable	MSKCC	Matched	62	NO	29.9	2.2	49.5	YES	754660
P-0001413-T01-IM3	P-0001413	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		403	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	45	NO				YES	754644
P-0001426-T01-IM3	P-0001426	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		829	70	PRAD	Not Available	0.95	Stable	MSKCC	Matched	71	NO	91.1	13.4	97.3	NO	NA
P-0001445-T01-IM3	P-0001445	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341		537	15	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.87	Stable	MSKCC	Matched	87	NO	44.1	3.3	69.1	YES	478869
P-0001446-T01-IM3	P-0001446	Prostate Cancer	Metastasis	Tumor	Kidney	Prostate	Prostate Adenocarcinoma	IMPACT341		674	40	PRAD	Not Available	2.41	Stable	MSKCC	Matched	70	NO	74.4	6.7	94	NO	NA
P-0001449-T02-IM5	P-0001449	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		807	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.56	Stable	MSKCC	Matched	59	NO	49.7	3.9	75.2	NO	NA
P-0001462-T01-IM3	P-0001462	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		392	30	PRAD	Not Available	2.11	Stable	MSKCC	Matched	58	NO	44.1	3.3	69.1	YES	754519
P-0001493-T01-IM3	P-0001493	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		966	30	PRAD	Not Available	0.07	Stable	MSKCC	Matched	64	NO	44.1	3.3	69.1	YES	754967
P-0001537-T01-IM3	P-0001537	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		469	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	MSKCC	Matched	65	NO				YES	500919
P-0001563-T01-IM3	P-0001563	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		678	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	66	NO				YES	754880
P-0001630-T01-IM3	P-0001630	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		383	30	PRAD	Not Available	2.47	Stable	MSKCC	Matched	63	NO	29.9	2.2	49.5	YES	482704
P-0001636-T01-IM3	P-0001636	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		375	15	PRAD	Not Available	2.29	Stable	MSKCC	Matched	70	NO	17.3	1.1	28.8	YES	1136839
P-0001639-T02-IM6	P-0001639	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 5q11-14 and 13q13-22. Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q11-21.	626	60	PRAD		0.88	Do not report	MSKCC	Matched	64	NO	25.2	1.8	41.8	YES	566375
P-0001684-T02-IM3	P-0001684	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		167	30	PRAD	Not Available	0.12	Stable	MSKCC	Matched	67	NO	17.3	1.1	28.8	YES	739441
P-0001694-T01-IM3	P-0001694	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		737	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	58	NO				YES	761038
P-0001697-T02-IM3	P-0001697	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341		247	NA	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.37	Stable	MSKCC	Matched	68	NO	43.0	3.3	67.1	YES	735016
P-0001698-T01-IM3	P-0001698	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT341		792	60	PRAD	Not Available	1.06	Stable	MSKCC	Matched	77	NO	68	5.6	90.3	YES	760753
P-0001717-T01-IM3	P-0001717	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT341		663	40	PRAD	Not Available	0.22	Stable	MSKCC	Matched	64	NO	17.3	1.1	28.8	YES	760746
P-0001768-T02-IM6	P-0001768	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arn 17q12-21.	876	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.45	Stable	MSKCC	Matched	57	NO	76.6	7.0	94.8	YES	678961
P-0001776-T01-IM3	P-0001776	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		530	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	62	NO	17.3	1.1	28.8	YES	881851
P-0001795-T01-IM3	P-0001795	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT341		1293	40	PRAD	Not Available	0.95	Stable	MSKCC	Matched	69	NO	29.9	2.2	49.5	YES	760686
P-0001822-T01-IM3	P-0001822	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		793	60	PRAD	Not Available	0.30	Stable	MSKCC	Matched	66	NO	17.3	1.1	28.8	YES	760696
P-0001829-T01-IM3	P-0001829	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		184	40	PRAD	Not Available	0.17	Stable	MSKCC	Matched	72	NO	29.9	2.2	49.5	YES	760716
P-0001845-T01-IM3	P-0001845	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		418	15	PRAD	Not Available	0.11	Stable	MSKCC	Matched	49	NO	44.1	3.3	69.1	YES	760935
P-0001859-T01-IM3	P-0001859	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		1139	40	PRAD	Not Available	0.09	Stable	MSKCC	Matched	81	NO	74.4	6.7	94	YES	748128
P-0001861-T01-IM3	P-0001861	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		509	11	PRAD	Not Available	0.00	Stable	MSKCC	Matched	59	NO	44.1	3.3	69.1	YES	760897
P-0001876-T02-IM5	P-0001876	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	379	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO				NO	NA
P-0001884-T01-IM3	P-0001884	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341		682	15	PRAD	Not Available	0.00	Stable	MSKCC	Matched	66	NO	85	8.9	96.4	YES	482698
P-0001895-T01-IM3	P-0001895	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		612	10	PRAD	Not Available	0.00	Stable	MSKCC	Matched	74	NO	58.6	4.5	83.5	YES	482699
P-0002101-T01-IM3	P-0002101	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		136	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.29	Stable	MSKCC	Matched	64	NO				YES	747593
P-0002123-T01-IM3	P-0002123	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		262	40	PRAD	Not Available	0.20	Stable	MSKCC	Matched	59	NO	17.3	1.1	28.8	YES	739905
P-0002149-T01-IM3	P-0002149	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		653	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	71	NO	29.9	2.2	49.5	YES	739814
P-0002196-T01-IM3	P-0002196	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		971	50	PRAD	Not Available	0.10	Stable	MSKCC	Matched	66	NO	44.1	3.3	69.1	YES	739626
P-0002206-T01-IM3	P-0002206	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		848	30	PRAD	Not Available	0.18	Stable	MSKCC	Matched	55	NO	29.9	2.2	49.5	NO	NA
P-0002223-T01-IM3	P-0002223	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		332	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	59	NO				YES	739696
P-0002273-T01-IM3	P-0002273	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		401	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.18	Stable	MSKCC	Matched	69	NO	43.0	3.3	67.1	YES	736502
P-0002289-T01-IM3	P-0002289	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		728	40	PRAD	Not Available	0.08	Stable	MSKCC	Matched	62	NO	44.1	3.3	69.1	YES	736494
P-0002303-T01-IM3	P-0002303	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		773	20	PRAD	Not Available	0.53	Stable	MSKCC	Unmatched	88	NO	74.4	6.7	94	YES	736524
P-0002304-T01-IM3	P-0002304	Prostate Cancer	Metastasis	Tumor	Testis	Prostate	Prostate Adenocarcinoma	IMPACT341		801	20	PRAD	Not Available	0.43	Stable	MSKCC	Matched	72	NO	68	5.6	90.3	YES	736517
P-0002306-T01-IM3	P-0002306	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		791	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	74	NO	44.1	3.3	69.1	YES	482707
P-0002314-T01-IM3	P-0002314	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		894	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	68	NO	29.9	2.2	49.5	YES	737526
P-0002333-T01-IM3	P-0002333	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		479	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	59	NO				YES	500943
P-0002334-T01-IM3	P-0002334	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		398	60	PRAD	Not Available	0.09	Stable	MSKCC	Matched	79	NO	17.3	1.1	28.8	YES	736056
P-0002364-T01-IM3	P-0002364	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		402	40	PRAD	Not Available	0.32	Stable	MSKCC	Matched	64	NO	44.1	3.3	69.1	YES	736171
P-0002375-T02-IM6	P-0002375	Prostate Cancer	Metastasis	Tumor	Muscle	Prostate	Prostate Adenocarcinoma	IMPACT468		699	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	MSKCC	Matched	68	NO	76.6	7	94.8	YES	1059990
P-0002382-T01-IM3	P-0002382	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		793	60	PRAD	Not Available	1.66	Stable	MSKCC	Matched	64	NO	58.6	4.5	83.5	YES	737588
P-0002397-T01-IM3	P-0002397	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		622	30	PRAD	Not Available	0.33	Stable	MSKCC	Matched	77	NO	44.1	3.3	69.1	YES	736066
P-0002398-T01-IM3	P-0002398	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		659	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	60	NO	44.1	3.3	69.1	YES	735995
P-0002431-T02-IM6	P-0002431	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		717	20	PRAD		0.00	Do not report	MSKCC	Matched	69	NO	25.2	1.8	41.8	YES	558157
P-0002432-T01-IM3	P-0002432	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341		724	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	59	NO				YES	736185
P-0002439-T01-IM3	P-0002439	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		458	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	68	NO	29.9	2.2	49.5	YES	500941
P-0002453-T01-IM3	P-0002453	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		411	NA	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	65	NO	17.1	1.1	28.3	YES	736257
P-0002499-T01-IM3	P-0002499	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	646	NA	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	52	NO	43.0	3.3	67.1	YES	735661
P-0002516-T01-IM3	P-0002516	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		1039	NA	PRAD	NA	-1	Do not report	MSKCC	Unmatched	66	NO	17.1	1.1	28.3	YES	735899
P-0002537-T02-IM5	P-0002537	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		669	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.38	Stable	MSKCC	Matched	77	NO	25.2	2	41.8	NO	NA
P-0002564-T01-IM3	P-0002564	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	Prostate acinar adenocarcinoma not PDA	468	50	PRAD	Not Available	0.29	Stable	MSKCC	Matched	81	NO	17.3	1.1	28.8	YES	735586
P-0002583-T01-IM3	P-0002583	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	Acinar not ductal	495	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	50	NO				YES	735567
P-0002612-T02-IM6	P-0002612	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of adequate tumor content. More comprehensive testing could be valuable.	413	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO				YES	980889
P-0002739-T03-IM6	P-0002739	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT468		706	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.81	Stable	MSKCC	Matched	61	NO	0.0	0.0	0.0	NO	NA
P-0002740-T01-IM3	P-0002740	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		271	20	PRAD	Not Available	0.86	Stable	MSKCC	Matched	62	NO	58.6	4.5	83.5	YES	734971
P-0002796-T01-IM3	P-0002796	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		281	20	PRAD	Not Available	0.11	Stable	MSKCC	Matched	66	NO	44.1	3.3	69.1	YES	735618
P-0002840-T02-IM3	P-0002840	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341	add back BAP1 p.R227C . This is a met from Run15-003    Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	767	60	PRAD	Not Available	0.16	Stable	MSKCC	Matched	59	NO	44.1	3.3	69.1	NO	NA
P-0002880-T01-IM3	P-0002880	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		528	30	PRAD	Not Available	0.17	Stable	MSKCC	Matched	70	NO	17.3	1.1	28.8	NO	NA
P-0002894-T01-IM3	P-0002894	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT341		663	50	PRAD	Not Available	0.98	Stable	MSKCC	Matched	61	NO	17.3	1.1	28.8	NO	NA
P-0002895-T01-IM3	P-0002895	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	181	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	76	NO				NO	NA
P-0002897-T01-IM3	P-0002897	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		159	40	PRAD	Not Available	0.32	Stable	MSKCC	Matched	74	NO	44.1	3.3	69.1	NO	NA
P-0002898-T02-IM5	P-0002898	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 16q, 17p and 18q      Note: The EPHA7 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	576	80	PRAD	Not Available	0.23	Stable	MSKCC	Matched	64	NO	68	5.9	90.4	NO	NA
P-0002901-T01-IM3	P-0002901	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		364	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.56	Stable	MSKCC	Matched	68	NO	29.9	2.2	49.5	NO	NA
P-0002959-T02-IM5	P-0002959	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		654	60	PRAD	Not Available	0.08	Stable	MSKCC	Matched	75	NO	37.9	3	60	NO	NA
P-0002961-T01-IM3	P-0002961	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	Note: The PTEN copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	424	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	52	NO	29.9	2.2	49.5	NO	NA
P-0002962-T01-IM3	P-0002962	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	Note: The BRCA2 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	803	60	PRAD	Not Available	0.09	Stable	MSKCC	Matched	65	NO	58.6	4.5	83.5	YES	482744
P-0002971-T02-IM5	P-0002971	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		623	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	72	NO	25.2	2	41.8	NO	NA
P-0002974-T01-IM3	P-0002974	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		967	70	PRAD	Not Available	1.49	Stable	MSKCC	Matched	70	NO	17.3	1.1	28.8	NO	NA
P-0002984-T01-IM3	P-0002984	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT341	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13q and Xp.	637	50	PRAD	Not Available	1.19	Stable	MSKCC	Matched	79	NO	68	5.6	90.3	NO	NA
P-0002990-T01-IM3	P-0002990	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		702	70	PRAD	Not Available	0.00	Stable	MSKCC	Matched	58	NO	29.9	2.2	49.5	NO	NA
P-0002999-T01-IM3	P-0002999	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	Note: A comparison of variant frequencies suggests the EGFR p.R252H mutation is subclonal.	468	70	PRAD	Not Available	0.39	Stable	MSKCC	Matched	72	NO	58.6	4.5	83.5	NO	NA
P-0003001-T01-IM3	P-0003001	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		410	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO				NO	NA
P-0003023-T01-IM3	P-0003023	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	741	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	58	NO	29.9	2.2	49.5	YES	500922
P-0003026-T01-IM3	P-0003026	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	532	20	PRAD	Not Available	0.0	Stable	MSKCC	Unmatched	55	NO				YES	500924
P-0003028-T01-IM3	P-0003028	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	577	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	60	NO	29.9	2.2	49.5	NO	NA
P-0003033-T02-IM5	P-0003033	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		596	50	PRAD	Not Available	0.54	Stable	MSKCC	Matched	59	NO	37.9	3	60	NO	NA
P-0003037-T01-IM5	P-0003037	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	644	30	PRAD	Not Available	0.17	Stable	MSKCC	Matched	65	NO	13.1	1	20.7	NO	NA
P-0003040-T01-IM5	P-0003040	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.      Note: The ERBB3 and GLI1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	791	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.12	Stable	MSKCC	Matched	85	NO	37.9	3	60	NO	NA
P-0003052-T01-IM5	P-0003052	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		382	40	PRAD	Not Available	0.16	Stable	MSKCC	Matched	68	NO	25.2	2	41.8	NO	NA
P-0003061-T01-IM5	P-0003061	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	236	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	61	NO				NO	NA
P-0003101-T03-IM5	P-0003101	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of focal Chromosome arm level gain and multiple Chromosome arm level losses.	1013	80	PRAD	Not Available	1.23	Stable	MSKCC	Matched	72	NO	59.8	4.9	84.1	YES	414500
P-0003139-T02-IM5	P-0003139	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		918	70	PRAD	Not Available	1.59	Stable	MSKCC	Matched	77	NO	13.1	1	20.7	NO	NA
P-0003150-T01-IM5	P-0003150	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		221	60	PRAD	Not Available	0.41	Stable	MSKCC	Matched	68	NO	25.2	2	41.8	NO	NA
P-0003226-T01-IM5	P-0003226	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		459	20	PRAD	Not Available	0.66	Stable	MSKCC	Matched	63	NO	37.9	3	60	NO	NA
P-0003390-T01-IM5	P-0003390	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		201	60	PRAD	Not Available	0.25	Stable	MSKCC	Matched	69	NO	25.2	2	41.8	YES	500942
P-0003395-T01-IM5	P-0003395	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		441	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.66	Stable	MSKCC	Matched	77	NO	25.2	2	41.8	NO	NA
P-0003400-T01-IM5	P-0003400	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20%). Negative results should be interpreted with caution.	669	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	77	NO	59.8	4.9	84.1	NO	NA
P-0003419-T02-IM5	P-0003419	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The PTEN copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	763		PRAD	Not Available	0.00	Stable	MSKCC	Matched	67	NO	37.9	3	60	NO	NA
P-0003442-T02-IM5	P-0003442	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome..	578	80	PRAD	Not Available	2.15	Stable	MSKCC	Matched	80	NO	49.7	3.9	75.2	NO	NA
P-0003450-T01-IM5	P-0003450	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome..	715	70	PRAD	Not Available	1.18	Stable	MSKCC	Matched	86	NO	37.9	3	60	NO	NA
P-0003468-T02-IM5	P-0003468	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.    Note: The PTEN, TP63, FOXP1 and RYBP copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	382	60	PRAD	Not Available	0.62	Stable	MSKCC	Matched	59	NO	59.8	4.9	84.1	NO	NA
P-0003504-T02-IM5	P-0003504	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	463	10	PRAD	Not Available	0.42	Stable	MSKCC	Matched	80	NO	37.9	3	60	NO	NA
P-0003506-T01-IM5	P-0003506	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	521	50	PRAD	Not Available	0.16	Stable	MSKCC	Matched	69	NO	25.2	2	41.8	NO	NA
P-0003511-T01-IM5	P-0003511	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		624	30	PRAD	Not Available	0.37	Stable	MSKCC	Matched	73	NO	37.9	3	60	NO	NA
P-0003519-T01-IM5	P-0003519	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	409	10	PRAD	Not Available	0.09	Stable	MSKCC	Matched	55	NO	25.2	2	41.8	NO	NA
P-0003525-T01-IM5	P-0003525	Prostate Cancer	Metastasis	Tumor	Pleura	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	476	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	74	NO				NO	NA
P-0003535-T01-IM5	P-0003535	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome..	921	80	PRAD	Not Available	1.16	Stable	MSKCC	Matched	76	NO	25.2	2	41.8	NO	NA
P-0003538-T01-IM5	P-0003538	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	632	60	PRAD	Not Available	0.75	Stable	MSKCC	Matched	68	NO	37.9	3	60	NO	NA
P-0003541-T01-IM5	P-0003541	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		572	30	PRAD	Not Available	1.52	Stable	MSKCC	Matched	52	NO	37.9	3	60	NO	NA
P-0003556-T01-IM5	P-0003556	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		393	30	PRAD	Not Available	0.08	Stable	MSKCC	Matched	73	NO	37.9	3	60	YES	482716
P-0003592-T01-IM5	P-0003592	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		404	60	PRAD	Not Available	0.16	Stable	MSKCC	Matched	75	NO	37.9	3	60	NO	NA
P-0003597-T01-IM5	P-0003597	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		218	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.62	Stable	MSKCC	Matched	69	NO	49.7	3.9	75.2	NO	NA
P-0003602-T01-IM5	P-0003602	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		459	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	65	NO	37.9	3	60	NO	NA
P-0003605-T01-IM5	P-0003605	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	481	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	65	NO				YES	500926
P-0003616-T01-IM5	P-0003616	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		142	60	PRAD	Not Available	0.78	Stable	MSKCC	Matched	75	NO	49.7	3.9	75.2	NO	NA
P-0003619-T01-IM5	P-0003619	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT410		472	80	PRAD	Not Available	1.21	Stable	MSKCC	Matched	62	NO	25.2	2	41.8	NO	NA
P-0003625-T01-IM5	P-0003625	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The GATA2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	455	70	PRAD	Not Available	1.37	Stable	MSKCC	Matched	63	NO	74.4	6.9	94.1	NO	NA
P-0003626-T01-IM5	P-0003626	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	575	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.88	Stable	MSKCC	Matched	68	NO				NO	NA
P-0003637-T01-IM5	P-0003637	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		344	60	PRAD	Not Available	0.08	Stable	MSKCC	Matched	68	NO	37.9	3	60	YES	482725
P-0003655-T01-IM5	P-0003655	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		591	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.48	Stable	MSKCC	Matched	61	NO	13.1	1	20.7	NO	NA
P-0003678-T02-IM6	P-0003678	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		646	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.16	Stable	MSKCC	Matched	79	NO	79.1	7.9	95.5	YES	1091879
P-0003684-T02-IM6	P-0003684	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q21-1q23.	772	40	PRAD		0.42	Do not report	MSKCC	Matched	66	YES	13.1	0.9	20.6	YES	526150
P-0003689-T01-IM5	P-0003689	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	103	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.10	Stable	MSKCC	Matched	71	NO				NO	NA
P-0003695-T01-IM5	P-0003695	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		294	30	PRAD	Not Available	0.09	Stable	MSKCC	Matched	74	NO	49.7	3.9	75.2	YES	482738
P-0003741-T01-IM5	P-0003741	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		231	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	70	NO	25.2	2	41.8	NO	NA
P-0003799-T01-IM5	P-0003799	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	510	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	61	NO	25.2	2	41.8	NO	NA
P-0003852-T01-IM5	P-0003852	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The EZH2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	541	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	53	NO	37.9	3	60	YES	482691
P-0003856-T01-IM5	P-0003856	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The NBN copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	329	70	PRAD	Not Available	0.00	Stable	MSKCC	Matched	58	NO	13.1	1	20.7	NO	NA
P-0003908-T01-IM3	P-0003908	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT341		704	70	PRAD	Not Available	0.00	Stable	MSKCC	Matched	71	NO	29.9	2.2	49.5	YES	478137
P-0003925-T01-IM3	P-0003925	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT341		670	60	PRAD	Not Available	0.00	Stable	MSKCC	Matched	73	NO	58.6	4.5	83.5	NO	NA
P-0003939-T01-IM3	P-0003939	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT341		894	60	PRAD	Not Available	0.08	Stable	MSKCC	Matched	64	NO	44.1	3.3	69.1	YES	473354
P-0003945-T01-IM3	P-0003945	Prostate Cancer	Metastasis	Tumor	Bladder Neck	Prostate	Prostate Adenocarcinoma	IMPACT341		534	90	PRAD	Not Available	0.09	Stable	MSKCC	Matched	83	NO	29.9	2.2	49.5	YES	478147
P-0003971-T02-IM5	P-0003971	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low sequencing depth of coverage of 102X, negative results should be interpreted with caution.	102	30	PRAD	Not Available	0.80	Stable	MSKCC	Matched	69	NO	25.2	2	41.8	NO	NA
P-0003993-T01-IM5	P-0003993	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		602	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.26	Stable	MSKCC	Matched	54	NO				NO	NA
P-0004039-T01-IM5	P-0004039	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	113	30	PRAD	Not Available	1.53	Stable	MSKCC	Matched	83	NO	25.2	2	41.8	NO	NA
P-0004061-T02-IM5	P-0004061	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 19p.          Note: The H3F3C,PIK3C2G,KRAS,ETV6,CDKN1B,NEGR1,FUBP1,EPHA7  copy number loss fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	716	50	PRAD	Not Available	0.90	Stable	MSKCC	Matched	74	NO	25.2	2	41.8	NO	NA
P-0004063-T01-IM5	P-0004063	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		224	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	73	NO	49.7	3.9	75.2	NO	NA
P-0004138-T02-IM6	P-0004138	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome..	538	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.94	Stable	MSKCC	Matched	63	NO	37.9	2.6	59.9	YES	757664
P-0004221-T01-IM5	P-0004221	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		426	30	PRAD	Not Available	0.07	Stable	MSKCC	Matched	60	NO	13.1	1	20.7	NO	NA
P-0004231-T01-IM5	P-0004231	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		951	60	PRAD	Not Available	3.14	Indeterminate	MSKCC	Matched	51	NO	13.1	1	20.7	NO	NA
P-0004243-T01-IM5	P-0004243	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome..	358	70	PRAD	Not Available	0.34	Stable	MSKCC	Matched	74	NO	59.8	4.9	84.1	NO	NA
P-0004283-T01-IM5	P-0004283	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low sequencing depth of coverage of 153X, negative results should be interpreted with caution.	153	40	PRAD	Not Available	1.06	Stable	MSKCC	Matched	78	NO				NO	NA
P-0004285-T01-IM5	P-0004285	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		471	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	60	NO	59.8	4.9	84.1	NO	NA
P-0004290-T03-IM5	P-0004290	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	797	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.11	Stable	MSKCC	Matched	52	NO	25.6	2.0	41.7	YES	500927
P-0004297-T02-IM5	P-0004297	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	160	30	PRAD	Not Available	0.59	Stable	MSKCC	Matched	63	NO	13.1	1	20.7	YES	416620
P-0004311-T01-IM5	P-0004311	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Variants in PTEN M198*  indicates the presence of sub-clones	387	50	PRAD	Not Available	1.19	Stable	MSKCC	Matched	68	NO	49.7	3.9	75.2	NO	NA
P-0004312-T01-IM5	P-0004312	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410		388	40	PRAD	Not Available	1.44	Stable	MSKCC	Matched	75	NO	68	5.9	90.4	NO	NA
P-0004325-T01-IM5	P-0004325	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	671	20	PRAD	Not Available	0.07	Stable	MSKCC	Matched	72	NO	13.1	1	20.7	NO	NA
P-0004343-T01-IM5	P-0004343	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	426	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	59	NO				NO	NA
P-0004345-T01-IM5	P-0004345	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		497	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	50	NO				YES	471076
P-0004355-T01-IM5	P-0004355	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The MCL1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	277	40	PRAD	Not Available	0.17	Stable	MSKCC	Matched	55	NO	37.9	3	60	NO	NA
P-0004389-T01-IM5	P-0004389	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		508	60	PRAD	Not Available	0.08	Stable	MSKCC	Matched	57	NO	13.1	1	20.7	NO	NA
P-0004435-T01-IM5	P-0004435	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		583	40	PRAD	Not Available	0.07	Stable	MSKCC	Matched	72	NO	49.7	3.9	75.2	YES	482759
P-0004448-T01-IM5	P-0004448	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		612	50	PRAD	Not Available	0.22	Stable	MSKCC	Matched	71	NO	13.1	1	20.7	NO	NA
P-0004482-T01-IM5	P-0004482	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p.	696	60	PRAD	Not Available	0.42	Stable	MSKCC	Matched	71	NO	13.1	1	20.7	NO	NA
P-0004489-T01-IM5	P-0004489	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome..	484	40	PRAD	Not Available	0.06	Stable	MSKCC	Matched	76	NO	59.8	4.9	84.1	NO	NA
P-0004508-T01-IM5	P-0004508	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The MLL2 p.R4468fs and p.L4462_L4466delinsQ mutations all occur in cis (same allele).	890	30	PRAD	Not Available	0.30	Stable	MSKCC	Matched	70	NO	59.8	4.9	84.1	YES	482749
P-0004514-T01-IM5	P-0004514	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		696	40	PRAD	Not Available	0.18	Stable	MSKCC	Matched	59	NO	59.8	4.9	84.1	NO	NA
P-0004522-T01-IM5	P-0004522	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	107	40	PRAD	Not Available	0.83	Stable	MSKCC	Matched	65	NO	59.8	4.9	84.1	YES	937838
P-0004526-T01-IM5	P-0004526	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	718	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	78	NO	25.2	2	41.8	YES	482686
P-0004532-T01-IM5	P-0004532	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		309	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.51	Stable	MSKCC	Matched	75	NO				NO	NA
P-0004538-T01-IM5	P-0004538	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		698	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	83	NO	13.1	1	20.7	YES	482712
P-0004539-T01-IM5	P-0004539	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		682	30	PRAD	Not Available	0.64	Stable	MSKCC	Matched	62	NO	49.7	3.9	75.2	NO	NA
P-0004556-T01-IM5	P-0004556	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	739	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	77	NO	37.9	3	60	NO	NA
P-0004593-T01-IM5	P-0004593	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The RASA1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	230	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.01	Stable	MSKCC	Matched	74	NO	85.9	9.8	96.2	NO	NA
P-0004594-T01-IM5	P-0004594	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		358	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	85	NO	37.9	3	60	YES	482768
P-0004597-T02-IM5	P-0004597	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		775	20	PRAD	Not Available	0.08	Stable	MSKCC	Matched	79	NO	37.9	3	60	NO	NA
P-0004600-T01-IM5	P-0004600	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		1047	40	PRAD	Not Available	2.84	Stable	MSKCC	Matched	60	NO	59.8	4.9	84.1	NO	NA
P-0004634-T01-IM5	P-0004634	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		700	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	69	NO				NO	NA
P-0004675-T01-IM5	P-0004675	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		742	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	61	NO	13.1	1	20.7	NO	NA
P-0004704-T01-IM5	P-0004704	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		433	40	PRAD	Not Available	0.81	Stable	MSKCC	Matched	82	NO	49.7	3.9	75.2	NO	NA
P-0004735-T01-IM5	P-0004735	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		581	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO	49.6	3.9	74.0	NO	NA
P-0004756-T01-IM5	P-0004756	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		384	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	66	NO	25.2	2	41.8	YES	482673
P-0004797-T01-IM5	P-0004797	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	494	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO				NO	NA
P-0004816-T01-IM5	P-0004816	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low sequencing depth of coverage of 181X, negative results should be interpreted with caution.	181	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.65	Stable	MSKCC	Matched	70	NO				NO	NA
P-0004826-T01-IM5	P-0004826	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: A comparison of variant frequencies suggests the MLL3 p.N4854_V4856delinsS mutation is subclonal.	681	40	PRAD	Not Available	0.16	Stable	MSKCC	Matched	72	NO	37.9	3	60	NO	NA
P-0004830-T01-IM5	P-0004830	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		412	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.33	Stable	MSKCC	Matched	80	NO	37.9	3	60	NO	NA
P-0004892-T01-IM5	P-0004892	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The MLL3 exon36 mutations all occur in cis (same allele).	904	40	PRAD	Not Available	0.07	Stable	MSKCC	Matched	67	NO	89.2	11.8	97.2	NO	NA
P-0004910-T02-IM5	P-0004910	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		316	60	PRAD	Not Available	2.44	Stable	MSKCC	Matched	64	NO	68	5.9	90.4	NO	NA
P-0004946-T01-IM5	P-0004946	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		565	40	PRAD	Not Available	0.18	Stable	MSKCC	Matched	74	NO	37.9	3	60	NO	NA
P-0005014-T01-IM5	P-0005014	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arm 5q11-5q13 and 6q15-6p22.     Note: The ETV6, CDKN1B, PMAIP1, and BCL2 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	759	60	PRAD	Not Available	1.45	Stable	MSKCC	Matched	79	NO	37.9	3	60	YES	482658
P-0005045-T01-IM5	P-0005045	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The PIK3C2G copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	412	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.00	Stable	MSKCC	Matched	74	NO	13.1	1	20.7	NO	NA
P-0005047-T01-IM5	P-0005047	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		856	30	PRAD	Not Available	0.56	Stable	MSKCC	Matched	65	NO	49.7	3.9	75.2	NO	NA
P-0005050-T01-IM5	P-0005050	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		802	80	PRAD	Not Available	1.06	Stable	MSKCC	Matched	68	NO	37.9	3	60	YES	482666
P-0005052-T02-IM5	P-0005052	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		344	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.10	Stable	MSKCC	Matched	53	NO				NO	NA
P-0005065-T02-IM5	P-0005065	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		395	60	PRAD	Not Available	0.25	Stable	MSKCC	Matched	63	NO	68	5.9	90.4	NO	NA
P-0005078-T01-IM5	P-0005078	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		319	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.32	Stable	MSKCC	Matched	67	NO	68	5.9	90.4	NO	NA
P-0005081-T01-IM5	P-0005081	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		319	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	68	NO				NO	NA
P-0005098-T01-IM5	P-0005098	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		422	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.00	Stable	MSKCC	Matched	53	NO	13.1	1	20.7	NO	NA
P-0005111-T01-IM5	P-0005111	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		566	30	PRAD	Not Available	2.15	Stable	MSKCC	Matched	63	NO	59.8	4.9	84.1	NO	NA
P-0005147-T01-IM5	P-0005147	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		512	60	PRAD	Not Available	0.00	Stable	MSKCC	Matched	72	NO	25.2	2	41.8	NO	NA
P-0005213-T01-IM5	P-0005213	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	674	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO	37.9	3	60	YES	482681
P-0005216-T01-IM5	P-0005216	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		870	10	PRAD	Not Available	2.33	Stable	MSKCC	Matched	74	NO	74.4	6.9	94.1	YES	482660
P-0005217-T03-IM5	P-0005217	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	855	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	MSKCC	Matched	58	NO	25.6	2.0	41.7	NO	NA
P-0005324-T01-IM5	P-0005324	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	361	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.20	Stable	MSKCC	Matched	69	NO				NO	NA
P-0005344-T01-IM5	P-0005344	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		607	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.75	Stable	MSKCC	Matched	64	NO	37.9	3	60	NO	NA
P-0005348-T01-IM5	P-0005348	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		717	10	PRAD	Not Available	0.30	Stable	MSKCC	Matched	78	NO	13.1	1	20.7	NO	NA
P-0005374-T01-IM5	P-0005374	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome..      Note: The SF3B1 and MYC copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	2148	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.97	Stable	MSKCC	Matched	75	NO	59.8	4.9	84.1	NO	NA
P-0005422-T01-IM5	P-0005422	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	650	10	PRAD	Not Available	0.00	Stable	MSKCC	Matched	69	NO	59.8	4.9	84.1	NO	NA
P-0005428-T01-IM5	P-0005428	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.        Note: Copy number profile is suggestive of broad copy number gains on Chromosome X and  Chromosome arms 8q and17q	542	40	PRAD	Not Available	0.59	Stable	MSKCC	Matched	74	NO	59.8	4.9	84.1	NO	NA
P-0005436-T02-IM5	P-0005436	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		1079	80	PRAD	Not Available	0.23	Stable	MSKCC	Matched	66	NO	37.9	3	60	YES	427767
P-0005445-T03-IM6	P-0005445	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		1050	60	PRAD		0.21	Do not report	MSKCC	Matched	72	NO	37.9	2.6	59.9	YES	497672
P-0005454-T02-IM5	P-0005454	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 3p13-21, 4q13-24, 10q24-26, 15q22-26, 16q, and Xq13-22. Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 8q21-24, 11q, and 15q13-21.	1053	80	PRAD	Not Available	1.47	Stable	MSKCC	Matched	63	NO	59.8	4.9	84.1	NO	NA
P-0005459-T01-IM5	P-0005459	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410		907	60	PRAD	Not Available	0.58	Stable	MSKCC	Matched	83	NO	59.8	4.9	84.1	NO	NA
P-0005460-T01-IM5	P-0005460	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		889	30	PRAD	Not Available	0.24	Stable	MSKCC	Matched	73	NO	25.2	2	41.8	YES	482734
P-0005463-T01-IM5	P-0005463	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	716	20	PRAD	Not Available	0.0	Stable	MSKCC	Matched	59	NO	13.1	1	20.7	NO	NA
P-0005503-T01-IM5	P-0005503	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	841	10	PRAD	Not Available	0.07	Stable	MSKCC	Matched	71	NO				NO	NA
P-0005535-T01-IM5	P-0005535	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.     Note: The CDKN1B exon 1 mutations all occur in cis (same allele).	910	50	PRAD	Not Available	0.31	Stable	MSKCC	Matched	62	NO	68	5.9	90.4	NO	NA
P-0005546-T01-IM5	P-0005546	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		861	20	PRAD	Not Available	0.17	Stable	MSKCC	Matched	81	NO	25.2	2	41.8	NO	NA
P-0005552-T01-IM5	P-0005552	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		667	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	76	NO	13.1	1	20.7	NO	NA
P-0005555-T01-IM5	P-0005555	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The CDK12 exon1 mutations all occur in cis (same allele).      Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13q including BRCA2 and RB1.	1119	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.10	Stable	MSKCC	Matched	66	NO	49.7	3.9	75.2	NO	NA
P-0005557-T01-IM5	P-0005557	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		762	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	56	NO				NO	NA
P-0005570-T01-IM5	P-0005570	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Assessment of the copy number profile is somewhat limited by increased background noise. False negatives cannot be ruled out.	529	40	PRAD	Not Available	0.09	Stable	MSKCC	Matched	78	NO	37.9	3	60	NO	NA
P-0005571-T01-IM5	P-0005571	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Negative results should be interpreted with caution.	291	60	PRAD	Not Available	0.18	Stable	MSKCC	Matched	57	NO	13.1	1	20.7	NO	NA
P-0005596-T01-IM5	P-0005596	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The RET, RB1, FOXO1, PLCG2 and FANCA copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	937	50	PRAD	Not Available	0.95	Stable	MSKCC	Matched	71	NO				NO	NA
P-0005630-T01-IM5	P-0005630	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		542	30	PRAD	Not Available	0.17	Stable	MSKCC	Matched	44	NO	49.7	3.9	75.2	NO	NA
P-0005636-T01-IM5	P-0005636	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The EPHA3 and AR copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1073	40	PRAD	Not Available	0.61	Stable	MSKCC	Matched	70	NO	49.7	3.9	75.2	NO	NA
P-0005639-T01-IM5	P-0005639	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		346	30	PRAD	Not Available	0.68	Stable	MSKCC	Matched	62	NO	49.7	3.9	75.2	NO	NA
P-0005649-T01-IM5	P-0005649	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	627	10	PRAD	Not Available	0.43	Stable	MSKCC	Matched	56	NO				NO	NA
P-0005692-T01-IM5	P-0005692	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		965	20	PRAD	MICROSATELLITE STABLE (MSS). See note.	0.0	Stable	MSKCC	Matched	73	NO	59.6	4.9	83.1	YES	482763
P-0005697-T03-IM5	P-0005697	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The ZFHX3 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	654	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.16	Stable	MSKCC	Matched	69	NO	25.6	2.0	41.7	NO	NA
P-0005698-T01-IM5	P-0005698	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		687	30	PRAD	Not Available	0.30	Stable	MSKCC	Matched	79	NO	13.1	1	20.7	NO	NA
P-0005713-T01-IM5	P-0005713	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	324	80	PRAD	Not Available	0.24	Stable	MSKCC	Matched	81	NO	49.7	3.9	75.2	NO	NA
P-0005756-T01-IM5	P-0005756	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 17p13 including TP53.      Note: The ATRX and MED12 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1188		PRAD	Not Available	2.62	Stable	MSKCC	Matched	83	NO	37.9	3	60	NO	NA
P-0005760-T01-IM5	P-0005760	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		675	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	66	NO	13.1	1	20.7	NO	NA
P-0005761-T01-IM5	P-0005761	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		936	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	78	NO	59.8	4.9	84.1	NO	NA
P-0005768-T02-IM5	P-0005768	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		527	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.00	Stable	MSKCC	Matched	78	NO	38.1	3.0	59.9	NO	NA
P-0005771-T02-IM5	P-0005771	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The FGFR1 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: Copy number profile is suggestive of broad copy number loss on Chromosome 6p22-25.	548	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.62	Stable	MSKCC	Matched	67	NO	38.1	3.0	59.9	NO	NA
P-0005774-T01-IM5	P-0005774	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		475	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	57	NO	37.9	3	60	NO	NA
P-0005787-T01-IM5	P-0005787	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		735	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	MSKCC	Matched	65	NO	37.9	3	60	NO	NA
P-0005802-T01-IM5	P-0005802	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		854	50	PRAD	Not Available	0.21	Stable	MSKCC	Matched	74	NO	25.2	2	41.8	NO	NA
P-0005804-T01-IM5	P-0005804	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		699	60	PRAD	Not Available	0.08	Stable	MSKCC	Matched	67	NO	25.2	2	41.8	YES	482755
P-0005806-T01-IM5	P-0005806	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		484	50	PRAD	Not Available	0.88	Stable	MSKCC	Matched	51	NO	25.2	2	41.8	NO	NA
P-0005810-T01-IM5	P-0005810	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		974	30	PRAD	Not Available	0.14	Stable	MSKCC	Matched	77	NO	25.2	2	41.8	YES	482654
P-0005811-T01-IM5	P-0005811	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1069	80	PRAD	Not Available	0.27	Stable	MSKCC	Matched	62	NO	25.2	2	41.8	NO	NA
P-0005864-T01-IM5	P-0005864	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		907	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	59	NO	37.9	3	60	NO	NA
P-0005867-T01-IM5	P-0005867	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		843	20	PRAD	Not Available	0.26	Stable	MSKCC	Matched	60	NO	74.4	6.9	94.1	NO	NA
P-0005890-T01-IM5	P-0005890	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	723	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	76	NO	13.1	1	20.7	NO	NA
P-0005902-T01-IM5	P-0005902	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: A comparison of variant frequencies suggests the CTNNB1 (p.S33A), CDK12 (p.T1463fs), and MLL2 (p.R5154Q) mutations are subclonal.	385	80	PRAD	Not Available	0.12	Stable	MSKCC	Matched	64	NO	59.8	4.9	84.1	NO	NA
P-0005933-T01-IM5	P-0005933	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The APC and RASA1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: The ZRSR2 and EIF1AX copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	836	70	PRAD	Not Available	0.43	Stable	MSKCC	Matched	71	NO	13.1	1	20.7	NO	NA
P-0005953-T01-IM5	P-0005953	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		982	70	PRAD	Not Available	1.63	Stable	MSKCC	Matched	54	NO	25.2	2	41.8	NO	NA
P-0005956-T01-IM5	P-0005956	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		785	80	PRAD	Not Available	0.08	Stable	MSKCC	Matched	61	NO	13.1	1	20.7	NO	NA
P-0005970-T02-IM5	P-0005970	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 16q and 18q. Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 5p, 7p, 8q, 16p13, and 17q22-25.	855	90	PRAD	Not Available	0.82	Stable	MSKCC	Matched	77	NO	37.9	3	60	YES	427875
P-0005976-T01-IM5	P-0005976	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		1409	80	PRAD	Not Available	3.53	Indeterminate	MSKCC	Matched	77	NO	49.7	3.9	75.2	NO	NA
P-0006029-T01-IM5	P-0006029	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		713	60	PRAD	Not Available	0.09	Stable	MSKCC	Matched	76	NO	74.4	6.9	94.1	NO	NA
P-0006057-T01-IM5	P-0006057	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	872	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	52	NO	25.2	2	41.8	NO	NA
P-0006099-T01-IM5	P-0006099	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	818	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	65	NO				NO	NA
P-0006108-T01-IM5	P-0006108	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		954	30	PRAD	Not Available	0.15	Stable	MSKCC	Matched	52	NO	37.9	3	60	NO	NA
P-0006128-T01-IM5	P-0006128	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		996	20	PRAD	Not Available	0.14	Stable	MSKCC	Matched	53	NO	25.2	2	41.8	NO	NA
P-0006212-T02-IM6	P-0006212	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		398	40	PRAD	MICROSATELLITE INSTABILITY-INDETERMINATE. This result is for investigational use only. See MSI note below.	3.34	Indeterminate	MSKCC	Matched	83	NO	13.1	0.9	20.6	YES	638008
P-0006226-T01-IM5	P-0006226	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		919	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	73	NO				NO	NA
P-0006231-T01-IM5	P-0006231	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410		1089	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.40	Stable	MSKCC	Matched	77	NO	59.8	4.9	84.1	NO	NA
P-0006247-T01-IM5	P-0006247	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		730	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	56	NO	13.1	1	20.7	NO	NA
P-0006346-T01-IM5	P-0006346	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		525	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	MSKCC	Matched	66	NO				NO	NA
P-0006378-T01-IM5	P-0006378	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		818	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	MSKCC	Matched	65	NO	37.9	3	60	NO	NA
P-0006379-T01-IM5	P-0006379	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	620	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	67	NO	49.7	3.9	75.2	NO	NA
P-0006389-T01-IM5	P-0006389	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low sequencing depth of coverage of 111, negative results should be interpreted with caution.	111	20	PRAD	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	3.49	Indeterminate	MSKCC	Matched	71	NO				NO	NA
P-0006393-T01-IM5	P-0006393	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low sequencing depth of coverage of 78X, negative results should be interpreted with caution.      Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	78	70	PRAD	Not Available	2.63	Stable	MSKCC	Matched	85	NO	37.9	3	60	NO	NA
P-0006440-T01-IM5	P-0006440	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		898	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	61	NO	13.1	1	20.7	NO	NA
P-0006461-T01-IM5	P-0006461	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The NBN, RAD21, MYC copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	799	30	PRAD	Not Available	0.08	Stable	MSKCC	Matched	75	NO	85	8.9	96.4	NO	NA
P-0006508-T01-IM5	P-0006508	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	217	70	PRAD	Not Available	1.65	Stable	MSKCC	Matched	63	NO	13.1	1	20.7	NO	NA
P-0006573-T01-IM5	P-0006573	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		235	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.88	Stable	MSKCC	Matched	67	NO				NO	NA
P-0006574-T01-IM5	P-0006574	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		589	70	PRAD	Not Available	0.09	Stable	MSKCC	Matched	64	NO	49.7	3.9	75.2	YES	482718
P-0006584-T01-IM5	P-0006584	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		618	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.53	Stable	MSKCC	Matched	77	NO	38.1	3.0	59.9	NO	NA
P-0006595-T01-IM5	P-0006595	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 13q and 16q.      Note: The ERBB4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	1175	70	PRAD	Not Available	1.43	Stable	MSKCC	Matched	66	NO	74.4	6.9	94.1	NO	NA
P-0006602-T03-IM6	P-0006602	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		545	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.58	Stable	MSKCC	Matched	71	NO	54.1	4.4	79.3	YES	727366
P-0006603-T01-IM5	P-0006603	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		658		PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	3.00	Stable	MSKCC	Matched	62	NO	13.8	1.0	21.9	NO	NA
P-0006619-T01-IM5	P-0006619	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		1047	30	PRAD	Not Available	0.14	Stable	MSKCC	Matched	49	NO	25.2	2	41.8	NO	NA
P-0006635-T01-IM5	P-0006635	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The TP53 exon4 mutations occur on different alleles.	879	70	PRAD	Not Available	0.00	Stable	MSKCC	Matched	54	NO	25.2	2	41.8	NO	NA
P-0006655-T01-IM5	P-0006655	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		625	60	PRAD	Not Available	0.00	Stable	MSKCC	Matched	74	NO	59.8	4.9	84.1	NO	NA
P-0006670-T01-IM5	P-0006670	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		395	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.50	Stable	MSKCC	Matched	70	NO	13.1	1	20.7	NO	NA
P-0006689-T01-IM5	P-0006689	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		617	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	47	NO				NO	NA
P-0006692-T01-IM5	P-0006692	Prostate Cancer	Metastasis	Tumor	Mediastinum	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q12 and 20q13	831	70	PRAD	Not Available	0.88	Stable	MSKCC	Matched	69	NO	68	5.9	90.4	YES	482655
P-0006749-T01-IM5	P-0006749	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome.	672	10	PRAD	Not Available	1.21	Stable	MSKCC	Matched	73	NO	59.8	4.9	84.1	YES	386210
P-0006751-T01-IM5	P-0006751	Prostate Cancer	Metastasis	Tumor	Epidural	Prostate	Prostate Adenocarcinoma	IMPACT410		879	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.28	Stable	MSKCC	Matched	75	NO	13.1	1	20.7	NO	NA
P-0006757-T01-IM5	P-0006757	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		644	30	PRAD	Not Available	0.08	Stable	MSKCC	Matched	53	NO	13.1	1	20.7	NO	NA
P-0006767-T02-IM6	P-0006767	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		542	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.19	Stable	MSKCC	Matched	82	NO	44.1	3.5	69.1	YES	702740
P-0006806-T01-IM5	P-0006806	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome..	856	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.49	Stable	MSKCC	Matched	66	NO	37.9	3	60	NO	NA
P-0006815-T01-IM5	P-0006815	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		413	60	PRAD	Not Available	0.19	Stable	MSKCC	Matched	57	NO	25.2	2	41.8	NO	NA
P-0006837-T02-IM5	P-0006837	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		1035	70	PRAD	Not Available	0.38	Stable	MSKCC	Matched	63	NO	37.9	3	60	YES	404971
P-0006840-T01-IM5	P-0006840	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1001	20	PRAD	Not Available	0.85	Stable	MSKCC	Matched	72	NO	85	8.9	96.4	NO	NA
P-0006856-T02-IM5	P-0006856	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome.	1014	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.73	Stable	MSKCC	Matched	75	NO	49.6	3.9	74.0	YES	464329
P-0006894-T02-IM6	P-0006894	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	346	30	PRAD		0.80	Do not report	MSKCC	Matched	63	NO				YES	571494
P-0006905-T01-IM5	P-0006905	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		981	10	PRAD	Not Available	2.89	Stable	MSKCC	Matched	74	NO	68	5.9	90.4	NO	NA
P-0006931-T01-IM5	P-0006931	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	650	20	PRAD	Not Available	0.07	Stable	MSKCC	Matched	54	NO	13.1	1	20.7	NO	NA
P-0006962-T01-IM5	P-0006962	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	790	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	66	NO	13.1	1	20.7	YES	482677
P-0006994-T01-IM5	P-0006994	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		852	40	PRAD	Not Available	0.57	Stable	MSKCC	Matched	65	NO	49.7	3.9	75.2	NO	NA
P-0006997-T01-IM5	P-0006997	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		537	20	PRAD	Not Available	0.33	Stable	MSKCC	Matched	57	NO	25.2	2	41.8	NO	NA
P-0007005-T01-IM5	P-0007005	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		814	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	66	NO	38.1	3.0	59.9	NO	NA
P-0007006-T01-IM5	P-0007006	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410		578	20	PRAD	Not Available	0.07	Stable	MSKCC	Matched	87	NO	49.7	3.9	75.2	NO	NA
P-0007025-T01-IM5	P-0007025	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms of 10q21 and 17p12-13   Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 5q32 and  5q35	981	10	PRAD	Not Available	0.30	Stable	MSKCC	Matched	63	NO	25.2	2	41.8	NO	NA
P-0007042-T01-IM5	P-0007042	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		759	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	55	NO				NO	NA
P-0007043-T02-IM6	P-0007043	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468		836	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.45	Stable	MSKCC	Matched	88	NO	37.9	2.6	59.9	YES	766188
P-0007078-T02-IM5	P-0007078	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		1341	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	71	NO	25.6	2.0	41.7	NO	NA
P-0007098-T01-IM5	P-0007098	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The PTEN copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	487	25	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.46	Stable	MSKCC	Matched	68	NO				NO	NA
P-0007137-T02-IM6	P-0007137	Prostate Cancer	Metastasis	Tumor	Vertebrate	Prostate	Prostate Adenocarcinoma	IMPACT468		758	30	PRAD		0.32	Do not report	MSKCC	Matched	74	NO	54.1	4.4	79.3	YES	556034
P-0007139-T01-IM5	P-0007139	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410		1049	70	PRAD	Not Available	0.51	Stable	MSKCC	Matched	60	NO	25.2	2	41.8	NO	NA
P-0007143-T01-IM5	P-0007143	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	756	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	MSKCC	Matched	71	NO				NO	NA
P-0007182-T01-IM5	P-0007182	Prostate Cancer	Metastasis	Tumor	Spine	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 8q      Note: Copy number profile is suggestive of broad copy number loss on Chromosome  arm of 17p	387	70	PRAD	Not Available	0.97	Stable	MSKCC	Matched	82	NO	37.9	3	60	NO	NA
P-0007184-T01-IM5	P-0007184	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The CCND1, FGF19, FGF4 and FGF3 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	700	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	61	NO	13.1	1	20.7	NO	NA
P-0007219-T02-IM6	P-0007219	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q (excluding RAD21).	1015	50	PRAD		1.13	Do not report	MSKCC	Matched	68	NO	13.1	0.9	20.6	YES	472895
P-0007267-T01-IM5	P-0007267	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		874	60	PRAD	Not Available	0.41	Stable	MSKCC	Matched	70	NO	25.2	2	41.8	NO	NA
P-0007289-T02-IM5	P-0007289	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13q14-22 including RB1.      Note: Copy number profile is suggestive of a fragmented genome.	657	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.84	Stable	MSKCC	Matched	74	NO	59.6	4.9	83.1	NO	NA
P-0007307-T02-IM5	P-0007307	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		864	70	PRAD	Not Available	1.11	Stable	MSKCC	Matched	62	NO	37.9	3	60	YES	427730
P-0007313-T01-IM5	P-0007313	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: A comparison of variant frequencies suggests the IRF4 p.C255Y mutation is subclonal.     Note: The HGF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.	624	80	PRAD	Not Available	0.41	Stable	MSKCC	Matched	78	NO	25.2	2	41.8	NO	NA
P-0007332-T01-IM5	P-0007332	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		231	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	70	NO	25.2	2	41.8	NO	NA
P-0007343-T02-IM6	P-0007343	Prostate Cancer	Metastasis	Tumor	Abdomen	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome..	1085	90	PRAD	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	3.42	Indeterminate	MSKCC	Matched	63	NO	54.1	4.4	79.3	YES	906019
P-0007346-T01-IM5	P-0007346	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	725	30	PRAD	Not Available	0.09	Stable	MSKCC	Matched	73	NO	13.1	1	20.7	NO	NA
P-0007350-T01-IM5	P-0007350	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	656	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO				NO	NA
P-0007351-T01-IM5	P-0007351	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	656	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	66	NO				NO	NA
P-0007358-T02-IM5	P-0007358	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		1028	90	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.49	Stable	MSKCC	Matched	83	NO	59.8	4.9	84.1	NO	NA
P-0007359-T01-IM5	P-0007359	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	570	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	64	NO	13.1	1	20.7	NO	NA
P-0007366-T01-IM5	P-0007366	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		656	50	PRAD	Not Available	0.22	Stable	MSKCC	Matched	57	NO	25.2	2	41.8	NO	NA
P-0007393-T01-IM5	P-0007393	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		853	80	PRAD	Not Available	0.72	Stable	MSKCC	Matched	66	NO	49.7	3.9	75.2	NO	NA
P-0007402-T01-IM5	P-0007402	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		763	25	PRAD	Not Available	0.17	Stable	MSKCC	Matched	62	NO	37.9	3	60	YES	482662
P-0007411-T02-IM5	P-0007411	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of copy number loss on Chromosome arm 6q16-6q22. Note: Copy number profile is suggestive of copy number gain on Chromosome arm 8q21-8q24.	854	40	PRAD	Not Available	0.41	Stable	MSKCC	Matched	54	NO	49.7	3.9	75.2	YES	396492
P-0007416-T01-IM5	P-0007416	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		361	95	PRAD	Not Available	2.88	Stable	MSKCC	Matched	64	NO	25.2	2	41.8	NO	NA
P-0007515-T01-IM5	P-0007515	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		924	95	PRAD	Not Available	1.43	Stable	MSKCC	Matched	59	NO	37.9	3	60	NO	NA
P-0007529-T01-IM5	P-0007529	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		721	40	PRAD	Not Available	0.09	Stable	MSKCC	Matched	75	NO	49.7	3.9	75.2	YES	482651
P-0007533-T01-IM5	P-0007533	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		811	80	PRAD	Not Available	1.22	Stable	MSKCC	Matched	77	NO	37.9	3	60	NO	NA
P-0007538-T01-IM5	P-0007538	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		234	25	PRAD	Not Available	2.46	Stable	MSKCC	Matched	44	NO	90.3	12.8	97.3	NO	NA
P-0007547-T01-IM5	P-0007547	Prostate Cancer	Metastasis	Tumor	Pleura	Prostate	Prostate Adenocarcinoma	IMPACT410		674	80	PRAD	Not Available	0.62	Stable	MSKCC	Matched	73	NO	13.1	1	20.7	NO	NA
P-0007576-T01-IM5	P-0007576	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		691	80	PRAD	Not Available	0.17	Stable	MSKCC	Matched	56	NO	37.9	3	60	NO	NA
P-0007625-T01-IM5	P-0007625	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		451	60	PRAD	Not Available	0.17	Stable	MSKCC	Matched	86	NO	25.2	2	41.8	NO	NA
P-0007629-T02-IM6	P-0007629	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		580	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.47	Stable	MSKCC	Matched	74	NO	54.1	4.4	79.3	NO	NA
P-0007647-T02-IM5	P-0007647	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		825	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.67	Stable	MSKCC	Matched	51	NO				YES	427860
P-0007655-T01-IM5	P-0007655	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	517	25	PRAD	Not Available	0.00	Stable	MSKCC	Matched	56	NO	13.1	1	20.7	NO	NA
P-0007734-T01-IM5	P-0007734	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		131	80	PRAD	Not Available	1.42	Stable	MSKCC	Matched	77	NO	37.9	3	60	NO	NA
P-0007749-T01-IM5	P-0007749	Prostate Cancer	Metastasis	Tumor	Omentum	Prostate	Prostate Adenocarcinoma	IMPACT410		884	40	PRAD	Not Available	0.38	Stable	MSKCC	Matched	62	NO	25.2	2	41.8	NO	NA
P-0007770-T01-IM5	P-0007770	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1170	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.62	Stable	MSKCC	Matched	66	NO				NO	NA
P-0007786-T01-IM5	P-0007786	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	639	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	70	NO	59.8	4.9	84.1	YES	482729
P-0007848-T01-IM5	P-0007848	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		654	60	PRAD	Not Available	0.00	Stable	MSKCC	Matched	73	NO	13.1	1	20.7	YES	482648
P-0007853-T01-IM5	P-0007853	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	880	15	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	68	NO				YES	886639
P-0007856-T01-IM5	P-0007856	Prostate Cancer	Metastasis	Tumor	Pelvic Nodule	Prostate	Prostate Adenocarcinoma	IMPACT410		724	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	MSKCC	Matched	81	NO	37.9	3	60	NO	NA
P-0007874-T01-IM5	P-0007874	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		619	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	65	NO	37.9	3	60	NO	NA
P-0007875-T02-IM6	P-0007875	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of numerous chromosome level losses and gains.	587	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	MSKCC	Matched	70	NO	63.5	5.3	87.8	YES	1037659
P-0007877-T01-IM5	P-0007877	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	617	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	62	NO	13.1	1	20.7	NO	NA
P-0007881-T01-IM5	P-0007881	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	415	30	PRAD	Not Available	0.22	Stable	MSKCC	Matched	59	NO	25.2	2	41.8	NO	NA
P-0007887-T02-IM6	P-0007887	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	542	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	MSKCC	Matched	70	YES	37.9	2.6	59.9	YES	644585
P-0007930-T01-IM5	P-0007930	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	301	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.21	Stable	MSKCC	Matched	48	NO				NO	NA
P-0007965-T01-IM5	P-0007965	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	703	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	70	NO	59.8	4.9	84.1	NO	NA
P-0007968-T01-IM5	P-0007968	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		468	80	PRAD	Not Available	0.78	Stable	MSKCC	Matched	56	NO	25.2	2	41.8	NO	NA
P-0008044-T01-IM5	P-0008044	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	676	25	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	60	NO				NO	NA
P-0008048-T01-IM5	P-0008048	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	918	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	76	NO	59.8	4.9	84.1	NO	NA
P-0008057-T01-IM5	P-0008057	Prostate Cancer	Metastasis	Tumor	Skull	Prostate	Prostate Adenocarcinoma	IMPACT410		846	25	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.15	Stable	MSKCC	Matched	62	NO	37.9	3	60	NO	NA
P-0008067-T01-IM5	P-0008067	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	231	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.83	Stable	MSKCC	Matched	77	NO	13.1	1	20.7	NO	NA
P-0008069-T02-IM5	P-0008069	Prostate Cancer	Metastasis	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 11q21-23.	1203	70	PRAD	Not Available	0.52	Stable	MSKCC	Matched	66	NO	59.8	4.9	84.1	YES	412986
P-0008074-T01-IM5	P-0008074	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	862	70	PRAD	Not Available	0.33	Stable	MSKCC	Matched	83	NO	25.2	2	41.8	NO	NA
P-0008077-T02-IM5	P-0008077	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		303	65	PRAD	Not Available	0.62	Stable	MSKCC	Matched	84	NO	74.4	6.9	94.1	NO	NA
P-0008098-T01-IM5	P-0008098	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The copy number profile is suggestive of an intragenic gain of MLL3 exons 1-42 and 47-59.	882	20	PRAD	Not Available	0.47	Stable	MSKCC	Matched	69	NO	59.8	4.9	84.1	YES	482646
P-0008139-T03-IM5	P-0008139	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		781	50	PRAD		0.85	Do not report	MSKCC	Matched	71	NO	49.7	3.9	75.2	YES	473743
P-0008147-T01-IM5	P-0008147	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	730	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	58	NO				NO	NA
P-0008206-T01-IM5	P-0008206	Prostate Cancer	Metastasis	Tumor	Neck	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome..	1141	70	PRAD	Not Available	1.55	Stable	MSKCC	Matched	57	NO	13.1	1	20.7	NO	NA
P-0008232-T01-IM5	P-0008232	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	373	60	PRAD	Not Available	0.18	Stable	MSKCC	Matched	68	NO	13.1	1	20.7	NO	NA
P-0008235-T01-IM5	P-0008235	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		788	35	PRAD	Not Available	0.08	Stable	MSKCC	Matched	79	NO	68	5.9	90.4	NO	NA
P-0008294-T01-IM5	P-0008294	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	523	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	71	NO				NO	NA
P-0008301-T01-IM5	P-0008301	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	916	10	PRAD	Not Available	0.16	Stable	MSKCC	Matched	60	NO	49.7	3.9	75.2	NO	NA
P-0008304-T01-IM5	P-0008304	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		615	60	PRAD	Not Available	0.00	Stable	MSKCC	Matched	55	NO	13.1	1	20.7	NO	NA
P-0008315-T01-IM5	P-0008315	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16q.	987	60	PRAD	Not Available	0.92	Stable	MSKCC	Matched	68	NO	59.8	4.9	84.1	NO	NA
P-0008326-T01-IM5	P-0008326	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	478	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.80	Stable	MSKCC	Matched	61	NO	25.6	2.0	41.7	YES	482669
P-0008330-T01-IM5	P-0008330	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		961	60	PRAD	Not Available	0.37	Stable	MSKCC	Matched	64	NO	25.2	2	41.8	NO	NA
P-0008335-T01-IM5	P-0008335	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		855	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	65	NO				NO	NA
P-0008339-T02-IM6	P-0008339	Prostate Cancer	Metastasis	Tumor	Sacral Mass	Prostate	Prostate Adenocarcinoma	IMPACT468		564	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	77	NO	53.0	4.4	77.2	NO	NA
P-0008344-T01-IM5	P-0008344	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		1035	20	PRAD	Not Available	0.47	Stable	MSKCC	Matched	74	NO	68	5.9	90.4	NO	NA
P-0008348-T02-IM5	P-0008348	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome.	1236	50	PRAD	Not Available	3.15	Indeterminate	MSKCC	Matched	71	NO	37.9	3	60	YES	413405
P-0008351-T01-IM5	P-0008351	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		632	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	63	NO	25.2	2	41.8	NO	NA
P-0008356-T01-IM5	P-0008356	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	464	20	PRAD	Not Available	0.08	Stable	MSKCC	Matched	55	NO	25.2	2	41.8	NO	NA
P-0008383-T01-IM5	P-0008383	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	878	10	PRAD	Not Available	0.37	Stable	MSKCC	Matched	54	NO	13.1	1	20.7	NO	NA
P-0008390-T01-IM5	P-0008390	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 15q and 16q.      Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p.	1331	70	PRAD	Not Available	2.48	Stable	MSKCC	Matched	72	NO	68	5.9	90.4	NO	NA
P-0008393-T01-IM5	P-0008393	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	463	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.29	Stable	MSKCC	Matched	64	NO				NO	NA
P-0008431-T01-IM5	P-0008431	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	840	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO				NO	NA
P-0008441-T01-IM5	P-0008441	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		960	70	PRAD	Not Available	2.07	Stable	MSKCC	Matched	77	NO	13.1	1	20.7	NO	NA
P-0008452-T01-IM5	P-0008452	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		540	60	PRAD	Not Available	0.00	Stable	MSKCC	Matched	61	NO	37.9	3	60	NO	NA
P-0008461-T01-IM5	P-0008461	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT410		716	40	PRAD	Not Available	0.72	Stable	MSKCC	Matched	70	NO	68	5.9	90.4	NO	NA
P-0008470-T01-IM5	P-0008470	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		441	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.84	Stable	MSKCC	Matched	74	NO	49.6	3.9	74.0	NO	NA
P-0008525-T02-IM6	P-0008525	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		568	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.27	Stable	MSKCC	Matched	73	NO	25.2	1.8	41.8	YES	1010385
P-0008542-T03-IM5	P-0008542	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	514	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.21	Stable	MSKCC	Matched	85	NO	25.6	2.0	41.7	NO	NA
P-0008581-T01-IM5	P-0008581	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		660	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO				NO	NA
P-0008591-T01-IM5	P-0008591	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT410		794	70	PRAD	Not Available	2.23	Stable	MSKCC	Matched	67	NO	25.2	2	41.8	NO	NA
P-0008592-T01-IM5	P-0008592	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		732	60	PRAD	Not Available	0.08	Stable	MSKCC	Matched	59	NO	25.2	2	41.8	NO	NA
P-0008597-T01-IM5	P-0008597	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		913	60	PRAD	Not Available	0.30	Stable	MSKCC	Matched	76	NO	13.1	1	20.7	NO	NA
P-0008655-T01-IM5	P-0008655	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	689	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	56	NO	25.2	2	41.8	NO	NA
P-0008661-T01-IM5	P-0008661	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		854	40	PRAD	Not Available	0.18	Stable	MSKCC	Matched	56	NO	49.7	3.9	75.2	NO	NA
P-0008667-T01-IM5	P-0008667	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	663	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	78	NO	25.2	2	41.8	NO	NA
P-0008669-T01-IM5	P-0008669	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1117	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.15	Stable	MSKCC	Matched	65	NO	25.2	2	41.8	NO	NA
P-0008769-T02-IM5	P-0008769	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		673	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	MSKCC	Matched	55	NO	49.6	3.9	74.0	NO	NA
P-0008771-T01-IM5	P-0008771	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		826	80	PRAD	Not Available	0.16	Stable	MSKCC	Matched	51	NO	37.9	3	60	NO	NA
P-0008810-T01-IM5	P-0008810	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		877	60	PRAD	Not Available	1.25	Stable	MSKCC	Matched	86	NO	37.9	3	60	NO	NA
P-0008812-T01-IM5	P-0008812	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		961	80	PRAD	Not Available	0.45	Stable	MSKCC	Matched	63	NO	13.1	1	20.7	NO	NA
P-0008832-T01-IM5	P-0008832	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		641	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.17	Stable	MSKCC	Matched	74	NO				NO	NA
P-0008852-T01-IM5	P-0008852	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		507	90	PRAD	Not Available	0.42	Stable	MSKCC	Matched	61	NO	68	5.9	90.4	YES	482722
P-0008858-T01-IM5	P-0008858	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		482	80	PRAD	Not Available	0.19	Stable	MSKCC	Matched	61	NO	74.4	6.9	94.1	NO	NA
P-0008869-T01-IM5	P-0008869	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		600	40	PRAD	Not Available	0.17	Stable	MSKCC	Matched	65	NO	37.9	3	60	NO	NA
P-0008879-T01-IM5	P-0008879	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		642	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	57	NO	13.1	1	20.7	NO	NA
P-0008920-T01-IM5	P-0008920	Prostate Cancer	Metastasis	Tumor	Testis	Prostate	Prostate Adenocarcinoma	IMPACT410		699	70	PRAD	Not Available	0.31	Stable	MSKCC	Matched	61	NO	49.7	3.9	75.2	YES	524140
P-0008928-T01-IM5	P-0008928	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1164	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	59	NO	49.6	3.9	74.0	NO	NA
P-0008954-T01-IM5	P-0008954	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		919	95	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.26	Stable	MSKCC	Matched	69	NO	13.1	1.0	20.7	NO	NA
P-0008960-T02-IM6	P-0008960	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		742	70	PRAD		0.96	Do not report	MSKCC	Matched	50	NO	13.1	0.9	20.6	YES	559295
P-0008966-T01-IM5	P-0008966	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q. Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 9p21-9p24 and 18q.	876	50	PRAD	Not Available	0.88	Stable	MSKCC	Matched	67	NO	68	5.9	90.4	NO	NA
P-0009002-T01-IM5	P-0009002	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	1058	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	59	NO	25.2	2	41.8	NO	NA
P-0009006-T01-IM5	P-0009006	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	253	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	72	NO				NO	NA
P-0009024-T01-IM5	P-0009024	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410		938	75	PRAD	Not Available	0.83	Stable	MSKCC	Matched	67	NO	13.1	1	20.7	YES	397899
P-0009044-T01-IM5	P-0009044	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		936	80	PRAD	Not Available	0.16	Stable	MSKCC	Matched	62	NO	59.8	4.9	84.1	NO	NA
P-0009056-T02-IM6	P-0009056	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16q13-22.	996	60	PRAD		2.61	Do not report	MSKCC	Matched	60	NO	63.5	5.3	87.8	YES	561643
P-0009073-T01-IM5	P-0009073	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	597	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.46	Stable	MSKCC	Matched	72	NO				YES	399006
P-0009077-T01-IM5	P-0009077	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	634	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO				YES	395740
P-0009082-T01-IM5	P-0009082	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		838	90	PRAD	Not Available	0.53	Stable	MSKCC	Matched	76	NO	25.2	2	41.8	YES	398097
P-0009085-T01-IM5	P-0009085	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		842	50	PRAD	Not Available	0.17	Stable	MSKCC	Matched	56	NO	37.9	3	60	NO	NA
P-0009090-T01-IM5	P-0009090	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	801	10	PRAD	Not Available	0.00	Stable	MSKCC	Matched	53	NO	13.1	1	20.7	NO	NA
P-0009151-T01-IM5	P-0009151	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		339	30	PRAD	Not Available	0.34	Stable	MSKCC	Matched	79	NO	25.2	2	41.8	YES	398330
P-0009175-T02-IM5	P-0009175	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage. Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	171	40	PRAD	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	3.52	Indeterminate	MSKCC	Matched	61	NO	25.6	2.0	41.7	YES	395730
P-0009190-T01-IM5	P-0009190	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		975	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	67	NO	25.2	2	41.8	YES	397822
P-0009286-T02-IM6	P-0009286	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	620	20	PRAD		0.07	Do not report	MSKCC	Matched	59	NO				YES	499176
P-0009338-T01-IM5	P-0009338	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: No alterations identified in the context of moderate tumor content . No silent mutations identified. More comprehensive testing could be valuable.	908	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	52	NO				YES	397917
P-0009352-T01-IM5	P-0009352	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		998	25	PRAD	Not Available	0.24	Stable	MSKCC	Matched	53	NO	37.9	3	60	YES	400271
P-0009361-T01-IM5	P-0009361	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		816	10	PRAD	Not Available	0.25	Stable	MSKCC	Matched	72	NO	13.1	1	20.7	YES	398102
P-0009374-T02-IM5	P-0009374	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		943	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.70	Stable	MSKCC	Matched	74	NO	37.9	3	60	YES	427713
P-0009393-T01-IM5	P-0009393	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	201	60	PRAD	Not Available	1.43	Stable	MSKCC	Matched	76	NO	13.1	1	20.7	YES	398084
P-0009399-T01-IM5	P-0009399	Prostate Cancer	Metastasis	Tumor	Pleura	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome.	1211	80	PRAD	Not Available	4.10	Indeterminate	MSKCC	Matched	76	NO	59.8	4.9	84.1	YES	397982
P-0009401-T02-IM6	P-0009401	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	850	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.92	Stable	MSKCC	Matched	75	NO	37.9	2.6	59.9	YES	1069580
P-0009402-T02-IM6	P-0009402	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		645	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.18	Stable	MSKCC	Matched	73	NO	53.0	4.4	77.2	NO	NA
P-0009409-T01-IM5	P-0009409	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		511	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	79	NO	13.1	1	20.7	YES	396381
P-0009420-T01-IM5	P-0009420	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		630	30	PRAD	Not Available	0.17	Stable	MSKCC	Matched	74	NO	49.7	3.9	75.2	YES	397856
P-0009448-T01-IM5	P-0009448	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	650	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	58	NO	49.7	3.9	75.2	YES	400310
P-0009463-T02-IM6	P-0009463	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		339	60	PRAD		0.09	Do not report	MSKCC	Matched	77	NO	25.2	1.8	41.8	YES	501624
P-0009502-T01-IM5	P-0009502	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	711	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	78	NO				YES	399092
P-0009536-T01-IM5	P-0009536	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		771	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	84	NO				YES	400273
P-0009543-T02-IM5	P-0009543	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT410		744	80	PRAD	Not Available	1.28	Stable	MSKCC	Matched	67	NO				YES	408462
P-0009546-T01-IM5	P-0009546	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		599	50	PRAD	Not Available	0.38	Stable	MSKCC	Matched	83	NO	13.1	1	20.7	YES	400348
P-0009556-T01-IM5	P-0009556	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		1013	30	PRAD	Not Available	0.08	Stable	MSKCC	Matched	56	NO	37.9	3	60	YES	400991
P-0009565-T01-IM5	P-0009565	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		1000	30	PRAD	Not Available	0.33	Stable	MSKCC	Matched	72	NO	59.8	4.9	84.1	YES	400349
P-0009640-T01-IM5	P-0009640	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		815	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	74	NO	13.1	1	20.7	NO	NA
P-0009654-T01-IM5	P-0009654	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q.	1449	40	PRAD	Not Available	0.60	Stable	MSKCC	Matched	59	NO	37.9	3	60	YES	401026
P-0009656-T01-IM5	P-0009656	Prostate Cancer	Metastasis	Tumor	Kidney	Prostate	Prostate Adenocarcinoma	IMPACT410		762	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.86	Stable	MSKCC	Matched	67	NO	37.9	3	60	YES	401034
P-0009659-T01-IM5	P-0009659	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample will be attempted if available.	881	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	75	NO				YES	401284
P-0009663-T01-IM5	P-0009663	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		320	30	PRAD	Not Available	2.66	Stable	MSKCC	Matched	70	NO	49.7	3.9	75.2	YES	401046
P-0009686-T01-IM5	P-0009686	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		985	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	MSKCC	Matched	50	NO	25.2	2	41.8	YES	401291
P-0009687-T01-IM5	P-0009687	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		610	60	PRAD	Not Available	0.75	Stable	MSKCC	Matched	52	NO	13.1	1	20.7	NO	NA
P-0009699-T01-IM5	P-0009699	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		714	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.16	Stable	MSKCC	Matched	72	NO	49.7	3.9	75.2	YES	404673
P-0009746-T02-IM5	P-0009746	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		1286	40	PRAD	Not Available	0.08	Stable	MSKCC	Matched	87	NO	13.1	1	20.7	YES	413423
P-0009786-T01-IM5	P-0009786	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		760	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.16	Stable	MSKCC	Matched	54	NO	25.2	2	41.8	YES	404148
P-0009787-T01-IM5	P-0009787	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		642	40	PRAD	Not Available	0.08	Stable	MSKCC	Matched	66	NO	13.1	1	20.7	YES	404222
P-0009817-T01-IM5	P-0009817	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	520	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	59	NO	37.9	3	60	YES	404119
P-0009818-T01-IM5	P-0009818	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		864	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO	25.2	2	41.8	YES	404153
P-0009819-T01-IM5	P-0009819	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		665	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	70	NO	13.1	1	20.7	YES	404131
P-0009843-T01-IM5	P-0009843	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	223	50	PRAD	Not Available	4.25	Indeterminate	MSKCC	Matched	74	NO	68	5.9	90.4	YES	404981
P-0009853-T01-IM5	P-0009853	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410		932	50	PRAD	Not Available	1.00	Stable	MSKCC	Matched	83	NO	68	5.9	90.4	YES	404021
P-0009904-T01-IM5	P-0009904	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	527	30	PRAD	Not Available	0.09	Stable	MSKCC	Matched	74	NO	49.7	3.9	75.2	YES	404969
P-0009908-T02-IM6	P-0009908	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 9p24 and 15q25-26.	904	50	PRAD		0.47	Do not report	MSKCC	Matched	64	YES	37.9	2.6	59.9	NO	NA
P-0009914-T01-IM5	P-0009914	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		738	50	PRAD	Not Available	0.46	Stable	MSKCC	Matched	70	NO	37.9	3	60	YES	404721
P-0009939-T01-IM5	P-0009939	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	417	20	PRAD	Not Available	0.55	Stable	MSKCC	Matched	75	NO	25.2	2	41.8	YES	404724
P-0009942-T01-IM5	P-0009942	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	274	40	PRAD	Not Available	0.36	Stable	MSKCC	Matched	76	NO	13.1	1	20.7	NO	NA
P-0009982-T01-IM5	P-0009982	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		1017	20	PRAD	Not Available	0.34	Stable	MSKCC	Matched	79	NO	49.7	3.9	75.2	YES	406050
P-0009989-T01-IM5	P-0009989	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1140	70	PRAD	Not Available	0.79	Stable	MSKCC	Matched	58	NO	59.8	4.9	84.1	YES	405971
P-0009990-T01-IM5	P-0009990	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	876	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	53	NO	13.1	1	20.7	YES	405973
P-0010015-T01-IM5	P-0010015	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 18q12-18q21.	1199	80	PRAD	Not Available	1.42	Stable	MSKCC	Matched	72	NO	49.7	3.9	75.2	YES	405386
P-0010029-T01-IM5	P-0010029	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1013	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	76	NO				YES	404127
P-0010045-T01-IM5	P-0010045	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	661	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	46	NO				YES	407372
P-0010071-T01-IM5	P-0010071	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		773	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	56	NO	37.9	3	60	YES	407348
P-0010075-T01-IM5	P-0010075	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		498	50	PRAD	Not Available	0.16	Stable	MSKCC	Matched	61	NO	59.8	4.9	84.1	YES	407363
P-0010076-T01-IM5	P-0010076	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	286	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	63	NO				YES	407352
P-0010078-T01-IM5	P-0010078	Prostate Cancer	Metastasis	Tumor	Adrenal Gland	Prostate	Prostate Adenocarcinoma	IMPACT410		617	30	PRAD	Not Available	0.38	Stable	MSKCC	Matched	74	NO	59.8	4.9	84.1	YES	407339
P-0010178-T02-IM6	P-0010178	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		691	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.61	Stable	MSKCC	Matched	77	NO	13.1	0.9	20.6	YES	667723
P-0010179-T01-IM5	P-0010179	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: No alterations identified in the context of high tumor content . Silent mutations identified were present in high percentage. If clinically indicated, more comprehensive testing could be valuable.	660	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.43	Stable	MSKCC	Matched	61	NO				YES	408459
P-0010180-T02-IM5	P-0010180	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		444	30	PRAD		1.39	Do not report	MSKCC	Matched	65	NO	13.1	1	20.7	YES	466999
P-0010230-T01-IM5	P-0010230	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	848	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.16	Stable	MSKCC	Matched	65	NO				YES	409724
P-0010237-T01-IM5	P-0010237	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		873	40	PRAD	Not Available	0.79	Stable	MSKCC	Matched	72	NO	59.8	4.9	84.1	YES	410791
P-0010240-T01-IM5	P-0010240	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		655	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	89	NO	59.8	4.9	84.1	YES	410701
P-0010248-T01-IM5	P-0010248	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	562	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	65	NO				YES	409773
P-0010272-T01-IM5	P-0010272	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		889	60	PRAD	Not Available	0.67	Stable	MSKCC	Matched	73	NO	49.7	3.9	75.2	YES	410799
P-0010309-T01-IM5	P-0010309	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1175	30	PRAD	Not Available	0.49	Stable	MSKCC	Matched	67	NO	49.7	3.9	75.2	YES	412952
P-0010315-T03-IM5	P-0010315	Prostate Cancer	Metastasis	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		834	20	PRAD		0.27	Do not report	MSKCC	Matched	68	NO	37.9	3	60	YES	466981
P-0010399-T02-IM6	P-0010399	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		513	30	PRAD		0.41	Do not report	MSKCC	Matched	66	NO	13.1	0.9	20.6	YES	488611
P-0010518-T01-IM5	P-0010518	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		1080	50	PRAD	Not Available	1.15	Stable	MSKCC	Matched	89	NO	74.4	6.9	94.1	YES	413910
P-0010523-T01-IM5	P-0010523	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		1336	30	PRAD	Not Available	0.47	Stable	MSKCC	Matched	82	NO	13.1	1	20.7	YES	412980
P-0010529-T01-IM5	P-0010529	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410		904	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.05	Stable	MSKCC	Matched	39	NO	37.9	3	60	YES	404196
P-0010538-T01-IM5	P-0010538	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7 and Chromosome arms 8q and 9q.	450	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.06	Stable	MSKCC	Matched	83	NO	78.5	7.9	94.6	YES	415158
P-0010565-T01-IM5	P-0010565	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1066	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.64	Stable	MSKCC	Matched	61	NO	25.2	2	41.8	YES	415177
P-0010572-T01-IM5	P-0010572	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		661	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	75	NO	37.9	3	60	YES	416575
P-0010639-T01-IM5	P-0010639	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		1030	70	PRAD	Not Available	0.53	Stable	MSKCC	Matched	68	NO	25.2	2	41.8	YES	418288
P-0010656-T01-IM5	P-0010656	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		748	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	77	NO	25.2	2	41.8	YES	416482
P-0010657-T01-IM5	P-0010657	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		937	40	PRAD	Not Available	0.07	Stable	MSKCC	Matched	61	NO	13.1	1	20.7	YES	416608
P-0010659-T01-IM5	P-0010659	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		820	30	PRAD	Not Available	0.38	Stable	MSKCC	Matched	77	NO	13.1	1	20.7	YES	416623
P-0010731-T01-IM5	P-0010731	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		529	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	65	NO	49.7	3.9	75.2	YES	418233
P-0010746-T01-IM5	P-0010746	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		1191	30	PRAD	Not Available	0.23	Stable	MSKCC	Matched	76	NO	25.2	2	41.8	YES	418291
P-0010752-T01-IM5	P-0010752	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	597	10	PRAD	Not Available	0.08	Stable	MSKCC	Matched	77	NO	37.9	3	60	YES	418245
P-0010794-T01-IM5	P-0010794	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: The copy number profile is indicative of an intragenic gain in NCOR1 (exons 23-46).	671	60	PRAD	Not Available	0.09	Stable	MSKCC	Matched	69	NO	13.1	1	20.7	YES	420412
P-0010796-T02-IM6	P-0010796	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		837	60	PRAD		2.04	Do not report	MSKCC	Matched	73	NO	25.2	1.8	41.8	YES	518401
P-0010811-T01-IM5	P-0010811	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		733	65	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	64	NO	37.9	3	60	YES	420307
P-0010823-T02-IM6	P-0010823	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		941	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.05	Stable	MSKCC	Matched	65	NO	79.1	7.9	95.5	YES	889679
P-0010870-T01-IM5	P-0010870	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	742	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	47	NO				YES	418714
P-0010920-T01-IM5	P-0010920	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		266	60	PRAD	Not Available	0.48	Stable	MSKCC	Matched	76	NO	13.1	1	20.7	YES	420380
P-0010950-T01-IM5	P-0010950	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	644	35	PRAD	Not Available	0.10	Stable	MSKCC	Matched	68	NO	25.2	2	41.8	YES	422630
P-0010952-T01-IM5	P-0010952	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	769	25	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	49	NO	25.2	2	41.8	YES	422677
P-0010953-T01-IM5	P-0010953	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1163	20	PRAD	Not Available	0.16	Stable	MSKCC	Matched	61	NO	25.2	2	41.8	YES	421592
P-0011003-T01-IM5	P-0011003	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		1267	25	PRAD	Not Available	0.00	Stable	MSKCC	Matched	68	NO	74.4	6.9	94.1	YES	421575
P-0011046-T01-IM5	P-0011046	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		582	35	PRAD	Not Available	0.38	Stable	MSKCC	Matched	65	NO	59.8	4.9	84.1	YES	422659
P-0011088-T01-IM5	P-0011088	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome.	1544	40	PRAD	Not Available	1.59	Stable	MSKCC	Matched	86	NO	37.9	3	60	YES	425078
P-0011090-T01-IM5	P-0011090	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1492	25	PRAD	Not Available	1.10	Stable	MSKCC	Matched	87	NO	59.8	4.9	84.1	YES	425115
P-0011092-T02-IM5	P-0011092	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	728	80	PRAD	Not Available	0.27	Stable	MSKCC	Matched	75	NO	13.1	1	20.7	YES	428569
P-0011093-T01-IM5	P-0011093	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		911	10	PRAD	Not Available	1.14	Stable	MSKCC	Matched	81	NO	25.2	2	41.8	YES	425074
P-0011096-T02-IM5	P-0011096	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT410		1008	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.59	Stable	MSKCC	Matched	64	NO	49.7	3.9	75.2	YES	450045
P-0011156-T01-IM5	P-0011156	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1069	50	PRAD	Not Available	0.0	Stable	MSKCC	Matched	78	NO	13.1	1	20.7	YES	423990
P-0011188-T01-IM5	P-0011188	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		524	80	PRAD	Not Available	0.11	Stable	MSKCC	Matched	63	NO	25.2	2	41.8	YES	427362
P-0011198-T01-IM5	P-0011198	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		711	65	PRAD	Not Available	0.00	Stable	MSKCC	Matched	56	NO	13.1	1	20.7	YES	427351
P-0011263-T01-IM5	P-0011263	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		640	80	PRAD	Not Available	0.16	Stable	MSKCC	Matched	61	NO	13.1	1	20.7	NO	NA
P-0011267-T01-IM5	P-0011267	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		877	85	PRAD	Not Available	0.08	Stable	MSKCC	Matched	62	NO	25.2	2	41.8	YES	427822
P-0011290-T01-IM5	P-0011290	Prostate Cancer	Metastasis	Tumor	Sacral Mass	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 3p11-13, 5q14, 7q21-31 and 13q14-33.	753	15	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.49	Stable	MSKCC	Matched	74	NO	37.9	3	60	YES	427021
P-0011294-T01-IM5	P-0011294	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	120	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.95	Stable	MSKCC	Matched	73	NO	13.1	1	20.7	YES	427865
P-0011299-T01-IM5	P-0011299	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		814	60	PRAD	Not Available	0.09	Stable	MSKCC	Matched	61	NO	25.2	2	41.8	YES	427359
P-0011310-T01-IM5	P-0011310	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		742	80	PRAD	Not Available	0.00	Stable	MSKCC	Matched	51	NO	13.1	1	20.7	YES	427341
P-0011363-T01-IM5	P-0011363	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		822	70	PRAD	Not Available	0.09	Stable	MSKCC	Matched	66	NO	25.2	2	41.8	YES	428514
P-0011364-T01-IM5	P-0011364	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		384	25	PRAD	Not Available	2.22	Stable	MSKCC	Matched	74	NO	13.1	1	20.7	YES	427323
P-0011367-T01-IM5	P-0011367	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		1042	80	PRAD	Not Available	0.72	Stable	MSKCC	Matched	72	NO	25.2	2	41.8	YES	427781
P-0011368-T01-IM5	P-0011368	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT410		1195	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.17	Stable	MSKCC	Matched	69	NO	37.9	3	60	YES	427789
P-0011370-T01-IM5	P-0011370	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1001	50	PRAD	Not Available	0.71	Stable	MSKCC	Matched	77	NO	13.1	1	20.7	NO	NA
P-0011377-T01-IM5	P-0011377	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		894	70	PRAD	Not Available	1.03	Stable	MSKCC	Matched	54	NO	49.7	3.9	75.2	YES	429400
P-0011399-T01-IM5	P-0011399	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1210	10	PRAD	Not Available	0.00	Stable	MSKCC	Matched	57	NO	13.1	1	20.7	YES	427808
P-0011429-T02-IM6	P-0011429	Prostate Cancer	Metastasis	Tumor	Rib	Prostate	Prostate Adenocarcinoma	IMPACT468		844	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.35	Stable	MSKCC	Matched	73	NO	25.5	1.8	41.6	NO	NA
P-0011437-T01-IM5	P-0011437	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1204	15	PRAD	Not Available	0.42	Stable	MSKCC	Matched	81	NO	25.2	2	41.8	YES	429393
P-0011465-T01-IM5	P-0011465	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	611	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	62	NO	13.1	1	20.7	YES	429353
P-0011472-T01-IM5	P-0011472	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out.	514	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.17	Stable	MSKCC	Matched	65	NO				YES	427892
P-0011475-T01-IM5	P-0011475	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		859	60	PRAD	Not Available	0.29	Stable	MSKCC	Matched	56	NO				YES	429454
P-0011483-T01-IM5	P-0011483	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		962	60	PRAD	Not Available	0.30	Stable	MSKCC	Matched	72	NO	49.7	3.9	75.2	YES	429316
P-0011515-T01-IM5	P-0011515	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		846	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO	13.8	1.0	21.9	YES	430393
P-0011525-T01-IM5	P-0011525	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	1104	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	85	NO				YES	430498
P-0011529-T01-IM5	P-0011529	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		657	80	PRAD	Not Available	0.61	Stable	MSKCC	Matched	74	NO	68	5.9	90.4	YES	430492
P-0011534-T01-IM5	P-0011534	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		799	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	72	NO	13.1	1	20.7	YES	430452
P-0011553-T01-IM5	P-0011553	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		816	40	PRAD	Not Available	0.08	Stable	MSKCC	Matched	78	NO	13.1	1	20.7	YES	432168
P-0011558-T01-IM5	P-0011558	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		601	40	PRAD	Not Available	0.09	Stable	MSKCC	Matched	72	NO	49.7	3.9	75.2	YES	432473
P-0011577-T01-IM5	P-0011577	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		884	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	71	NO	68	5.9	90.4	YES	432238
P-0012025-T01-IM5	P-0012025	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		986	50	PRAD	Not Available	0.09	Stable	MSKCC	Matched	70	NO	37.9	3	60	YES	432144
P-0012026-T01-IM5	P-0012026	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		794	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	63	NO	37.9	3	60	YES	432316
P-0012029-T01-IM5	P-0012029	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		862	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.18	Stable	MSKCC	Matched	63	NO				YES	432303
P-0012030-T01-IM5	P-0012030	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		815	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.19	Stable	MSKCC	Matched	60	NO	25.2	2	41.8	YES	432135
P-0012031-T01-IM5	P-0012031	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		440	90	PRAD	Not Available	0.68	Stable	MSKCC	Matched	82	NO	13.1	1	20.7	YES	432141
P-0012039-T01-IM5	P-0012039	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: No alterations identified in the context of high tumor content. More comprehensive testing could be valuable.	519	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	74	NO				YES	432145
P-0012046-T01-IM5	P-0012046	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		906	30	PRAD	Not Available	0.43	Stable	MSKCC	Matched	52	NO	13.1	1	20.7	YES	432139
P-0012048-T01-IM5	P-0012048	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		729	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	77	NO	37.9	3	60	YES	433472
P-0012104-T02-IM6	P-0012104	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		704	70	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.28	Stable	MSKCC	Matched	81	NO	54.1	4.4	79.3	YES	649887
P-0012109-T01-IM5	P-0012109	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		1001	60	PRAD	Not Available	2.72	Stable	MSKCC	Matched	75	NO	59.8	4.9	84.1	YES	433474
P-0012132-T01-IM5	P-0012132	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		754	40	PRAD	Not Available	0.28	Stable	MSKCC	Matched	61	NO	13.1	1	20.7	YES	434372
P-0012136-T01-IM5	P-0012136	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low sequencing depth of coverage of 171X, negative results should be interpreted with caution.	171	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.84	Stable	MSKCC	Matched	71	NO				YES	434438
P-0012141-T01-IM5	P-0012141	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		649	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.43	Stable	MSKCC	Matched	63	NO				YES	434376
P-0012145-T01-IM5	P-0012145	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		609	40	PRAD	Not Available	0.08	Stable	MSKCC	Matched	82	NO	74.4	6.9	94.1	YES	434482
P-0012181-T02-IM6	P-0012181	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		880	30	PRAD		0.00	Do not report	MSKCC	Matched	63	NO	54.1	4.4	79.3	YES	515770
P-0012184-T01-IM5	P-0012184	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gains on Chromosome 7 and Chromosome arms 3q21-23 and Xq22-25. Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6q15-21, 9p21, 15q15-21, and 16q13-23.	628	70	PRAD	Not Available	0.53	Stable	MSKCC	Matched	77	NO	49.7	3.9	75.2	YES	434505
P-0012197-T01-IM5	P-0012197	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome.	272	60	PRAD	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	3.71	Indeterminate	MSKCC	Matched	61	NO	13.1	1	20.7	YES	435765
P-0012258-T01-IM5	P-0012258	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated. Note: Copy number profile is suggestive of broad copy number loss of 2q34-36.	566	50	PRAD	Not Available	0.08	Stable	MSKCC	Matched	64	NO	37.9	3	60	YES	437488
P-0012271-T01-IM5	P-0012271	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		726	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.23	Stable	MSKCC	Matched	61	NO				YES	437332
P-0012275-T01-IM5	P-0012275	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		512	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	84	NO				YES	437438
P-0012284-T01-IM5	P-0012284	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		978	70	PRAD	Not Available	0.21	Stable	MSKCC	Matched	72	NO	25.2	2	41.8	YES	437805
P-0012304-T01-IM5	P-0012304	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	895	20	PRAD	Not Available	0.00	Stable	MSKCC	Matched	67	NO	13.1	1	20.7	YES	437804
P-0012321-T01-IM5	P-0012321	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		859	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	74	NO	37.9	3	60	YES	437866
P-0012322-T01-IM5	P-0012322	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		761	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO				YES	437884
P-0012324-T01-IM5	P-0012324	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		864	80	PRAD	Not Available	0.00	Stable	MSKCC	Matched	83	NO	25.2	2	41.8	YES	437479
P-0012326-T01-IM5	P-0012326	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		615	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	70	NO	59.8	4.9	84.1	YES	437363
P-0012327-T01-IM5	P-0012327	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		789	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	74	NO	13.1	1	20.7	YES	437480
P-0012328-T01-IM5	P-0012328	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	837	15	PRAD	Not Available	0.00	Stable	MSKCC	Matched	68	NO	13.1	1	20.7	YES	437856
P-0012332-T01-IM5	P-0012332	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		473	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.85	Stable	MSKCC	Matched	69	NO	49.7	3.9	75.2	YES	438112
P-0012368-T01-IM5	P-0012368	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome.	772	20	PRAD	Not Available	1.18	Stable	MSKCC	Matched	72	NO	59.8	4.9	84.1	YES	435696
P-0012375-T01-IM5	P-0012375	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	629	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.44	Stable	MSKCC	Matched	71	NO	37.9	3	60	NO	NA
P-0012507-T01-IM5	P-0012507	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		947	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	56	NO	59.8	4.9	84.1	NO	NA
P-0012513-T01-IM5	P-0012513	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		772	60	PRAD	Not Available	0.16	Stable	MSKCC	Matched	67	NO	68	5.9	90.4	YES	438477
P-0012543-T01-IM5	P-0012543	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		782	60	PRAD	Not Available	0.08	Stable	MSKCC	Matched	61	NO	25.2	2	41.8	YES	441840
P-0012555-T01-IM5	P-0012555	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1036	60	PRAD	Not Available	0.28	Stable	MSKCC	Matched	61	NO	13.1	1	20.7	YES	442149
P-0012576-T01-IM5	P-0012576	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	856	10	PRAD	Not Available	0.00	Stable	MSKCC	Matched	68	NO				YES	441998
P-0012624-T01-IM5	P-0012624	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		878	60	PRAD	Not Available	0.09	Stable	MSKCC	Matched	57	NO	37.9	3	60	YES	443097
P-0012630-T02-IM6	P-0012630	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		834	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.45	Stable	MSKCC	Matched	71	NO	25.2	1.8	41.8	YES	1047412
P-0012643-T01-IM5	P-0012643	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome.	1015	60	PRAD	Not Available	1.11	Stable	MSKCC	Matched	55	NO	37.9	3	60	YES	441788
P-0012669-T02-IM6	P-0012669	Prostate Cancer	Metastasis	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		743	30	PRAD		0.00	Do not report	MSKCC	Matched	79	NO	37.9	2.6	59.9	NO	NA
P-0012675-T02-IM6	P-0012675	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p13, 4q12-4q13, and 13q14-13q33.	849	60	PRAD		0.68	Do not report	MSKCC	Matched	60	NO	25.2	1.8	41.8	YES	521247
P-0012676-T01-IM5	P-0012676	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample is recommended.	341	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	74	NO				YES	441970
P-0012711-T01-IM5	P-0012711	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		866	40	PRAD	Not Available	0.00	Stable	MSKCC	Matched	75	NO	79.1	7.9	95.5	YES	449056
P-0012741-T01-IM5	P-0012741	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		865	70	PRAD	Not Available	0.00	Stable	MSKCC	Matched	54	NO	13.1	1	20.7	YES	448183
P-0012834-T02-IM6	P-0012834	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		942	30	PRAD		0.00	Do not report	MSKCC	Matched	84	NO	44.1	3.5	69.1	YES	535263
P-0012857-T01-IM5	P-0012857	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out.	509	40	PRAD	Not Available	1.07	Stable	MSKCC	Matched	74	NO	49.7	3.9	75.2	YES	449118
P-0012914-T01-IM5	P-0012914	Prostate Cancer	Metastasis	Tumor	Right retroperitoneal lymph node	Prostate	Prostate Adenocarcinoma	IMPACT410		1104	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.35	Stable	MSKCC	Matched	61	NO	25.2	2	41.8	YES	448108
P-0012929-T01-IM5	P-0012929	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		702	70	PRAD	Not Available	0.16	Stable	MSKCC	Matched	61	NO	25.2	2	41.8	YES	449694
P-0012930-T01-IM5	P-0012930	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number losses of Chromosome arms 3q26-28, 15q13-21, and 22q11-12.	948	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.35	Stable	MSKCC	Matched	75	NO	13.1	1	20.7	YES	449686
P-0012995-T01-IM5	P-0012995	Prostate Cancer	Metastasis	Tumor	Adrenal Gland	Prostate	Prostate Adenocarcinoma	IMPACT410		966	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.25	Stable	MSKCC	Matched	81	NO	38.1	3.0	59.9	YES	449085
P-0013000-T01-IM5	P-0013000	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		942	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	85	NO	59.6	4.9	83.1	YES	449801
P-0013022-T01-IM5	P-0013022	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		733	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	69	NO	49.7	3.9	75.2	YES	449878
P-0013030-T01-IM5	P-0013030	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	103	10	PRAD	Not Available	2.56	Stable	MSKCC	Matched	55	NO	13.1	1	20.7	YES	449840
P-0013031-T01-IM5	P-0013031	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		778	60	PRAD	Not Available	0.08	Stable	MSKCC	Matched	71	NO	85.9	9.8	96.6	YES	449861
P-0013032-T02-IM6	P-0013032	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	649	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.31	Stable	MSKCC	Matched	72	NO	76.6	7.0	94.8	YES	1306407
P-0013036-T02-IM6	P-0013036	Prostate Cancer	Metastasis	Tumor	Iliac Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	464	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	76	NO	63.5	5.3	87.8	YES	1137399
P-0013037-T01-IM5	P-0013037	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		705	70	PRAD	Not Available	1.03	Stable	MSKCC	Matched	67	NO	85.9	9.8	96.6	YES	449838
P-0013038-T01-IM5	P-0013038	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		932	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	MSKCC	Matched	66	NO				YES	449855
P-0013115-T01-IM5	P-0013115	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		833	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.76	Stable	MSKCC	Matched	78	NO	68	5.9	90.4	YES	451871
P-0013184-T01-IM5	P-0013184	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	712	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	MSKCC	Matched	69	NO				YES	453206
P-0013223-T01-IM5	P-0013223	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		764	30	PRAD	Not Available	0.16	Stable	MSKCC	Matched	56	NO	37.9	3	60	YES	453055
P-0013245-T01-IM5	P-0013245	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		667	30	PRAD	Not Available	0.08	Stable	MSKCC	Matched	59	NO	25.2	2	41.8	YES	454705
P-0013336-T01-IM5	P-0013336	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		660	40	PRAD	Not Available	0.31	Stable	MSKCC	Matched	75	NO	25.2	2	41.8	YES	458709
P-0013339-T01-IM5	P-0013339	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		779	60	PRAD	Not Available	0.00	Stable	MSKCC	Matched	53	NO	37.9	3	60	YES	468432
P-0013340-T01-IM5	P-0013340	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		671	20	PRAD	Not Available	0.16	Stable	MSKCC	Matched	57	NO	49.7	3.9	75.2	YES	458641
P-0013348-T01-IM5	P-0013348	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		480	40	PRAD	Not Available	0.57	Stable	MSKCC	Matched	74	NO	13.1	1	20.7	YES	458556
P-0013358-T01-IM5	P-0013358	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		930	60	PRAD	Not Available	0.72	Stable	MSKCC	Matched	66	NO	25.2	2	41.8	YES	458183
P-0013372-T01-IM5	P-0013372	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1162	40	PRAD	Not Available	1.43	Stable	MSKCC	Matched	54	NO	13.1	1	20.7	YES	458645
P-0013401-T01-IM5	P-0013401	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1028	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.11	Stable	MSKCC	Matched	63	NO	59.8	4.9	84.1	YES	458135
P-0013457-T01-IM5	P-0013457	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		937	60	PRAD	Not Available	1.05	Stable	MSKCC	Matched	80	NO	37.9	3	60	YES	459197
P-0013465-T01-IM5	P-0013465	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		984	60	PRAD	Not Available	3.31	Indeterminate	MSKCC	Matched	82	NO	13.1	1	20.7	YES	458774
P-0013502-T01-IM5	P-0013502	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		1031	30	PRAD	Not Available	0.00	Stable	MSKCC	Matched	77	NO	37.9	3	60	YES	459216
P-0013503-T02-IM6	P-0013503	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		809	80	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.41	Stable	MSKCC	Matched	66	NO	43.0	3.5	67.2	YES	650736
P-0013505-T01-IM5	P-0013505	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1076	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	MSKCC	Matched	75	NO	79.1	7.9	95.5	YES	459203
P-0013526-T01-IM5	P-0013526	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome.	767	60	PRAD	Not Available	0.73	Stable	MSKCC	Matched	65	NO	49.7	3.9	75.2	YES	460423
P-0013631-T01-IM5	P-0013631	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		801	50	PRAD	Not Available	0.00	Stable	MSKCC	Matched	67	NO	49.7	3.9	75.2	YES	462396
P-0013660-T01-IM5	P-0013660	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		862	80	PRAD	Not Available	0.00	Stable	MSKCC	Matched	69	NO	37.9	3	60	YES	461031
P-0013671-T01-IM5	P-0013671	Prostate Cancer	Metastasis	Tumor	Rectum	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low sequencing depth of coverage of 92X, negative results should be interpreted with caution.	92	40	PRAD	Not Available	5.88	Indeterminate	MSKCC	Matched	77	NO	13.1	1	20.7	YES	461028
P-0013674-T01-IM5	P-0013674	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		1062	50	PRAD	Not Available	0.41	Stable	MSKCC	Matched	67	NO	13.1	1	20.7	YES	461075
P-0013681-T01-IM5	P-0013681	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT410		804	30	PRAD	Not Available	0.15	Stable	MSKCC	Matched	86	NO	13.1	1	20.7	YES	663228
P-0013697-T01-IM5	P-0013697	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of a fragmented genome.	877	60	PRAD	Not Available	0.96	Stable	MSKCC	Matched	77	NO	49.7	3.9	75.2	YES	464339
P-0013729-T01-IM5	P-0013729	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 2p and 5q.Note: Copy number profile is suggestive of broad copy number losses on Chromosome 10 and Chromosome arms 7p21-p22, 11q23, 13q14-q22, and 16q.	862	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.01	Stable	MSKCC	Matched	64	NO				YES	464335
P-0013732-T01-IM5	P-0013732	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q21-24.	957	20	PRAD	Not Available	1.88	Stable	MSKCC	Matched	74	NO	59.8	4.9	84.1	YES	465512
P-0013733-T01-IM5	P-0013733	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		587	40	PRAD	Not Available	0.47	Stable	MSKCC	Matched	67	NO	25.2	2	41.8	YES	465460
P-0013791-T01-IM5	P-0013791	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		614	30	PRAD		0.00	Do not report	MSKCC	Matched	60	NO				YES	465572
P-0013797-T01-IM5	P-0013797	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		340	80	PRAD		4.28	Do not report	MSKCC	Matched	67	NO	25.2	2	41.8	YES	465575
P-0013808-T02-IM6	P-0013808	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 17p.	889	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.57	Stable	MSKCC	Matched	76	NO	38.1	2.6	59.9	YES	1055341
P-0013809-T01-IM5	P-0013809	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		376	30	PRAD		1.61	Do not report	MSKCC	Matched	86	NO	25.2	2	41.8	YES	466862
P-0013810-T01-IM5	P-0013810	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1074	50	PRAD		0.45	Do not report	MSKCC	Matched	68	NO				YES	466865
P-0013811-T01-IM5	P-0013811	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	881	30	PRAD		0.00	Do not report	MSKCC	Matched	66	NO				YES	466921
P-0013812-T01-IM5	P-0013812	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		229	60	PRAD		1.55	Do not report	MSKCC	Matched	69	NO	25.2	2	41.8	YES	466895
P-0013837-T01-IM5	P-0013837	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		999	70	PRAD		0.58	Do not report	MSKCC	Matched	65	NO	25.2	2	41.8	YES	467026
P-0013843-T01-IM5	P-0013843	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		394	40	PRAD		0.47	Do not report	MSKCC	Matched	75	NO	37.9	3	60	YES	467639
P-0013844-T02-IM6	P-0013844	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		999	30	PRAD		0.36	Do not report	MSKCC	Matched	63	NO				YES	497548
P-0013850-T01-IM5	P-0013850	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution. Note: Low sequencing depth of coverage of 171X, negative results should be interpreted with caution.	171	10	PRAD		1.54	Do not report	MSKCC	Matched	74	NO	37.9	3	60	YES	466951
P-0013858-T01-IM5	P-0013858	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT410		885	30	PRAD		0.67	Do not report	MSKCC	Matched	70	NO	59.8	4.9	84.1	YES	466984
P-0013865-T02-IM6	P-0013865	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		1144	80	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.24	Stable	MSKCC	Matched	85	NO	13.1	0.9	20.6	YES	621651
P-0013911-T01-IM5	P-0013911	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	505	20	PRAD		0.08	Do not report	MSKCC	Matched	72	NO	25.2	2	41.8	YES	470263
P-0013936-T01-IM5	P-0013936	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 9p21.	668	60	PRAD		0.39	Do not report	MSKCC	Matched	69	NO	13.1	1	20.7	YES	468748
P-0013949-T01-IM5	P-0013949	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	229	10	PRAD		0.00	Do not report	MSKCC	Matched	67	NO				YES	470247
P-0013950-T01-IM5	P-0013950	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	514	20	PRAD		0.00	Do not report	MSKCC	Matched	60	NO	13.1	1	20.7	YES	471309
P-0013957-T01-IM5	P-0013957	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Note: Low sequencing depth of coverage of 183X. Negative results should be interpreted with caution.	183	30	PRAD		0.00	Do not report	MSKCC	Matched	75	NO	25.2	2	41.8	YES	471368
P-0013958-T01-IM5	P-0013958	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16q. Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 16p. Note: No other alterations identified in the context of adequate tumor content by morphological review. More comprehensive testing could be valuable.	505	40	PRAD		0.00	Do not report	MSKCC	Matched	63	NO				YES	470271
P-0014004-T01-IM5	P-0014004	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		936	80	PRAD		2.32	Do not report	MSKCC	Matched	71	NO	37.9	3	60	YES	471519
P-0014009-T01-IM5	P-0014009	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		900	50	PRAD		1.38	Do not report	MSKCC	Matched	69	NO	59.8	4.9	84.1	YES	472191
P-0014014-T01-IM5	P-0014014	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		367	30	PRAD		0.07	Do not report	MSKCC	Matched	72	NO	13.8	0.9	21.8	YES	472813
P-0014076-T01-IM5	P-0014076	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p. Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 3p11-21, 3q27-28, 9p, 13q, and 18q.	1194	40	PRAD		0.46	Stable	MSKCC	Matched	57	NO	68	5.9	90.4	YES	473695
P-0014080-T01-IM5	P-0014080	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		658	60	PRAD		0.00	Do not report	MSKCC	Matched	51	NO	25.2	2	41.8	YES	473758
P-0014202-T01-IM6	P-0014202	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	747	20	PRAD		0.00	Do not report	MSKCC	Matched	68	NO	25.2	1.8	41.8	YES	476971
P-0014204-T01-IM6	P-0014204	Prostate Cancer	Metastasis	Tumor	Omentum	Prostate	Prostate Adenocarcinoma	IMPACT468		903	70	PRAD		1.13	Do not report	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	476964
P-0014235-T01-IM6	P-0014235	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a broad copy number loss on Chromosome arm 16q22-24. Confirmatory testing by an alternate method is suggested, if clinically indicated.	885	30	PRAD		1.03	Do not report	MSKCC	Matched	64	NO	73.7	6.1	93.5	YES	477075
P-0014249-T01-IM6	P-0014249	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	459	20	PRAD		1.69	Do not report	MSKCC	Matched	86	NO	25.2	1.8	41.8	YES	477755
P-0014254-T02-IM6	P-0014254	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		1209	60	PRAD		0.54	Do not report	MSKCC	Matched	68	NO	13.1	0.9	20.6	YES	529440
P-0014256-T01-IM6	P-0014256	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	304	30	PRAD		3.14	Do not report	MSKCC	Matched	76	NO	25.2	1.8	41.8	YES	477763
P-0014299-T01-IM6	P-0014299	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	297	70	PRAD		1.86	Do not report	MSKCC	Matched	68	NO	44.1	3.5	69.1	YES	479135
P-0014333-T02-IM6	P-0014333	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		988	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.83	Stable	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	584668
P-0014341-T01-IM6	P-0014341	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		415	30	PRAD		0.63	Do not report	MSKCC	Matched	68	NO				YES	479970
P-0014390-T01-IM6	P-0014390	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		1005	60	PRAD		0.29	Do not report	MSKCC	Matched	50	NO	44.1	3.5	69.1	YES	483178
P-0014395-T01-IM6	P-0014395	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		726	20	PRAD		0.43	Do not report	MSKCC	Matched	70	NO	25.2	1.8	41.8	YES	480752
P-0014400-T01-IM6	P-0014400	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low sequencing depth of coverage of 68X, MSIsensor and negative results should be interpreted with caution.	68	10	PRAD		3.01	Do not report	MSKCC	Matched	83	NO	54.1	4.4	79.3	YES	480797
P-0014403-T01-IM6	P-0014403	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low sequencing depth of coverage of 100X, MSIsensor and negative results should be interpreted with caution.	100	20	PRAD		0.16	Do not report	MSKCC	Matched	55	NO				YES	480765
P-0014408-T01-IM6	P-0014408	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		1103	50	PRAD		1.42	Do not report	MSKCC	Matched	75	NO	63.5	5.3	87.8	YES	479995
P-0014412-T01-IM6	P-0014412	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		821	50	PRAD		0.00	Do not report	MSKCC	Matched	72	NO	25.2	1.8	41.8	YES	480139
P-0014414-T01-IM6	P-0014414	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		836	60	PRAD		0.31	Do not report	MSKCC	Matched	58	NO	13.1	0.9	20.6	YES	482545
P-0014417-T01-IM6	P-0014417	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	754	20	PRAD		0.07	Do not report	MSKCC	Matched	78	NO	13.1	0.9	20.6	YES	482578
P-0014425-T01-IM6	P-0014425	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation and copy number results should be interpreted with caution.	586	20	PRAD		0.07	Do not report	MSKCC	Matched	66	NO	25.2	1.8	41.8	YES	482618
P-0014427-T01-IM6	P-0014427	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	598	10	PRAD		0.15	Do not report	MSKCC	Matched	70	NO				YES	482581
P-0014429-T01-IM6	P-0014429	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	423	10	PRAD		0.90	Do not report	MSKCC	Matched	70	NO	13.1	0.9	20.6	YES	482633
P-0014438-T01-IM6	P-0014438	Prostate Cancer	Primary	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		666	80	PRAD		2.45	Do not report	MSKCC	Matched	68	NO	37.9	2.6	59.9	YES	482622
P-0014467-T01-IM6	P-0014467	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		918	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.72	Stable	MSKCC	Matched	47	NO	44.1	3.5	69.1	YES	483867
P-0014523-T01-IM6	P-0014523	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		688	40	PRAD		0.48	Do not report	MSKCC	Matched	74	NO	63.5	5.3	87.8	YES	484471
P-0014527-T01-IM6	P-0014527	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	779	20	PRAD		0.00	Do not report	MSKCC	Matched	81	NO	25.2	1.8	41.8	YES	483424
P-0014530-T01-IM6	P-0014530	Prostate Cancer	Metastasis	Tumor	Rectum	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	840	10	PRAD		0.07	Do not report	MSKCC	Matched	81	NO	44.1	3.5	69.1	YES	483407
P-0014531-T01-IM6	P-0014531	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	897	10	PRAD		0.24	Do not report	MSKCC	Matched	68	NO	13.1	0.9	20.6	YES	483382
P-0014557-T01-IM6	P-0014557	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		859	30	PRAD		0.13	Do not report	MSKCC	Matched	69	NO	44.1	3.5	69.1	YES	485039
P-0014566-T01-IM6	P-0014566	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		1203	40	PRAD		0.00	Do not report	MSKCC	Matched	74	NO	73.7	6.1	93.5	YES	485049
P-0014571-T01-IM6	P-0014571	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468		927	50	PRAD		0.21	Do not report	MSKCC	Matched	78	NO	54.1	4.4	79.3	YES	484528
P-0014591-T01-IM6	P-0014591	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		614	60	PRAD		0.00	Do not report	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	487340
P-0014597-T01-IM6	P-0014597	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		762	40	PRAD		0.06	Do not report	MSKCC	Matched	53	NO	25.2	1.8	41.8	NO	NA
P-0014598-T01-IM6	P-0014598	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		729	10	PRAD		0.12	Do not report	MSKCC	Matched	77	NO	37.9	2.6	59.9	YES	487314
P-0014613-T01-IM6	P-0014613	Prostate Cancer	Metastasis	Tumor	Adrenal	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 8p11 and 8q11-24.	802	50	PRAD		0.65	Do not report	MSKCC	Matched	65	NO	37.9	2.6	59.9	NO	NA
P-0014629-T01-IM6	P-0014629	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		704	20	PRAD		0.21	Do not report	MSKCC	Matched	72	NO	38.1	2.6	59.9	YES	487361
P-0014686-T01-IM6	P-0014686	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q13-21.	600	30	PRAD		0.18	Do not report	MSKCC	Matched	69	NO				YES	487311
P-0014689-T02-IM6	P-0014689	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		253	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.30	Stable	MSKCC	Matched	65	NO	13.1	0.9	20.6	YES	976709
P-0014701-T01-IM6	P-0014701	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468		1104	50	PRAD		0.24	Do not report	MSKCC	Matched	72	NO	44.1	3.5	69.1	YES	488383
P-0014717-T01-IM6	P-0014717	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	406	20	PRAD		0.18	Do not report	MSKCC	Matched	70	NO				YES	487332
P-0014819-T01-IM6	P-0014819	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	834	10	PRAD		0.00	Do not report	MSKCC	Matched	81	NO				YES	488517
P-0014841-T01-IM6	P-0014841	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 9p21.	810	60	PRAD		0.58	Do not report	MSKCC	Matched	67	NO	13.1	0.9	20.6	YES	490633
P-0014888-T01-IM6	P-0014888	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		677	65	PRAD		0.00	Do not report	MSKCC	Matched	59	NO	13.1	0.9	20.6	YES	424038
P-0014892-T01-IM6	P-0014892	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		760	40	PRAD		0.07	Do not report	MSKCC	Matched	53	NO	44.1	3.5	69.1	YES	492917
P-0014931-T01-IM6	P-0014931	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		688	50	PRAD		0.22	Do not report	MSKCC	Matched	76	NO	54.1	4.4	79.3	YES	496713
P-0014991-T01-IM6	P-0014991	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	95	30	PRAD	NA	13.75	Do not report	MSKCC	Matched	84	NO	44.1	3.5	69.1	YES	493481
P-0014992-T01-IM6	P-0014992	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative copy number results should be interpreted with caution.	280	20	PRAD		0.48	Do not report	MSKCC	Matched	63	NO	37.9	2.6	59.9	YES	493607
P-0014996-T02-IM6	P-0014996	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	490	20	PRAD		0.30	Do not report	MSKCC	Matched	80	NO	25.2	1.8	41.8	YES	526887
P-0015011-T01-IM6	P-0015011	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	128	20	PRAD	NA	16.58	Do not report	MSKCC	Matched	74	NO				YES	496062
P-0015015-T01-IM6	P-0015015	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.Note: Low tumor content (approximately 20% or less). Negative mutation and copy number results should be interpreted with caution.	209	20	PRAD		2.44	Do not report	MSKCC	Matched	70	NO	25.2	1.8	41.8	YES	496051
P-0015026-T01-IM6	P-0015026	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	888	20	PRAD		0.00	Do not report	MSKCC	Matched	68	NO	25.2	1.8	41.8	NO	NA
P-0015060-T01-IM6	P-0015060	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 11q.	779	20	PRAD		0.15	Do not report	MSKCC	Matched	66	NO	13.1	0.9	20.6	YES	498547
P-0015064-T01-IM6	P-0015064	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q13-13q22.	692	20	PRAD		0.15	Do not report	MSKCC	Matched	59	NO	43.0	3.5	67.2	YES	498493
P-0015070-T01-IM6	P-0015070	Prostate Cancer	Metastasis	Tumor	Sacral Mass	Prostate	Prostate Adenocarcinoma	IMPACT468		698	20	PRAD		0.15	Do not report	MSKCC	Matched	48	NO	54.1	4.4	79.3	YES	498406
P-0015102-T01-IM6	P-0015102	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		807	50	PRAD		0.12	Do not report	MSKCC	Matched	67	NO	44.1	3.5	69.1	YES	498551
P-0015131-T01-IM6	P-0015131	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		823	30	PRAD		0.08	Do not report	MSKCC	Matched	50	NO	25.2	1.8	41.8	YES	497650
P-0015132-T01-IM6	P-0015132	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		733	30	PRAD		0.08	Do not report	MSKCC	Matched	72	NO	54.1	4.4	79.3	YES	497644
P-0015133-T01-IM6	P-0015133	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	363	10	PRAD		0.41	Do not report	MSKCC	Matched	79	NO				YES	498535
P-0015134-T01-IM6	P-0015134	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		733	50	PRAD		0.34	Do not report	MSKCC	Matched	61	NO	54.1	4.4	79.3	YES	497592
P-0015155-T01-IM6	P-0015155	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		750	30	PRAD		0.00	Do not report	MSKCC	Matched	61	NO	25.2	1.8	41.8	YES	497654
P-0015184-T01-IM6	P-0015184	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		604	50	PRAD		0.32	Do not report	MSKCC	Matched	76	NO	25.2	1.8	41.8	YES	499271
P-0015206-T02-IM6	P-0015206	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		424	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	71	NO	82.2	8.8	96.1	YES	1019324
P-0015209-T01-IM6	P-0015209	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468		809	30	PRAD		0.00	Do not report	MSKCC	Matched	77	NO	37.9	2.6	59.9	YES	500832
P-0015211-T01-IM6	P-0015211	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		782	40	PRAD		6.83	Do not report	MSKCC	Matched	67	NO	91.4	14	97.4	YES	498766
P-0015239-T01-IM6	P-0015239	Prostate Cancer	Metastasis	Tumor	Soft Tissue Back	Prostate	Prostate Adenocarcinoma	IMPACT468		607	50	PRAD		0.37	Do not report	MSKCC	Matched	77	NO	37.9	2.6	59.9	YES	497683
P-0015250-T01-IM6	P-0015250	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		642	40	PRAD		0.30	Do not report	MSKCC	Matched	69	NO	73.7	6.1	93.5	YES	499327
P-0015278-T01-IM6	P-0015278	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		838	30	PRAD		0.00	Do not report	MSKCC	Matched	66	NO	25.2	1.8	41.8	YES	501622
P-0015284-T01-IM6	P-0015284	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	184	40	PRAD		1.66	Do not report	MSKCC	Matched	69	NO	25.2	1.8	41.8	YES	500814
P-0015302-T01-IM6	P-0015302	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		780	40	PRAD		0.46	Do not report	MSKCC	Matched	61	NO	37.9	2.6	59.9	YES	501600
P-0015324-T01-IM6	P-0015324	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	808	10	PRAD		0.00	Do not report	MSKCC	Matched	66	NO	13.1	0.9	20.6	YES	501590
P-0015333-T01-IM6	P-0015333	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		619	30	PRAD		0.00	Do not report	MSKCC	Matched	56	NO	25.2	1.8	41.8	YES	502759
P-0015345-T01-IM6	P-0015345	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Reflex testing by Archer FusionPlexTM Custom Solid Panel will also be performed and the results will be reported in a separate accession number.	929	70	PRAD		0.51	Do not report	MSKCC	Matched	81	YES	54.1	4.4	79.3	YES	501588
P-0015406-T01-IM6	P-0015406	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		432	20	PRAD		0.28	Do not report	MSKCC	Matched	75	NO	54.1	4.4	79.3	YES	503116
P-0015448-T01-IM6	P-0015448	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		837	30	PRAD		0.00	Do not report	MSKCC	Matched	70	NO	37.9	2.6	59.9	YES	504624
P-0015450-T01-IM6	P-0015450	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		712	30	PRAD		0.00	Do not report	MSKCC	Matched	64	NO	13.1	0.9	20.6	YES	504671
P-0015452-T01-IM6	P-0015452	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results cannot be excluded due to insufficient coverage.	141	30	PRAD		1.89	Do not report	MSKCC	Matched	68	NO	54.1	4.4	79.3	YES	504986
P-0015479-T01-IM6	P-0015479	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		454	10	PRAD		0.00	Do not report	MSKCC	Matched	71	NO	13.1	0.9	20.6	YES	506026
P-0015482-T01-IM6	P-0015482	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		613	30	PRAD		0.00	Do not report	MSKCC	Matched	66	NO				YES	504538
P-0015545-T01-IM6	P-0015545	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		725	50	PRAD		0.11	Do not report	MSKCC	Matched	56	NO	37.9	2.6	59.9	YES	509841
P-0015547-T01-IM6	P-0015547	Prostate Cancer	Metastasis	Tumor	Sacral Mass	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	724	20	PRAD		0.05	Do not report	MSKCC	Matched	59	NO	13.1	0.9	20.6	YES	509847
P-0015552-T01-IM6	P-0015552	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		650	20	PRAD		0.13	Do not report	MSKCC	Matched	66	NO	37.9	2.6	59.9	YES	510673
P-0015597-T01-IM6	P-0015597	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		519	40	PRAD		0.00	Do not report	MSKCC	Matched	50	NO	37.9	2.6	59.9	NO	NA
P-0015618-T01-IM6	P-0015618	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome..	896	20	PRAD		0.28	Do not report	MSKCC	Matched	82	NO	73.7	6.1	93.5	YES	509920
P-0015628-T01-IM6	P-0015628	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		942	30	PRAD		0.98	Do not report	MSKCC	Matched	59	NO	54.1	4.4	79.3	YES	511771
P-0015744-T01-IM6	P-0015744	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		386	50	PRAD		0.08	Do not report	MSKCC	Matched	55	NO	13.1	0.9	20.6	NO	NA
P-0015748-T01-IM6	P-0015748	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	271	30	PRAD		3.46	Do not report	MSKCC	Matched	68	NO				YES	510464
P-0015767-T01-IM6	P-0015767	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	818	10	PRAD		0.12	Do not report	MSKCC	Matched	71	NO	54.1	4.4	79.3	YES	514981
P-0015778-T01-IM6	P-0015778	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of adequate tumor content. More comprehensive testing could be valuable.	794	30	PRAD		0.07	Do not report	MSKCC	Matched	60	NO				YES	515064
P-0015788-T01-IM6	P-0015788	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of high tumor content. More comprehensive testing could be valuable.	534	30	PRAD		0.00	Do not report	MSKCC	Matched	65	NO				YES	513215
P-0015813-T01-IM6	P-0015813	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		817	20	PRAD		1.19	Do not report	MSKCC	Matched	57	NO	73.7	6.1	93.5	YES	515158
P-0015817-T01-IM6	P-0015817	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		262	50	PRAD		2.48	Do not report	MSKCC	Matched	72	NO	13.1	0.9	20.6	YES	515718
P-0015836-T01-IM6	P-0015836	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low sequencing depth of coverage of 105x, MSIsensor and negative results should be interpreted with caution.	105	40	PRAD	NA	15.85	Do not report	MSKCC	Matched	71	NO	37.9	2.6	59.9	YES	515864
P-0015837-T01-IM6	P-0015837	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		710	40	PRAD		7.99	Do not report	MSKCC	Matched	75	NO	85.9	9.7	96.5	YES	515826
P-0015842-T01-IM6	P-0015842	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		760	50	PRAD		0.06	Do not report	MSKCC	Matched	71	NO	13.1	0.9	20.6	YES	515893
P-0015850-T01-IM6	P-0015850	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		968	60	PRAD		0.07	Do not report	MSKCC	Matched	61	NO	13.1	0.9	20.6	YES	515722
P-0015906-T01-IM6	P-0015906	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q11-8q24.3.	546	50	PRAD		0.36	Do not report	MSKCC	Matched	63	NO	13.1	0.9	20.6	YES	515830
P-0015925-T02-IM6	P-0015925	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome..	692	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.52	Stable	MSKCC	Matched	74	NO	25.2	1.8	41.8	YES	729366
P-0015960-T02-IM6	P-0015960	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		431	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.42	Stable	MSKCC	Matched	58	NO	44.1	3.5	69.1	YES	1063363
P-0015962-T01-IM6	P-0015962	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	853	40	PRAD		0.34	Do not report	MSKCC	Matched	56	NO	44.1	3.5	69.1	YES	517761
P-0015991-T01-IM6	P-0015991	Prostate Cancer	Metastasis	Tumor	Spine (Bone)	Prostate	Prostate Adenocarcinoma	IMPACT468		835	30	PRAD		0.25	Do not report	MSKCC	Matched	78	NO	54.1	4.4	79.3	YES	518730
P-0016004-T01-IM6	P-0016004	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		620	30	PRAD		0.15	Do not report	MSKCC	Matched	70	NO	25.2	1.8	41.8	YES	518668
P-0016059-T01-IM6	P-0016059	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	294	20	PRAD		0.08	Do not report	MSKCC	Matched	60	NO	25.2	1.8	41.8	YES	520025
P-0016064-T01-IM6	P-0016064	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		488	30	PRAD		0.18	Do not report	MSKCC	Matched	71	NO	25.2	1.8	41.8	YES	520056
P-0016087-T01-IM6	P-0016087	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		478	50	PRAD		0.00	Do not report	MSKCC	Matched	55	NO	25.2	1.8	41.8	YES	523110
P-0016117-T01-IM6	P-0016117	Prostate Cancer	Metastasis	Tumor	Colon	Prostate	Prostate Adenocarcinoma	IMPACT468		606	80	PRAD		0.35	Do not report	MSKCC	Matched	73	NO	54.1	4.4	79.3	YES	524097
P-0016134-T01-IM6	P-0016134	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		593	30	PRAD		0.29	Do not report	MSKCC	Matched	72	NO	25.2	1.8	41.8	YES	524087
P-0016214-T01-IM6	P-0016214	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		762	60	PRAD		0.14	Do not report	MSKCC	Matched	70	NO	76.6	7	94.8	YES	526132
P-0016218-T01-IM6	P-0016218	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		709	30	PRAD		0.00	Do not report	MSKCC	Matched	62	NO	13.1	0.9	20.6	YES	526177
P-0016220-T01-IM6	P-0016220	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		712	10	PRAD		0.00	Do not report	MSKCC	Matched	83	NO	25.2	1.8	41.8	YES	526225
P-0016236-T01-IM6	P-0016236	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		724	20	PRAD		0.07	Do not report	MSKCC	Matched	64	NO	25.2	1.8	41.8	NO	NA
P-0016248-T01-IM6	P-0016248	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	527	50	PRAD		0.00	Do not report	MSKCC	Matched	81	NO	25.2	1.8	41.8	NO	NA
P-0016288-T01-IM6	P-0016288	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		907	30	PRAD		0.18	Do not report	MSKCC	Matched	66	NO	73.7	6.1	93.5	YES	526925
P-0016295-T01-IM6	P-0016295	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		719	50	PRAD		0.00	Do not report	MSKCC	Matched	50	NO	25.2	1.8	41.8	YES	525009
P-0016296-T01-IM6	P-0016296	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT468		741	20	PRAD		0.00	Do not report	MSKCC	Matched	73	NO	44.1	3.5	69.1	YES	524188
P-0016305-T01-IM6	P-0016305	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	854	20	PRAD		0.07	Do not report	MSKCC	Matched	59	NO	13.1	0.9	20.6	YES	527403
P-0016307-T01-IM6	P-0016307	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		955	40	PRAD		0.00	Do not report	MSKCC	Matched	84	NO	37.9	2.6	59.9	YES	527528
P-0016313-T01-IM6	P-0016313	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		847	50	PRAD		0.00	Do not report	MSKCC	Matched	68	YES	13.1	0.9	20.6	YES	527546
P-0016320-T01-IM6	P-0016320	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	545	20	PRAD		0.00	Do not report	MSKCC	Matched	69	NO	25.2	1.8	41.8	YES	527041
P-0016325-T01-IM6	P-0016325	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		899	50	PRAD		0.52	Do not report	MSKCC	Matched	82	NO	44.1	3.5	69.1	YES	526361
P-0016339-T01-IM6	P-0016339	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	490	60	PRAD		0.07	Do not report	MSKCC	Matched	74	NO	13.1	0.9	20.6	YES	526905
P-0016342-T01-IM6	P-0016342	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		665	30	PRAD		0.00	Do not report	MSKCC	Matched	69	NO	37.9	2.6	59.9	YES	526919
P-0016386-T01-IM6	P-0016386	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		503	40	PRAD		0.15	Do not report	MSKCC	Matched	71	NO				YES	526961
P-0016393-T01-IM6	P-0016393	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		728	50	PRAD		0.00	Do not report	MSKCC	Matched	73	NO	13.1	0.9	20.6	YES	527046
P-0016396-T01-IM6	P-0016396	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		893	60	PRAD		0.57	Do not report	MSKCC	Matched	72	NO	25.2	1.8	41.8	YES	524158
P-0016405-T01-IM6	P-0016405	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8.	709	50	PRAD		0.41	Do not report	MSKCC	Matched	80	NO	13.1	0.9	20.6	YES	525642
P-0016422-T01-IM6	P-0016422	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	793	10	PRAD		0.15	Do not report	MSKCC	Matched	69	NO				YES	528588
P-0016446-T01-IM6	P-0016446	Prostate Cancer	Metastasis	Tumor	Mediastinum	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	372	80	PRAD		1.33	Do not report	MSKCC	Matched	83	NO	54.1	4.4	79.3	YES	529436
P-0016450-T01-IM6	P-0016450	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		770	60	PRAD		1.02	Do not report	MSKCC	Matched	78	NO	13.1	0.9	20.6	YES	528642
P-0016490-T01-IM6	P-0016490	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	973	10	PRAD		0.00	Do not report	MSKCC	Matched	70	NO	13.1	0.9	20.6	YES	529381
P-0016534-T01-IM6	P-0016534	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		766	10	PRAD		0.00	Do not report	MSKCC	Matched	70	NO	13.1	0.9	20.6	YES	530325
P-0016538-T01-IM6	P-0016538	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		1150	10	PRAD		0.47	Do not report	MSKCC	Matched	58	NO	73.7	6.1	93.5	YES	530265
P-0016548-T01-IM6	P-0016548	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		795	30	PRAD		0.36	Do not report	MSKCC	Matched	74	NO	25.2	1.8	41.8	YES	532408
P-0016594-T01-IM6	P-0016594	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	234	40	PRAD		0.24	Do not report	MSKCC	Matched	54	NO	37.9	2.6	59.9	YES	534078
P-0016617-T01-IM6	P-0016617	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3q13-23, 8p, and 16q23-24.	744	60	PRAD		0.35	Do not report	MSKCC	Matched	68	NO	13.1	0.9	20.6	YES	533570
P-0016650-T01-IM6	P-0016650	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	807	10	PRAD		0.00	Do not report	MSKCC	Matched	78	NO				YES	537085
P-0016698-T01-IM6	P-0016698	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		370	50	PRAD		1.34	Do not report	MSKCC	Matched	70	NO	25.2	1.8	41.8	YES	538566
P-0016731-T01-IM6	P-0016731	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: The copy number profile is suggestive of broad copy number loss on Chromosome arm 19p13.12 - 19p13.3.	556	50	PRAD		1.68	Do not report	MSKCC	Matched	83	NO	73.7	6.1	93.5	YES	533519
P-0016733-T01-IM6	P-0016733	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		861	70	PRAD		0.35	Do not report	MSKCC	Matched	61	NO	79.1	7.9	95.5	YES	533564
P-0016768-T01-IM6	P-0016768	Prostate Cancer	Metastasis	Tumor	Iliac Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	319	50	PRAD		0.68	Do not report	MSKCC	Matched	58	NO	82.2	8.8	96.1	YES	536961
P-0016812-T01-IM6	P-0016812	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q21.32-23.	922	60	PRAD		0.78	Do not report	MSKCC	Matched	76	NO	44.1	3.5	69.1	YES	538536
P-0016876-T01-IM6	P-0016876	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		679	50	PRAD		0.00	Do not report	MSKCC	Matched	64	NO	25.2	1.8	41.8	YES	540981
P-0016877-T01-IM6	P-0016877	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 9p, 12p, 17p12-13, and 19q13.2-13.33.	834	50	PRAD		0.08	Do not report	MSKCC	Matched	59	NO	25.2	1.8	41.8	YES	541035
P-0016883-T01-IM6	P-0016883	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		954	50	PRAD		1.06	Do not report	MSKCC	Matched	72	NO	37.9	2.6	59.9	YES	540898
P-0016895-T01-IM6	P-0016895	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468		937	10	PRAD		0.00	Do not report	MSKCC	Matched	70	NO	37.9	2.6	59.9	YES	541895
P-0016911-T01-IM6	P-0016911	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		949	60	PRAD		0.65	Do not report	MSKCC	Matched	68	NO	13.1	0.9	20.6	YES	540894
P-0016914-T01-IM6	P-0016914	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		888	20	PRAD		0.07	Do not report	MSKCC	Matched	77	NO	37.9	2.6	59.9	YES	541021
P-0016919-T01-IM6	P-0016919	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		628	40	PRAD		0.40	Do not report	MSKCC	Matched	75	NO	37.9	2.6	59.9	YES	541027
P-0016921-T01-IM6	P-0016921	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q21-23.	1061	60	PRAD		1.11	Do not report	MSKCC	Matched	65	NO	44.1	3.5	69.1	YES	540988
P-0016930-T01-IM6	P-0016930	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	619	20	PRAD		0.00	Do not report	MSKCC	Matched	79	NO	25.2	1.8	41.8	YES	540934
P-0016933-T01-IM6	P-0016933	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		676	30	PRAD		0.00	Do not report	MSKCC	Matched	78	NO	25.2	1.8	41.8	YES	541850
P-0016941-T01-IM6	P-0016941	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		919	50	PRAD		0.00	Do not report	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	543218
P-0016961-T01-IM6	P-0016961	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		610	10	PRAD		0.24	Do not report	MSKCC	Matched	83	NO	13.1	0.9	20.6	YES	543274
P-0016983-T02-IM6	P-0016983	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT468		738	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.20	Stable	MSKCC	Matched	68	NO	62.5	5.3	86.0	YES	657486
P-0016986-T01-IM6	P-0016986	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		553	40	PRAD		0.00	Do not report	MSKCC	Matched	57	NO	37.9	2.6	59.9	YES	543722
P-0016990-T01-IM6	P-0016990	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		579	60	PRAD		1.39	Do not report	MSKCC	Matched	64	NO	25.2	1.8	41.8	YES	543167
P-0017041-T01-IM6	P-0017041	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		947	50	PRAD		1.49	Do not report	MSKCC	Matched	65	NO	73.7	6.1	93.5	YES	544915
P-0017065-T01-IM6	P-0017065	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		813	40	PRAD		0.26	Do not report	MSKCC	Matched	57	NO	13.1	0.9	20.6	YES	543906
P-0017097-T01-IM6	P-0017097	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		1012	80	PRAD		0.44	Do not report	MSKCC	Matched	84	NO	73.7	6.1	93.5	YES	543753
P-0017168-T01-IM6	P-0017168	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		581	50	PRAD		0.36	Do not report	MSKCC	Matched	73	NO	25.2	1.8	41.8	YES	547247
P-0017169-T01-IM6	P-0017169	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q13-8q24.21.	1047	50	PRAD		0.28	Do not report	MSKCC	Matched	77	NO	63.5	5.3	87.8	YES	544968
P-0017177-T01-IM6	P-0017177	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.Note: No alterations identified in the context of high tumor content .Silent mutations identified were present in high percentage.More comprehensive testing could be valuable.Note: Low sequencing depth of coverage of 124x, MSIsensor and negative results should be interpreted with caution.	124	40	PRAD		7.27	Do not report	MSKCC	Matched	73	NO				YES	547259
P-0017227-T01-IM6	P-0017227	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	263	20	PRAD		0.29	Do not report	MSKCC	Matched	57	NO	13.1	0.9	20.6	YES	558758
P-0017232-T01-IM6	P-0017232	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		894	60	PRAD		2.30	Do not report	MSKCC	Matched	68	NO	13.1	0.9	20.6	YES	547342
P-0017235-T01-IM6	P-0017235	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	765	10	PRAD		0.07	Do not report	MSKCC	Matched	70	NO	25.2	1.8	41.8	YES	547372
P-0017245-T01-IM6	P-0017245	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		439	20	PRAD		0.22	Do not report	MSKCC	Matched	60	NO				YES	556684
P-0017262-T01-IM6	P-0017262	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		726	50	PRAD		0.07	Do not report	MSKCC	Matched	66	NO	25.2	1.8	41.8	YES	563026
P-0017271-T01-IM6	P-0017271	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		911	50	PRAD		1.60	Do not report	MSKCC	Matched	63	NO	37.9	2.6	59.9	YES	552311
P-0017287-T01-IM6	P-0017287	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		680	60	PRAD		1.07	Do not report	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	549268
P-0017312-T01-IM6	P-0017312	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		787	40	PRAD		0.00	Do not report	MSKCC	Matched	62	NO	13.1	0.9	20.6	YES	549974
P-0017376-T01-IM6	P-0017376	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		886	30	PRAD		0.50	Do not report	MSKCC	Matched	79	NO	63.5	5.3	87.8	YES	552434
P-0017491-T01-IM6	P-0017491	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		823	50	PRAD		0.13	Do not report	MSKCC	Matched	58	NO	37.9	2.6	59.9	YES	554093
P-0017494-T01-IM6	P-0017494	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		729	40	PRAD		0.07	Do not report	MSKCC	Matched	70	NO	37.9	2.6	59.9	NO	NA
P-0017524-T01-IM6	P-0017524	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q13-24.21.	940	50	PRAD		0.27	Do not report	MSKCC	Matched	78	NO	54.1	4.4	79.3	YES	554060
P-0017530-T01-IM5	P-0017530	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		1021	50	PRAD		0.00	Do not report	MSKCC	Matched	62	NO	13.1	1	20.7	YES	562207
P-0017543-T01-IM5	P-0017543	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		637	40	PRAD		0.40	Do not report	MSKCC	Matched	76	NO	59.8	4.9	84.1	YES	580416
P-0017548-T01-IM5	P-0017548	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT410		482	30	PRAD		0.00	Do not report	MSKCC	Matched	72	NO	59.8	4.9	84.1	YES	562219
P-0017560-T01-IM5	P-0017560	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		407	30	PRAD		0.56	Do not report	MSKCC	Matched	71	NO	25.2	2	41.8	YES	556598
P-0017605-T01-IM5	P-0017605	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410		846	60	PRAD		0.00	Do not report	MSKCC	Matched	53	NO	25.2	2	41.8	YES	556109
P-0017615-T01-IM5	P-0017615	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT410		1189	60	PRAD		0.58	Do not report	MSKCC	Matched	51	NO	25.2	2	41.8	YES	556568
P-0017662-T01-IM5	P-0017662	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT410	Note: A TMPRSS2 intronic deletion is detected with very low read support.  A broader rearrangement involving TMPRSS2 such as a TMPRSS2-ERG structural variant cannot be ruled out.  Further testing by an alternative method may be performed upon request.	492	20	PRAD		0.31	Do not report	MSKCC	Matched	71	NO	37.9	3	60	YES	560920
P-0017686-T01-IM6	P-0017686	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q including MYC.	668	50	PRAD		0.00	Do not report	MSKCC	Matched	60	NO	37.9	2.6	59.9	NO	NA
P-0017703-T01-IM6	P-0017703	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		559	60	PRAD		0.15	Do not report	MSKCC	Matched	60	NO	37.9	2.6	59.9	YES	558326
P-0017707-T01-IM6	P-0017707	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of adequate tumor content. More comprehensive testing could be valuable.	625	50	PRAD		0.00	Do not report	MSKCC	Matched	64	NO				YES	559133
P-0017708-T01-IM6	P-0017708	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		453	30	PRAD		0.47	Do not report	MSKCC	Matched	71	NO	63.5	5.3	87.8	YES	558071
P-0017730-T01-IM6	P-0017730	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	634	50	PRAD		0.07	Do not report	MSKCC	Matched	67	NO	25.2	1.8	41.8	YES	558871
P-0017733-T01-IM6	P-0017733	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6p22.2.	557	60	PRAD		0.15	Do not report	MSKCC	Matched	71	NO	37.9	2.6	59.9	YES	559158
P-0017754-T02-IM6	P-0017754	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		447	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	65	NO	37.9	2.6	59.9	YES	1262470
P-0017774-T01-IM6	P-0017774	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		537	50	PRAD		0.00	Do not report	MSKCC	Matched	46	NO	25.2	1.8	41.8	YES	560069
P-0017810-T01-IM6	P-0017810	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		698	40	PRAD		0.13	Do not report	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	558327
P-0017844-T01-IM6	P-0017844	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		425	50	PRAD		0.09	Do not report	MSKCC	Matched	72	NO	25.2	1.8	41.8	YES	563087
P-0017882-T01-IM6	P-0017882	Prostate Cancer	Metastasis	Tumor	Adrenal	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome.	779	60	PRAD		1.10	Do not report	MSKCC	Matched	67	NO	37.9	2.6	59.9	YES	566314
P-0017886-T01-IM6	P-0017886	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468		870	70	PRAD		0.17	Do not report	MSKCC	Matched	71	NO	63.5	5.3	87.8	YES	566397
P-0017889-T01-IM6	P-0017889	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		349	80	PRAD		2.08	Do not report	MSKCC	Matched	80	NO	44.1	3.5	69.1	YES	566303
P-0017890-T01-IM6	P-0017890	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	251	40	PRAD		1.12	Do not report	MSKCC	Matched	51	NO	37.9	2.6	59.9	YES	567285
P-0017892-T01-IM6	P-0017892	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		583	40	PRAD		0.29	Do not report	MSKCC	Matched	83	NO	63.5	5.3	87.8	YES	563073
P-0017932-T01-IM6	P-0017932	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		793	30	PRAD		0.17	Do not report	MSKCC	Matched	74	NO	37.9	2.6	59.9	YES	559237
P-0017940-T01-IM6	P-0017940	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		510	40	PRAD		0.00	Do not report	MSKCC	Matched	69	NO	25.2	1.8	41.8	YES	561018
P-0017944-T01-IM6	P-0017944	Prostate Cancer	Metastasis	Tumor	Vertebrate	Prostate	Prostate Adenocarcinoma	IMPACT468		1044	20	PRAD		0.19	Do not report	MSKCC	Matched	75	NO	37.9	2.6	59.9	YES	563130
P-0017960-T01-IM6	P-0017960	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 13q14.	946	70	PRAD		0.07	Do not report	MSKCC	Matched	83	NO	54.1	4.4	79.3	NO	NA
P-0017964-T01-IM6	P-0017964	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		857	30	PRAD		0.00	Do not report	MSKCC	Matched	65	NO	13.1	0.9	20.6	YES	566175
P-0017987-T01-IM6	P-0017987	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 8p, 13q13-14 and 16q.	741	50	PRAD		0.12	Do not report	MSKCC	Matched	59	NO	37.9	2.6	59.9	YES	565022
P-0017988-T01-IM6	P-0017988	Prostate Adenocarcinoma	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a different sample is advised, if clinically indicated.	582	10	PRAD		0.00	Do not report	MSKCC	Matched	74	NO	0.0	0.0	0.0	YES	587346
P-0017989-T01-IM6	P-0017989	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		753	40	PRAD		0.00	Do not report	MSKCC	Matched	73	NO	25.2	1.8	41.8	YES	565023
P-0018038-T01-IM6	P-0018038	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		582	30	PRAD		0.89	Do not report	MSKCC	Matched	74	NO	25.2	1.8	41.8	YES	567344
P-0018068-T01-IM6	P-0018068	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 1p36, 2q14-22, 4q12, 5q11-22 (except RASA1), 6q15-22, 8p11-12, 12p12-13 (except KRAS), and 16q.	527	60	PRAD		0.80	Do not report	MSKCC	Matched	66	NO	44.1	3.5	69.1	YES	569182
P-0018086-T01-IM6	P-0018086	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		987	50	PRAD		0.00	Do not report	MSKCC	Matched	54	NO	73.7	6.1	93.5	YES	566383
P-0018090-T01-IM6	P-0018090	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	642	10	PRAD		0.40	Do not report	MSKCC	Matched	59	NO	13.1	0.9	20.6	YES	565044
P-0018093-T01-IM6	P-0018093	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	551	40	PRAD		0.00	Do not report	MSKCC	Matched	74	NO	13.1	0.9	20.6	YES	566213
P-0018117-T01-IM6	P-0018117	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		807	30	PRAD		0.92	Do not report	MSKCC	Matched	86	NO	87.1	10.5	96.9	YES	568137
P-0018127-T01-IM6	P-0018127	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		436	40	PRAD		0.00	Do not report	MSKCC	Matched	61	NO	13.1	0.9	20.6	YES	568168
P-0018149-T01-IM6	P-0018149	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		322	30	PRAD		0.00	Do not report	MSKCC	Matched	59	NO	13.1	0.9	20.6	YES	569329
P-0018151-T01-IM6	P-0018151	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	303	10	PRAD		0.00	Do not report	MSKCC	Matched	56	NO				YES	569187
P-0018174-T01-IM6	P-0018174	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	843	20	PRAD		0.00	Do not report	MSKCC	Matched	59	NO	25.2	1.8	41.8	YES	573320
P-0018178-T03-IM6	P-0018178	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		525	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	88	NO	25.2	1.8	41.8	YES	1155260
P-0018217-T01-IM6	P-0018217	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16q12-23.	595	60	PRAD		0.00	Do not report	MSKCC	Matched	71	NO	37.9	2.6	59.9	YES	571481
P-0018221-T01-IM6	P-0018221	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6q21-22 and 8p.	686	50	PRAD		0.19	Do not report	MSKCC	Matched	86	NO	25.2	1.8	41.8	YES	574119
P-0018235-T01-IM6	P-0018235	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		535	50	PRAD		0.15	Do not report	MSKCC	Matched	67	NO	13.1	0.9	20.6	YES	569371
P-0018297-T01-IM6	P-0018297	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		870	20	PRAD		0.00	Do not report	MSKCC	Matched	54	NO	25.2	1.8	41.8	YES	574190
P-0018302-T01-IM6	P-0018302	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		629	40	PRAD		0.29	Do not report	MSKCC	Matched	72	NO	44.1	3.5	69.1	YES	577043
P-0018315-T01-IM6	P-0018315	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		609	50	PRAD		0.54	Do not report	MSKCC	Matched	80	NO	44.1	3.5	69.1	YES	574884
P-0018384-T01-IM6	P-0018384	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	618	10	PRAD		0.00	Do not report	MSKCC	Matched	72	YES	13.1	0.9	20.6	YES	571538
P-0018395-T01-IM6	P-0018395	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		774	30	PRAD		0.08	Do not report	MSKCC	Matched	85	NO	63.5	5.3	87.8	YES	579624
P-0018396-T01-IM6	P-0018396	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	656	10	PRAD		0.00	Do not report	MSKCC	Matched	>90	NO	37.9	2.6	59.9	YES	581856
P-0018489-T01-IM6	P-0018489	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		689	20	PRAD		0.00	Do not report	MSKCC	Matched	79	NO	73.7	6.1	93.5	YES	584611
P-0018518-T01-IM6	P-0018518	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		714	50	PRAD		0.16	Do not report	MSKCC	Matched	74	NO	54.1	4.4	79.3	YES	578744
P-0018524-T01-IM6	P-0018524	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	436	20	PRAD		0.00	Do not report	MSKCC	Matched	69	YES	25.2	1.8	41.8	YES	577153
P-0018556-T01-IM6	P-0018556	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		916	30	PRAD		0.14	Do not report	MSKCC	Matched	74	NO	44.1	3.5	69.1	YES	577162
P-0018581-T01-IM6	P-0018581	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 5q13-31, 11q23-24, and 17p12-13.	722	60	PRAD		0.52	Do not report	MSKCC	Matched	70	NO	37.9	2.6	59.9	YES	577109
P-0018588-T02-IM6	P-0018588	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		690	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.41	Stable	MSKCC	Matched	67	NO	37.9	2.6	59.9	YES	743275
P-0018605-T01-IM6	P-0018605	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		1028	60	PRAD		2.28	Do not report	MSKCC	Matched	72	NO	37.9	2.6	59.9	YES	584372
P-0018607-T03-IM6	P-0018607	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		536	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	67	NO	73.7	6.1	93.5	NO	NA
P-0018625-T01-IM6	P-0018625	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	597	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO				YES	581676
P-0018627-T01-IM6	P-0018627	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p13.	388	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.89	Stable	MSKCC	Matched	71	NO	63.5	5.3	87.8	YES	583653
P-0018649-T01-IM6	P-0018649	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		1118	30	PRAD		0.12	Do not report	MSKCC	Matched	78	NO	13.1	0.9	20.6	YES	581641
P-0018659-T02-IM6	P-0018659	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		657	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.50	Stable	MSKCC	Matched	60	NO	63.5	5.3	87.8	YES	597276
P-0018668-T01-IM6	P-0018668	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		665	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO	44.1	3.5	69.1	YES	583640
P-0018703-T01-IM6	P-0018703	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 15% based on variant frequencies of silent mutations and morphology). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	334	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.04	Stable	MSKCC	Matched	59	NO				YES	586365
P-0018704-T01-IM6	P-0018704	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		730	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.15	Stable	MSKCC	Matched	69	NO	13.1	0.9	20.6	YES	584770
P-0018713-T01-IM6	P-0018713	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		815	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO	25.2	1.8	41.8	YES	584759
P-0018779-T01-IM6	P-0018779	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		231	60	PRAD	MICROSATELLITE INSTABILITY-INDETERMINATE. This result is for investigational use only. See MSI note below.	3.61	Indeterminate	MSKCC	Matched	60	NO	54.1	4.4	79.3	YES	585838
P-0018791-T01-IM6	P-0018791	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p34-36, 10q23-24, and 13q12.11-34.	726	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.73	Stable	MSKCC	Matched	78	NO	54.1	4.4	79.3	YES	585825
P-0018798-T01-IM6	P-0018798	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		622	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.30	Stable	MSKCC	Matched	61	NO	37.9	2.6	59.9	YES	585784
P-0018812-T01-IM6	P-0018812	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	570	50	PRAD		1.14	Do not report	MSKCC	Matched	79	YES	44.1	3.5	69.1	YES	587331
P-0018866-T01-IM6	P-0018866	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	586	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	MSKCC	Matched	62	NO				YES	589957
P-0018870-T01-IM6	P-0018870	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q14-q22.	793	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.90	Stable	MSKCC	Matched	73	NO	25.2	1.8	41.8	YES	588971
P-0018918-T01-IM6	P-0018918	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q. Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 16q.	802	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.45	Stable	MSKCC	Matched	52	NO	25.2	1.8	41.8	YES	581397
P-0018956-T01-IM6	P-0018956	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		732	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	>90	NO	63.5	5.3	87.8	YES	589063
P-0019023-T01-IM6	P-0019023	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		774	70	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.01	Stable	MSKCC	Matched	72	NO	44.1	3.5	69.1	YES	591851
P-0019030-T02-IM6	P-0019030	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		589	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.14	Stable	MSKCC	Matched	73	NO	25.2	1.8	41.8	YES	630038
P-0019043-T01-IM6	P-0019043	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	402	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.12	Stable	MSKCC	Matched	82	NO	25.2	1.8	41.8	YES	589970
P-0019059-T01-IM6	P-0019059	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		385	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.34	Stable	MSKCC	Matched	57	NO	37.9	2.6	59.9	YES	593539
P-0019105-T01-IM6	P-0019105	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		617	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.27	Stable	MSKCC	Matched	71	NO	37.9	2.6	59.9	YES	593250
P-0019114-T01-IM6	P-0019114	Prostate Cancer	Metastasis	Tumor	Sacral Mass	Prostate	Prostate Adenocarcinoma	IMPACT468		702	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.34	Stable	MSKCC	Matched	76	NO	54.1	4.4	79.3	YES	595384
P-0019212-T03-IM6	P-0019212	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		536	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	75	NO	76.6	7	94.8	YES	607765
P-0019273-T01-IM6	P-0019273	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		638	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	MSKCC	Matched	68	NO	13.1	0.9	20.6	YES	603777
P-0019278-T01-IM6	P-0019278	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		500	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.08	Stable	MSKCC	Matched	81	NO	37.9	2.6	59.9	YES	597290
P-0019324-T01-IM6	P-0019324	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		695	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.39	Stable	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	599647
P-0019332-T01-IM6	P-0019332	Prostate Cancer	Metastasis	Tumor	Adrenal Gland	Prostate	Prostate Adenocarcinoma	IMPACT468		606	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.43	Stable	MSKCC	Matched	68	NO	13.1	0.9	20.6	YES	597236
P-0019420-T01-IM6	P-0019420	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		885	70	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.00	Stable	MSKCC	Matched	76	NO	25.2	1.8	41.8	YES	602942
P-0019462-T01-IM6	P-0019462	Prostate Cancer	Metastasis	Tumor	Epidural	Prostate	Prostate Adenocarcinoma	IMPACT468		640	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.06	Stable	MSKCC	Matched	56	NO	63.5	5.3	87.8	YES	600758
P-0019520-T01-IM6	P-0019520	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		387	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.09	Stable	MSKCC	Matched	71	NO	25.2	1.8	41.8	YES	601958
P-0019580-T01-IM6	P-0019580	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	408	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	MSKCC	Matched	67	NO	13.1	0.9	20.6	YES	601918
P-0019581-T01-IM6	P-0019581	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		382	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.51	Stable	MSKCC	Matched	68	NO	25.2	1.8	41.8	YES	607013
P-0019582-T01-IM6	P-0019582	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		853	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.46	Stable	MSKCC	Matched	77	NO	89.2	11.4	97.1	YES	606860
P-0019584-T01-IM6	P-0019584	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 2p22-23, 8p, 12p12-13, 16p13.3, and 16q12-34.	694	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.57	Stable	MSKCC	Matched	62	NO	44.1	3.5	69.1	YES	606928
P-0019623-T02-IM6	P-0019623	Prostate Cancer	Metastasis	Tumor	Adrenal Gland	Prostate	Prostate Adenocarcinoma	IMPACT468		629	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO	44.1	3.5	69.1	YES	908674
P-0019624-T01-IM6	P-0019624	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		705	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.45	Stable	MSKCC	Matched	70	NO	44.1	3.5	69.1	YES	607856
P-0019663-T01-IM6	P-0019663	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	550	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	66	YES				YES	606004
P-0019692-T01-IM6	P-0019692	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		511	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.24	Stable	MSKCC	Matched	67	NO	13.1	0.9	20.6	YES	607046
P-0019695-T01-IM6	P-0019695	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	361	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.60	Stable	MSKCC	Matched	65	NO	37.9	2.6	59.9	YES	607892
P-0019777-T01-IM6	P-0019777	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		771	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	MSKCC	Matched	67	NO	25.2	1.8	41.8	YES	608141
P-0019781-T01-IM6	P-0019781	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		565	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.16	Stable	MSKCC	Matched	53	NO	44.1	3.5	69.1	YES	611136
P-0019782-T01-IM6	P-0019782	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		607	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.26	Stable	MSKCC	Matched	79	NO	76.6	7	94.8	YES	610187
P-0019815-T01-IM6	P-0019815	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		292	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	2.89	Stable	MSKCC	Matched	77	NO	13.1	0.9	20.6	NO	NA
P-0019819-T02-IM6	P-0019819	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		726	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO	44.1	3.5	69.1	YES	1069828
P-0019830-T01-IM6	P-0019830	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		454	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.81	Stable	MSKCC	Matched	70	NO	25.2	1.8	41.8	YES	610137
P-0019840-T01-IM6	P-0019840	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		913	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.59	Stable	MSKCC	Matched	80	YES	73.7	6.1	93.5	YES	608106
P-0019842-T01-IM6	P-0019842	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		479	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.08	Stable	MSKCC	Matched	64	NO	44.1	3.5	69.1	YES	610617
P-0019863-T01-IM6	P-0019863	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		867	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.25	Stable	MSKCC	Matched	67	NO	25.2	1.8	41.8	YES	610658
P-0019918-T01-IM6	P-0019918	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		217	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.71	Stable	MSKCC	Matched	77	NO	44.1	3.5	69.1	YES	616422
P-0019927-T01-IM6	P-0019927	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		918	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.11	Stable	MSKCC	Matched	69	NO	54.1	4.4	79.3	YES	616432
P-0019930-T01-IM6	P-0019930	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		924	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.06	Stable	MSKCC	Matched	79	NO	25.2	1.8	41.8	YES	618741
P-0019931-T01-IM6	P-0019931	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of adequate tumor content. More comprehensive testing could be valuable.	306	20	PRAD	NA	1.83	Do not report	MSKCC	Matched	61	NO				YES	616756
P-0019933-T01-IM6	P-0019933	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		930	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.36	Stable	MSKCC	Matched	68	NO	76.6	7	94.8	YES	616418
P-0020013-T01-IM6	P-0020013	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	353	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.09	Stable	MSKCC	Matched	67	YES				YES	616878
P-0020023-T01-IM6	P-0020023	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		514	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	73	NO	25.2	1.8	41.8	YES	616875
P-0020035-T01-IM6	P-0020035	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations are identified in the context of adequate tumor content by morphologic review. More comprehensive testing could be valuable.	449	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	60	NO				YES	615593
P-0020078-T01-IM6	P-0020078	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		676	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	MSKCC	Matched	68	YES	54.1	4.4	79.3	YES	617787
P-0020083-T01-IM6	P-0020083	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		661	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	64	NO	25.2	1.8	41.8	NO	NA
P-0020111-T01-IM6	P-0020111	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		609	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.14	Stable	MSKCC	Matched	62	NO	13.1	0.9	20.6	YES	616794
P-0020132-T01-IM6	P-0020132	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		624	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	54	NO	25.2	1.8	41.8	YES	620152
P-0020150-T02-IM6	P-0020150	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 3q13-26.2 and 20q, excluding SRC. Note: Copy number profile is suggestive of multiple chromosome arm level losses, including PTEN on 10q23. Confirmation by an alternate method is recommended if clinically indicated.	656	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.57	Stable	MSKCC	Matched	69	NO	38.1	2.6	59.9	YES	1562594
P-0020190-T01-IM6	P-0020190	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	497	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	72	NO	13.1	0.9	20.6	YES	620889
P-0020218-T01-IM6	P-0020218	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		927	80	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.91	Stable	MSKCC	Matched	67	NO	63.5	5.3	87.8	YES	618802
P-0020237-T01-IM6	P-0020237	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		716	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.06	Stable	MSKCC	Matched	53	NO	13.1	0.9	20.6	YES	620202
P-0020394-T01-IM6	P-0020394	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		1034	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.71	Stable	MSKCC	Matched	65	NO	63.5	5.3	87.8	YES	624894
P-0020424-T01-IM6	P-0020424	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		811	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.46	Stable	MSKCC	Matched	44	NO	54.1	4.4	79.3	YES	625937
P-0020482-T01-IM6	P-0020482	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		868	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO	44.1	3.5	69.1	YES	627188
P-0020492-T01-IM6	P-0020492	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	667	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.21	Stable	MSKCC	Matched	68	NO	37.9	2.6	59.9	YES	627205
P-0020495-T01-IM6	P-0020495	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		619	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.83	Stable	MSKCC	Matched	74	NO	25.2	1.8	41.8	YES	627090
P-0020512-T01-IM6	P-0020512	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		831	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	MSKCC	Matched	69	NO	25.2	1.8	41.8	YES	628717
P-0020581-T01-IM6	P-0020581	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6q15-22,  8p, 8q24.3, and 13q13-14 (including BRCA2).	491	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	MSKCC	Matched	58	NO	25.2	1.8	41.8	YES	630539
P-0020650-T01-IM6	P-0020650	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	939	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.33	Stable	MSKCC	Matched	77	NO	73.7	6.1	93.5	YES	633638
P-0020676-T01-IM6	P-0020676	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	617	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	54	NO				YES	634651
P-0020704-T01-IM6	P-0020704	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	424	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.70	Stable	MSKCC	Matched	72	NO	37.9	2.6	59.9	YES	634571
P-0020725-T01-IM6	P-0020725	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		267	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.37	Stable	MSKCC	Matched	75	NO	13.1	0.9	20.6	YES	649762
P-0020734-T01-IM6	P-0020734	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		472	80	PRAD	MICROSATELLITE INSTABILITY-INDETERMINATE. This result is for investigational use only. See MSI note below.	3.69	Indeterminate	MSKCC	Matched	61	NO	25.2	1.8	41.8	YES	634717
P-0020750-T01-IM6	P-0020750	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		897	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	MSKCC	Matched	58	NO	25.2	1.8	41.8	YES	635438
P-0020784-T01-IM6	P-0020784	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		799	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.06	Stable	MSKCC	Matched	76	NO	25.2	1.8	41.8	YES	639627
P-0020792-T01-IM6	P-0020792	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		283	80	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.85	Stable	MSKCC	Matched	63	NO	44.1	3.5	69.1	YES	638059
P-0020802-T01-IM6	P-0020802	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		863	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.46	Stable	MSKCC	Matched	67	NO	44.1	3.5	69.1	YES	638568
P-0020812-T01-IM6	P-0020812	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of multiple chromosome arm level losses and gains.	1184	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.24	Stable	MSKCC	Matched	72	NO	37.9	2.6	59.9	YES	638589
P-0020815-T01-IM6	P-0020815	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations are detected in the context of adequate tumor content. Silent mutation was identified. More comprehensive testing could be valuable.	611	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	60	NO				YES	639592
P-0020833-T01-IM6	P-0020833	Prostate Cancer	Metastasis	Tumor	Spine (Bone)	Prostate	Prostate Adenocarcinoma	IMPACT468		1106	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.24	Stable	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	638530
P-0020843-T01-IM6	P-0020843	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		515	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.42	Stable	MSKCC	Matched	69	NO	13.8	0.9	21.8	YES	638596
P-0020847-T02-IM6	P-0020847	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		657	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.26	Stable	MSKCC	Matched	73	NO				YES	659454
P-0020866-T01-IM6	P-0020866	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		672	70	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.36	Stable	MSKCC	Matched	71	NO	54.1	4.4	79.3	YES	641550
P-0020882-T01-IM6	P-0020882	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		1138	70	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.73	Stable	MSKCC	Matched	63	NO	25.2	1.8	41.8	YES	639539
P-0020906-T01-IM6	P-0020906	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	648	50	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	62	YES				YES	640329
P-0020919-T01-IM6	P-0020919	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		650	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO	13.1	0.9	20.6	YES	640424
P-0020984-T01-IM6	P-0020984	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		736	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.55	Stable	MSKCC	Matched	71	NO	38.1	2.6	59.9	NO	NA
P-0021023-T01-IM6	P-0021023	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		809	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.41	Stable	MSKCC	Matched	76	NO	25.2	1.8	41.8	YES	644945
P-0021025-T01-IM6	P-0021025	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	498	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	57	YES	13.1	0.9	20.6	YES	644756
P-0021083-T01-IM6	P-0021083	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	731	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	85	NO	37.9	2.6	59.9	YES	650383
P-0021104-T01-IM6	P-0021104	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		530	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.26	Stable	MSKCC	Matched	72	NO	25.2	1.8	41.8	YES	649957
P-0021122-T01-IM6	P-0021122	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	478	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	83	NO	13.1	0.9	20.6	YES	650808
P-0021183-T01-IM6	P-0021183	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		316	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.65	Stable	MSKCC	Matched	52	NO	25.2	1.8	41.8	YES	656031
P-0021239-T01-IM6	P-0021239	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		681	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.12	Stable	MSKCC	Matched	76	NO	44.1	3.5	69.1	YES	648316
P-0021240-T01-IM6	P-0021240	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome..	600	70	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.51	Stable	MSKCC	Matched	60	NO	44.1	3.5	69.1	YES	649142
P-0021241-T01-IM6	P-0021241	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		678	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.20	Stable	MSKCC	Matched	62	NO	13.1	0.9	20.6	YES	649798
P-0021253-T01-IM6	P-0021253	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	415	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.08	Stable	MSKCC	Matched	66	NO	13.1	0.9	20.6	YES	652171
P-0021254-T01-IM6	P-0021254	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		474	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.59	Stable	MSKCC	Matched	72	NO	44.1	3.5	69.1	YES	649875
P-0021260-T01-IM6	P-0021260	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		525	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.43	Stable	MSKCC	Matched	51	NO	13.1	0.9	20.6	YES	649713
P-0021271-T02-IM6	P-0021271	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		560	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	>90	NO	43.0	3.5	67.2	NO	NA
P-0021274-T01-IM6	P-0021274	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		626	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	56	YES	13.1	0.9	20.6	YES	652121
P-0021282-T01-IM6	P-0021282	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		501	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	74	YES	37.9	2.6	59.9	YES	662131
P-0021287-T01-IM6	P-0021287	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	617	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	MSKCC	Matched	57	NO				YES	652208
P-0021297-T01-IM6	P-0021297	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		402	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.82	Stable	MSKCC	Matched	69	NO	43.0	3.5	67.2	YES	651060
P-0021310-T01-IM6	P-0021310	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 13q, 16q and 17p.	845	80	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.74	Stable	MSKCC	Matched	84	NO	62.5	5.3	86.0	YES	653242
P-0021342-T01-IM6	P-0021342	Prostate Cancer	Metastasis	Tumor	Sternum	Prostate	Prostate Adenocarcinoma	IMPACT468		900	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.50	Stable	MSKCC	Matched	85	NO	63.5	5.3	87.8	YES	656460
P-0021386-T01-IM6	P-0021386	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		607	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	60	NO	25.2	1.8	41.8	YES	653308
P-0021388-T01-IM6	P-0021388	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		533	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO	37.9	2.6	59.9	YES	653628
P-0021461-T01-IM6	P-0021461	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	560	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	MSKCC	Matched	80	NO	25.2	1.8	41.8	NO	NA
P-0021482-T01-IM6	P-0021482	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		630	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.18	Stable	MSKCC	Matched	74	NO	25.2	1.8	41.8	YES	662808
P-0021486-T01-IM6	P-0021486	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		657	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	MSKCC	Matched	72	NO	44.1	3.5	69.1	YES	659200
P-0021525-T01-IM6	P-0021525	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	962	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO	62.5	5.3	86.0	YES	657392
P-0021542-T01-IM6	P-0021542	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q.	557	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.30	Stable	MSKCC	Matched	68	NO	44.1	3.5	69.1	YES	659307
P-0021546-T01-IM6	P-0021546	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		658	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.27	Stable	MSKCC	Matched	61	NO	37.9	2.6	59.9	YES	659468
P-0021547-T01-IM6	P-0021547	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		658	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.40	Stable	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	662314
P-0021561-T01-IM6	P-0021561	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		816	60	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.26	Stable	MSKCC	Matched	82	NO	38.1	2.6	59.9	YES	657450
P-0021564-T01-IM6	P-0021564	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		532	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.85	Stable	MSKCC	Matched	63	NO	25.5	1.8	41.6	YES	657420
P-0021577-T01-IM6	P-0021577	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	660	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.33	Stable	MSKCC	Matched	65	NO	25.2	1.8	41.8	YES	665518
P-0021594-T01-IM6	P-0021594	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q21-22, 8p, and 11q22.3-24. Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q11-21.	782	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.21	Stable	MSKCC	Matched	86	NO	37.9	2.6	59.9	YES	663286
P-0021596-T01-IM6	P-0021596	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468		1019	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.71	Stable	MSKCC	Matched	60	NO	37.9	2.6	59.9	YES	663257
P-0021597-T02-IM6	P-0021597	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		391	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO	13.1	0.9	20.6	YES	732676
P-0021603-T01-IM6	P-0021603	Prostate Cancer	Metastasis	Tumor	Abdomen	Prostate	Prostate Adenocarcinoma	IMPACT468		615	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.58	Stable	MSKCC	Matched	62	NO	53.0	4.4	77.2	YES	662287
P-0021620-T01-IM6	P-0021620	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	735	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	57	NO	54.1	4.4	79.3	YES	665503
P-0021626-T01-IM6	P-0021626	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		613	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO	37.9	2.6	59.9	YES	666060
P-0021627-T01-IM6	P-0021627	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		628	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	MSKCC	Matched	80	NO	44.1	3.5	69.1	YES	666055
P-0021698-T01-IM6	P-0021698	Prostate Cancer	Metastasis	Tumor	Spine (Bone)	Prostate	Prostate Adenocarcinoma	IMPACT468		632	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.31	Stable	MSKCC	Matched	76	NO	63.5	5.3	87.8	YES	666040
P-0021702-T01-IM6	P-0021702	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		737	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	72	NO	63.5	5.3	87.8	YES	665499
P-0021711-T01-IM6	P-0021711	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative copy number results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Additional mutation or structural variant may not be detected due to low tumor content.	522	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	83	NO	25.2	1.8	41.8	YES	666020
P-0021723-T01-IM6	P-0021723	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated. Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	605	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.28	Stable	MSKCC	Matched	78	NO	13.1	0.9	20.6	YES	665570
P-0021725-T01-IM6	P-0021725	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		634	40	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	81	NO	37.9	2.6	59.9	YES	665525
P-0021728-T01-IM6	P-0021728	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	735	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	MSKCC	Matched	60	YES	25.2	1.8	41.8	YES	666191
P-0021782-T01-IM6	P-0021782	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		968	30	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.19	Stable	MSKCC	Matched	71	NO	37.9	2.6	59.9	YES	666034
P-0021792-T01-IM6	P-0021792	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		645	80	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.34	Stable	MSKCC	Matched	62	NO	13.1	0.9	20.6	YES	666054
P-0021823-T01-IM6	P-0021823	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		800	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	74	NO	54.1	4.4	79.3	YES	665596
P-0021852-T01-IM6	P-0021852	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	606	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	55	NO				YES	667588
P-0021853-T01-IM6	P-0021853	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	926	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	85	NO	63.5	5.3	87.8	YES	667658
P-0021854-T01-IM6	P-0021854	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	686	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.00	Stable	MSKCC	Matched	72	NO	25.2	1.8	41.8	YES	667782
P-0021874-T01-IM6	P-0021874	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	987	20	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	MSKCC	Matched	65	NO	25.2	1.8	41.8	YES	663211
P-0021894-T01-IM6	P-0021894	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	433	10	PRAD	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.01	Stable	MSKCC	Matched	65	NO	44.1	3.5	69.1	YES	667632
P-0021909-T01-IM6	P-0021909	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative copy number results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Additional mutation and structural variant may not be detected due to low tumor content.	752	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO	13.1	0.9	20.6	YES	670223
P-0021922-T01-IM6	P-0021922	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		651	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.05	Stable	MSKCC	Matched	45	NO	37.9	2.6	59.9	YES	673329
P-0021927-T01-IM6	P-0021927	Prostate Cancer	Metastasis	Tumor	Chest Wall	Prostate	Prostate Adenocarcinoma	IMPACT468		343	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.71	Stable	MSKCC	Matched	68	YES	54.1	4.4	79.3	YES	670217
P-0021928-T01-IM6	P-0021928	Prostate Cancer	Metastasis	Tumor	Rib	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 19p13, 16q13-24 (including CDH1), and 11q22-24 (including ATM).	874	90	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.30	Stable	MSKCC	Matched	70	NO	44.1	3.5	69.1	YES	668997
P-0021931-T01-IM6	P-0021931	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		619	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	65	NO	13.1	0.9	20.6	YES	668994
P-0022060-T01-IM6	P-0022060	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	300	20	PRAD	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	4.72	Indeterminate	MSKCC	Matched	70	NO	44.1	3.5	69.1	YES	673408
P-0022067-T01-IM6	P-0022067	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	704	10	PRAD	NA	0.00	Do not report	MSKCC	Matched	81	NO				YES	671615
P-0022083-T01-IM6	P-0022083	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		810	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.24	Stable	MSKCC	Matched	66	NO	13.1	0.9	20.6	YES	675641
P-0022092-T01-IM6	P-0022092	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		504	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	MSKCC	Matched	66	NO	25.2	1.8	41.8	YES	677126
P-0022099-T01-IM6	P-0022099	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	754	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	75	NO	44.1	3.5	69.1	YES	675543
P-0022114-T02-IM6	P-0022114	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		565	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.68	Stable	MSKCC	Matched	74	NO	44.1	3.5	69.1	YES	751512
P-0022117-T01-IM6	P-0022117	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	This sample has been nominated for analysis using the Archer targeted RNAseq assay to help further characterize the structural variants identified. Assay will be performed if additional material is available and results will be reported under a separate accession number.	342	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.61	Stable	MSKCC	Matched	56	NO	44.1	3.5	69.1	YES	679018
P-0022179-T01-IM6	P-0022179	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		604	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.28	Stable	MSKCC	Matched	81	NO	44.1	3.5	69.1	YES	678807
P-0022181-T01-IM6	P-0022181	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		571	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	72	NO	37.9	2.6	59.9	YES	678953
P-0022189-T01-IM6	P-0022189	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	This sample has been nominated for further analysis using the Archer targeted RNAseq assay to help characterize the structural variant involving the TMPRSS2 gene. Assay will be performed if additional material is available and results will be reported under a separate accession number.	594	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	MSKCC	Matched	66	YES	13.1	0.9	20.6	YES	682581
P-0022197-T01-IM6	P-0022197	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		559	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	88	NO	37.9	2.6	59.9	YES	684103
P-0022249-T01-IM6	P-0022249	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		485	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.23	Stable	MSKCC	Matched	59	NO	25.2	1.8	41.8	YES	684074
P-0022252-T01-IM6	P-0022252	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	828	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.39	Stable	MSKCC	Matched	68	NO	44.1	3.5	69.1	YES	682435
P-0022255-T01-IM6	P-0022255	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	482	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	70	NO	44.1	3.5	69.1	YES	681402
P-0022340-T01-IM6	P-0022340	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		667	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.40	Stable	MSKCC	Matched	77	NO	37.9	2.6	59.9	YES	685295
P-0022343-T01-IM6	P-0022343	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		531	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	53	NO	13.1	0.9	20.6	YES	686625
P-0022383-T01-IM6	P-0022383	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		625	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.23	Stable	MSKCC	Matched	70	NO	73.7	6.1	93.5	YES	686465
P-0022406-T01-IM6	P-0022406	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		818	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	MSKCC	Matched	72	NO				YES	686433
P-0022420-T01-IM6	P-0022420	Prostate Cancer	Metastasis	Tumor	Bladder	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 3p13, 12p, and 16q.	495	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.85	Stable	MSKCC	Matched	89	NO	44.1	3.5	69.1	YES	687822
P-0022430-T01-IM6	P-0022430	Prostate Cancer	Metastasis	Tumor	Rib	Prostate	Prostate Adenocarcinoma	IMPACT468		853	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.77	Stable	MSKCC	Matched	85	NO	76.6	7	94.8	YES	687902
P-0022437-T01-IM6	P-0022437	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		678	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.48	Stable	MSKCC	Matched	66	NO	44.1	3.5	69.1	YES	687710
P-0022439-T02-IM6	P-0022439	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q (including MYC).	769	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.18	Stable	MSKCC	Matched	55	NO	13.1	0.9	20.6	YES	714398
P-0022446-T01-IM6	P-0022446	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		481	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	55	NO				YES	688908
P-0022455-T01-IM6	P-0022455	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		563	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO	37.9	2.6	59.9	YES	688931
P-0022470-T01-IM6	P-0022470	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		1544	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.13	Stable	MSKCC	Matched	72	NO	25.2	1.8	41.8	YES	690491
P-0022482-T01-IM6	P-0022482	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: This sample has been nominated for further analysis using the Archer targeted RNAseq assay as an apparent driver-negative cancer. Assay will be performed if additional material is available and results will be reported under a separate accession number.	1030	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	72	YES	37.9	2.6	59.9	YES	691126
P-0022557-T01-IM6	P-0022557	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		777	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.57	Stable	MSKCC	Matched	73	NO	25.2	1.8	41.8	YES	705421
P-0022559-T01-IM6	P-0022559	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	512	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	690293
P-0022584-T02-IM6	P-0022584	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		733	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.15	Stable	MSKCC	Matched	58	NO	13.1	0.9	20.6	YES	1082706
P-0022611-T01-IM6	P-0022611	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		722	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.28	Stable	MSKCC	Matched	78	NO	76.6	7	94.8	YES	685194
P-0022637-T01-IM6	P-0022637	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	647	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	72	NO	25.2	1.8	41.8	YES	697102
P-0022641-T01-IM6	P-0022641	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	553	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO	37.9	2.6	59.9	YES	697081
P-0022672-T01-IM6	P-0022672	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		750	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.28	Stable	MSKCC	Matched	74	NO	37.9	2.6	59.9	YES	698494
P-0022700-T01-IM6	P-0022700	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		880	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.29	Stable	MSKCC	Matched	64	NO	13.1	0.9	20.6	YES	694453
P-0022707-T01-IM6	P-0022707	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		792	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.75	Stable	MSKCC	Matched	75	NO	54.1	4.4	79.3	YES	696030
P-0022778-T01-IM6	P-0022778	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		633	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.98	Stable	MSKCC	Matched	57	NO	25.2	1.8	41.8	YES	700533
P-0022780-T01-IM6	P-0022780	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		453	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	61	NO	25.2	1.8	41.8	YES	699500
P-0022782-T01-IM6	P-0022782	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		563	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	MSKCC	Matched	77	NO	0.0	0.0	0.0	YES	700602
P-0022798-T01-IM6	P-0022798	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 8p.	951	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	MSKCC	Matched	70	NO	44.1	3.5	69.1	YES	700524
P-0022825-T01-IM6	P-0022825	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q13-22.	642	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.73	Stable	MSKCC	Matched	89	NO	37.9	2.6	59.9	YES	700598
P-0022865-T01-IM6	P-0022865	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		370	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.32	Stable	MSKCC	Matched	74	NO	54.1	4.4	79.3	YES	596217
P-0022892-T01-IM6	P-0022892	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		328	30	PRAD	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	3.02	Indeterminate	MSKCC	Matched	64	NO	37.9	2.6	59.9	YES	703886
P-0022904-T01-IM6	P-0022904	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		528	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	MSKCC	Matched	73	NO	54.1	4.4	79.3	YES	703893
P-0022905-T01-IM6	P-0022905	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of adequate tumor content .Silent mutations identified were present in high percentage. More comprehensive testing could be valuable.	660	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	MSKCC	Matched	70	NO				YES	703940
P-0022911-T01-IM6	P-0022911	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	597	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO	25.2	1.8	41.8	YES	703941
P-0022920-T01-IM6	P-0022920	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q13-25.	647	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.20	Stable	MSKCC	Matched	65	NO	44.1	3.5	69.1	YES	702522
P-0022953-T01-IM6	P-0022953	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Detection of copy number changes by alternate methods is suggested if clinically indicated.	296	30	PRAD	NA	4.75	Do not report	MSKCC	Matched	70	NO	54.1	4.4	79.3	YES	702507
P-0022956-T01-IM6	P-0022956	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of adequate tumor content by morphologic review. Silent mutations detected were present in at low percentage, which may indicate suboptimal tumor content. Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	354	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.85	Stable	MSKCC	Matched	55	NO				YES	702612
P-0023008-T01-IM6	P-0023008	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	406	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.52	Stable	MSKCC	Matched	74	NO	25.2	1.8	41.8	YES	706975
P-0023026-T01-IM6	P-0023026	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low sequencing depth of coverage of 144X,  negative results should be interpreted with caution. Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	144	20	PRAD	NA	8.47	Do not report	MSKCC	Matched	50	NO	13.1	0.9	20.6	YES	712870
P-0023027-T01-IM6	P-0023027	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	894	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	MSKCC	Matched	72	NO				YES	712323
P-0023028-T01-IM6	P-0023028	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		963	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.01	Stable	MSKCC	Matched	57	NO	25.2	1.8	41.8	YES	712380
P-0023030-T01-IM6	P-0023030	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		635	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.27	Stable	MSKCC	Matched	69	NO	63.5	5.3	87.8	YES	713423
P-0023036-T01-IM6	P-0023036	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	614	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	60	NO				YES	712314
P-0023060-T01-IM6	P-0023060	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		646	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.44	Stable	MSKCC	Matched	79	NO	44.1	3.5	69.1	YES	713377
P-0023065-T01-IM6	P-0023065	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	488	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO	13.1	0.9	20.6	YES	711511
P-0023070-T01-IM6	P-0023070	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	324	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	68	NO	13.1	0.9	20.6	YES	707082
P-0023124-T01-IM6	P-0023124	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	559	10	PRAD	NA	0.00	Do not report	MSKCC	Matched	72	NO	13.1	0.9	20.6	YES	713386
P-0023170-T01-IM6	P-0023170	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		717	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.37	Stable	MSKCC	Matched	73	NO	25.2	1.8	41.8	YES	691560
P-0023249-T02-IM6	P-0023249	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT468		602	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.71	Stable	MSKCC	Matched	66	NO	38.1	2.6	59.9	YES	1061501
P-0023270-T01-IM6	P-0023270	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative copy number results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Additional mutation and structural variant may not be detected due to low tumor content.	439	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	65	NO	25.2	1.8	41.8	YES	714347
P-0023276-T01-IM6	P-0023276	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		695	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	61	NO	25.2	1.8	41.8	YES	718613
P-0023318-T01-IM6	P-0023318	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		689	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.66	Stable	MSKCC	Matched	70	NO	63.5	5.3	87.8	YES	714353
P-0023345-T01-IM6	P-0023345	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		602	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.38	Stable	MSKCC	Matched	70	NO	92.3	14.9	97.5	YES	715556
P-0023346-T01-IM6	P-0023346	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	394	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	73	NO				YES	715626
P-0023401-T02-IM6	P-0023401	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6q15-22, 10q24-26, 12p, 13q, and 16q.	664	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.18	Stable	MSKCC	Matched	66	NO	37.9	2.6	59.9	YES	1096177
P-0023404-T01-IM6	P-0023404	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	324	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	67	NO	13.1	0.9	20.6	YES	722841
P-0023419-T01-IM6	P-0023419	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome..	780	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.38	Stable	MSKCC	Matched	88	NO	25.2	1.8	41.8	YES	718948
P-0023462-T01-IM6	P-0023462	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		652	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.76	Stable	MSKCC	Matched	74	NO	37.9	2.6	59.9	YES	721730
P-0023509-T01-IM6	P-0023509	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	679	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	MSKCC	Matched	72	NO	25.2	1.8	41.8	YES	725817
P-0023546-T02-IM6	P-0023546	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		498	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.82	Stable	MSKCC	Matched	51	NO	37.9	2.6	59.9	YES	723572
P-0023550-T01-IM6	P-0023550	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	608	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO				YES	722923
P-0023561-T01-IM6	P-0023561	Prostate Cancer	Metastasis	Tumor	Bone (Femur)	Prostate	Prostate Adenocarcinoma	IMPACT468		455	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.26	Stable	MSKCC	Matched	66	NO	44.1	3.5	69.1	YES	722881
P-0023594-T01-IM6	P-0023594	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		789	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	79	NO	54.1	4.4	79.3	YES	726196
P-0023605-T01-IM6	P-0023605	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		710	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	77	NO	44.1	3.5	69.1	YES	690414
P-0023621-T01-IM6	P-0023621	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		784	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	67	NO	44.1	3.5	69.1	YES	726197
P-0023625-T01-IM6	P-0023625	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	488	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.23	Stable	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	727532
P-0023629-T01-IM6	P-0023629	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	402	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	73	NO	13.1	0.9	20.6	YES	727528
P-0023666-T01-IM6	P-0023666	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		420	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.64	Stable	MSKCC	Matched	81	NO	54.1	4.4	79.3	NO	NA
P-0023707-T01-IM6	P-0023707	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		564	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO	13.1	0.9	20.6	NO	NA
P-0023730-T01-IM6	P-0023730	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	470	10	PRAD	NA	0.00	Do not report	MSKCC	Matched	51	NO				YES	729371
P-0023741-T01-IM6	P-0023741	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	692	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.30	Stable	MSKCC	Matched	67	NO	73.7	6.1	93.5	YES	729460
P-0023753-T01-IM6	P-0023753	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		530	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	69	NO	25.2	1.8	41.8	YES	733064
P-0023760-T01-IM6	P-0023760	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		171	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.19	Stable	MSKCC	Matched	55	NO	25.2	1.8	41.8	YES	731970
P-0023769-T01-IM6	P-0023769	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		317	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO	37.9	2.6	59.9	NO	NA
P-0023838-T01-IM6	P-0023838	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		371	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.19	Stable	MSKCC	Matched	68	NO	37.9	2.6	59.9	YES	733018
P-0023839-T02-IM6	P-0023839	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	635	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	76	NO	44.1	3.5	69.1	YES	755800
P-0023855-T01-IM6	P-0023855	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		211	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.17	Stable	MSKCC	Matched	65	NO	73.7	6.1	93.5	YES	732680
P-0023866-T01-IM6	P-0023866	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p34-36, 2p16-22, 16q13-24, and 19p13.3-13.12.	705	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.29	Stable	MSKCC	Matched	63	NO	44.1	3.5	69.1	YES	730141
P-0023870-T01-IM6	P-0023870	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.. Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	86	30	PRAD	NA	6.17	Do not report	MSKCC	Matched	61	NO	13.1	0.9	20.6	YES	754440
P-0023874-T01-IM6	P-0023874	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Additional mutations may not be detected due to low tumor content.	348	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	85	NO	37.9	2.6	59.9	YES	738607
P-0023907-T01-IM6	P-0023907	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20%). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution. Note: This sample has been nominated for further analysis using the Archer targeted RNAseq assay as an apparent driver-negative cancer. Assay will be performed if additional material is available and results will be reported under a separate accession number (M17-30854).	520	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.16	Stable	MSKCC	Matched	66	YES				YES	738623
P-0023928-T01-IM6	P-0023928	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		666	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	740833
P-0023945-T01-IM6	P-0023945	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	378	10	PRAD	NA	0.00	Do not report	MSKCC	Matched	63	NO				YES	743270
P-0023958-T02-IM6	P-0023958	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT468		567	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.78	Stable	MSKCC	Matched	65	NO	38.1	2.6	59.9	YES	1516813
P-0023961-T01-IM6	P-0023961	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		761	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.38	Stable	MSKCC	Matched	63	NO	37.9	2.6	59.9	YES	740814
P-0023967-T01-IM6	P-0023967	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution. Additional mutations may not be detected due to low tumor content.	587	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	88	NO	13.1	0.9	20.6	YES	751430
P-0023988-T01-IM6	P-0023988	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		626	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	MSKCC	Matched	86	NO	37.9	2.6	59.9	YES	633614
P-0024028-T01-IM6	P-0024028	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	514	10	PRAD	NA	0.00	Do not report	MSKCC	Matched	70	NO				YES	740730
P-0024076-T02-IM6	P-0024076	Prostate Cancer	Metastasis	Tumor	Epidural	Prostate	Prostate Adenocarcinoma	IMPACT468		723	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	MSKCC	Matched	70	NO	37.9	2.6	59.9	YES	1054211
P-0024080-T02-IM6	P-0024080	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		905	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.26	Stable	MSKCC	Matched	70	NO	37.9	2.6	59.9	YES	766166
P-0024087-T01-IM6	P-0024087	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		760	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	79	NO	13.1	0.9	20.6	YES	749159
P-0024095-T01-IM6	P-0024095	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		682	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.48	Stable	MSKCC	Matched	85	NO	44.1	3.5	69.1	YES	749152
P-0024097-T01-IM6	P-0024097	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	262	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.13	Stable	MSKCC	Matched	68	NO	37.9	2.6	59.9	NO	NA
P-0024117-T01-IM6	P-0024117	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		706	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.37	Stable	MSKCC	Matched	62	NO	37.9	2.6	59.9	YES	752160
P-0024119-T01-IM6	P-0024119	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		381	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	72	NO	13.1	0.9	20.6	NO	NA
P-0024140-T01-IM6	P-0024140	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		472	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	59	NO	13.1	0.9	20.6	YES	752166
P-0024169-T01-IM6	P-0024169	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	391	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO	13.1	0.9	20.6	NO	NA
P-0024179-T01-IM6	P-0024179	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	686	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO				YES	751446
P-0024217-T02-IM6	P-0024217	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		1035	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO	37.9	2.6	59.9	YES	926076
P-0024220-T01-IM6	P-0024220	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: This sample has been nominated for further analysis using the Archer targeted RNAseq assay as an apparent driver-negative cancer. Assay will be performed if additional material is available and results will be reported under a separate accession number.	483	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.23	Stable	MSKCC	Matched	77	YES	25.2	1.8	41.8	YES	751527
P-0024248-T01-IM6	P-0024248	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of adequate tumor content .Silent mutations identified were present in high percentage.More comprehensive testing could be valuable.	301	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO				YES	750942
P-0024249-T01-IM6	P-0024249	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		700	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.98	Stable	MSKCC	Matched	76	NO	54.1	4.4	79.3	YES	751482
P-0024307-T01-IM6	P-0024307	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 3q21-28 and 8q21-24.	293	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.53	Stable	MSKCC	Matched	70	NO	25.2	1.8	41.8	YES	769268
P-0024316-T01-IM6	P-0024316	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	786	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	67	NO	44.1	3.5	69.1	YES	755720
P-0024325-T02-IM6	P-0024325	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of multiple chromosome level gains.	687	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.33	Stable	MSKCC	Matched	58	NO	25.5	1.8	41.6	NO	NA
P-0024427-T01-IM6	P-0024427	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 16q22-24.	740	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	MSKCC	Matched	73	YES	25.2	1.8	41.8	YES	757667
P-0024461-T01-IM6	P-0024461	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		694	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO	44.1	3.5	69.1	YES	754680
P-0024522-T01-IM6	P-0024522	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		567	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO	25.2	1.8	41.8	YES	757164
P-0024534-T01-IM6	P-0024534	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		665	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.88	Stable	MSKCC	Matched	80	NO	44.1	3.5	69.1	YES	753455
P-0024538-T01-IM6	P-0024538	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of multiple chromosome arm level losses and gains.	508	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.94	Stable	MSKCC	Matched	67	NO	63.5	5.3	87.8	YES	757646
P-0024545-T01-IM6	P-0024545	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	250	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.48	Stable	MSKCC	Matched	70	NO	13.1	0.9	20.6	YES	760740
P-0024554-T01-IM6	P-0024554	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		817	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.30	Stable	MSKCC	Matched	69	NO	37.9	2.6	59.9	YES	758407
P-0024580-T01-IM6	P-0024580	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		650	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.31	Stable	MSKCC	Matched	66	NO	13.1	0.9	20.6	YES	758484
P-0024589-T02-IM6	P-0024589	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		536	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.10	Stable	MSKCC	Matched	73	NO	13.1	0.9	20.6	YES	1025990
P-0024598-T02-IM6	P-0024598	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		748	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.42	Stable	MSKCC	Matched	71	NO	25.2	1.8	41.8	YES	879808
P-0024600-T01-IM6	P-0024600	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		317	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.35	Stable	MSKCC	Matched	83	YES	54.1	4.4	79.3	YES	759340
P-0024648-T01-IM6	P-0024648	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		456	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.65	Stable	MSKCC	Matched	51	NO				YES	760376
P-0024662-T01-IM6	P-0024662	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		534	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	55	NO				YES	762954
P-0024679-T01-IM6	P-0024679	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		616	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	MSKCC	Matched	60	YES	13.1	0.9	20.6	YES	760777
P-0024686-T01-IM6	P-0024686	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	758	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	MSKCC	Matched	71	NO	44.1	3.5	69.1	YES	763008
P-0024762-T01-IM6	P-0024762	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		826	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.35	Stable	MSKCC	Matched	55	NO	25.2	1.8	41.8	YES	762981
P-0024898-T01-IM6	P-0024898	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		527	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	MSKCC	Matched	41	NO	25.2	1.8	41.8	YES	863961
P-0024903-T01-IM6	P-0024903	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative MSIsensor and copy number results should be interpreted with caution. Additional mutations may not be detected due to low tumor content.	683	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	59	NO	13.1	0.9	20.6	YES	769231
P-0024913-T01-IM6	P-0024913	Prostate Cancer	Metastasis	Tumor	lymphnodes	Prostate	Prostate Adenocarcinoma	IMPACT468		672	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.88	Stable	MSKCC	Matched	55	NO	25.2	1.8	41.8	YES	760385
P-0024996-T01-IM6	P-0024996	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	360	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO	37.9	2.6	59.9	YES	880154
P-0025002-T01-IM6	P-0025002	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		454	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	MSKCC	Matched	78	NO	25.2	1.8	41.8	YES	879949
P-0025030-T01-IM6	P-0025030	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		730	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	877364
P-0025044-T01-IM6	P-0025044	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		832	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.78	Stable	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	877565
P-0025077-T02-IM6	P-0025077	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		774	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	895290
P-0025086-T01-IM6	P-0025086	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		727	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO	25.2	1.8	41.8	YES	877448
P-0025087-T01-IM6	P-0025087	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of multiple chromosome level losses.	719	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	MSKCC	Matched	60	NO	13.1	0.9	20.6	YES	885579
P-0025097-T01-IM6	P-0025097	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		804	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.71	Stable	MSKCC	Matched	53	NO	73.7	6.1	93.5	YES	880090
P-0025137-T01-IM6	P-0025137	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		729	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.51	Stable	MSKCC	Matched	77	NO	37.9	2.6	59.9	YES	875492
P-0025138-T02-IM6	P-0025138	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		1011	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.46	Stable	MSKCC	Matched	73	NO	37.9	2.6	59.9	YES	909534
P-0025139-T01-IM6	P-0025139	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		732	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.55	Stable	MSKCC	Matched	77	NO	37.9	2.6	59.9	YES	884603
P-0025140-T01-IM6	P-0025140	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	465	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO	37.9	2.6	59.9	YES	885400
P-0025150-T01-IM6	P-0025150	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		574	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.27	Stable	MSKCC	Matched	48	NO	25.2	1.8	41.8	YES	885392
P-0025153-T01-IM6	P-0025153	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468		874	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.55	Stable	MSKCC	Matched	53	NO	44.1	3.5	69.1	YES	885359
P-0025216-T01-IM6	P-0025216	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number results should be interpreted with caution. Additional structural variants may not be detected due to low tumor content.	531	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	60	NO				YES	881792
P-0025222-T02-IM6	P-0025222	Prostate Cancer	Metastasis	Tumor	Retroperitenium	Prostate	Prostate Adenocarcinoma	IMPACT468		477	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.31	Stable	MSKCC	Matched	67	NO	54.1	4.4	79.3	YES	1336309
P-0025228-T01-IM6	P-0025228	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative MSIsensor, copy number and structural variant results should be interpreted with caution. Additional mutations may not be detected due to low tumor content.	704	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.15	Stable	MSKCC	Matched	72	NO	44.1	3.5	69.1	YES	885430
P-0025243-T01-IM6	P-0025243	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		673	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO	87.1	10.5	96.9	YES	884504
P-0025276-T01-IM6	P-0025276	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		907	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	67	NO	73.7	6.1	93.5	YES	884405
P-0025319-T01-IM6	P-0025319	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		512	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	81	NO	25.2	1.8	41.8	YES	884375
P-0025329-T01-IM6	P-0025329	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	949	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	82	NO	37.9	2.6	59.9	YES	888265
P-0025332-T01-IM6	P-0025332	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		858	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.90	Stable	MSKCC	Matched	64	NO				YES	889681
P-0025364-T01-IM6	P-0025364	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		670	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.91	Stable	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	889760
P-0025414-T01-IM6	P-0025414	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q31-44.	1041	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.94	Stable	MSKCC	Matched	55	NO	44.1	3.5	69.1	YES	888230
P-0025455-T01-IM6	P-0025455	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		693	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO	44.1	3.5	69.1	YES	892803
P-0025469-T01-IM6	P-0025469	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		420	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO	13.1	0.9	20.6	YES	891342
P-0025494-T01-IM6	P-0025494	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q11-24 including MYC.	567	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.56	Stable	MSKCC	Matched	78	NO	13.1	0.9	20.6	NO	NA
P-0025503-T01-IM6	P-0025503	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	915	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO	44.1	3.5	69.1	YES	718945
P-0025506-T01-IM6	P-0025506	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	580	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	45	NO	13.1	0.9	20.6	YES	892751
P-0025550-T01-IM6	P-0025550	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		518	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.23	Stable	MSKCC	Matched	71	NO	54.1	4.4	79.3	YES	894231
P-0025562-T01-IM6	P-0025562	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		369	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	65	NO				YES	894113
P-0025571-T01-IM6	P-0025571	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		566	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.11	Stable	MSKCC	Matched	62	NO	13.1	0.9	20.6	YES	894075
P-0025576-T01-IM6	P-0025576	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	258	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.49	Stable	MSKCC	Matched	71	NO	25.2	1.8	41.8	YES	891398
P-0025650-T01-IM6	P-0025650	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		997	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.39	Stable	MSKCC	Matched	72	NO	37.9	2.6	59.9	YES	885550
P-0025676-T01-IM6	P-0025676	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile from IMPACT assay and allele specific copy number analysis by FACETS suggests copy neutral loss of heterozygosity on Chromosome arm 11q22.3-11q24, including ATM. The results by FACETS are for investigational use. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	741	90	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.77	Stable	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	897376
P-0025680-T01-IM6	P-0025680	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	493	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	75	NO	13.1	0.9	20.6	YES	899286
P-0025705-T01-IM6	P-0025705	Prostate Cancer	Metastasis	Tumor	Epidural	Prostate	Prostate Adenocarcinoma	IMPACT468	The MSIsensor score is not reported due to lower than expected overall coverage.	150	30	PRAD	NA	4.51	Do not report	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	895719
P-0025709-T01-IM6	P-0025709	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		316	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.23	Stable	MSKCC	Matched	64	NO	25.2	1.8	41.8	YES	897338
P-0025718-T01-IM6	P-0025718	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of adequate tumor content by morphologic review. Silent mutations are present. More comprehensive testing could be valuable.	680	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	68	YES				YES	899953
P-0025759-T01-IM6	P-0025759	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		865	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	67	NO	25.2	1.8	41.8	YES	903276
P-0025760-T01-IM6	P-0025760	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		547	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	59	NO	25.2	1.8	41.8	YES	903060
P-0025793-T01-IM6	P-0025793	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		655	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.34	Stable	MSKCC	Matched	49	NO	13.1	0.9	20.6	YES	903272
P-0025823-T01-IM6	P-0025823	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q24.	1100	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.31	Stable	MSKCC	Matched	61	NO	25.2	1.8	41.8	YES	907497
P-0025851-T01-IM6	P-0025851	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		616	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.27	Stable	MSKCC	Matched	71	NO	76.6	7	94.8	YES	903678
P-0025880-T01-IM6	P-0025880	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		495	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	59	NO	54.1	4.4	79.3	NO	NA
P-0025901-T01-IM6	P-0025901	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Additional mutations, copy number alterations, and structural variants may not be detected due to low tumor content. These results, as well as low (stable) MSIsensor score, should be interpreted with caution. Repeat testing on a separate sample with higher tumor content may be considered if clinically indicated.	464	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	49	NO	25.2	1.8	41.8	NO	NA
P-0025903-T01-IM6	P-0025903	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	578	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	64	NO				NO	NA
P-0025904-T01-IM6	P-0025904	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		413	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	68	NO	44.1	3.5	69.1	NO	NA
P-0025988-T01-IM6	P-0025988	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		776	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.38	Stable	MSKCC	Matched	71	YES	54.1	4.4	79.3	YES	909620
P-0025990-T01-IM6	P-0025990	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low sequencing coverage depth (186X). In addition, absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	186	10	PRAD	NA	0.79	Do not report	MSKCC	Matched	81	NO				YES	909486
P-0026009-T01-IM6	P-0026009	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	716	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO	25.2	1.8	41.8	YES	909529
P-0026072-T01-IM6	P-0026072	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	943	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.18	Stable	MSKCC	Matched	72	NO	37.9	2.6	59.9	YES	908688
P-0026097-T01-IM6	P-0026097	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		356	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	77	NO	44.1	3.5	69.1	YES	915062
P-0026139-T01-IM6	P-0026139	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		551	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	65	NO	13.1	0.9	20.6	YES	915600
P-0026143-T01-IM6	P-0026143	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of adequate tumor content. Silent mutation(s) present. More comprehensive testing could be valuable if clinically indicated.	529	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO				YES	916428
P-0026152-T01-IM6	P-0026152	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		718	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	MSKCC	Matched	73	NO	44.1	3.5	69.1	YES	915650
P-0026153-T01-IM6	P-0026153	Prostate Cancer	Metastasis	Tumor	Chest Wall	Prostate	Prostate Adenocarcinoma	IMPACT468		873	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.38	Stable	MSKCC	Matched	77	NO	73.7	6.1	93.5	YES	915542
P-0026159-T01-IM6	P-0026159	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	398	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	61	NO				YES	916418
P-0026162-T01-IM6	P-0026162	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		592	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.34	Stable	MSKCC	Matched	67	NO	63.5	5.3	87.8	YES	916420
P-0026196-T01-IM6	P-0026196	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		548	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	81	NO	13.1	0.9	20.6	NO	NA
P-0026202-T01-IM6	P-0026202	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		599	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.32	Stable	MSKCC	Matched	74	NO	25.2	1.8	41.8	YES	916819
P-0026212-T01-IM6	P-0026212	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		311	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	84	NO	25.2	1.8	41.8	YES	916940
P-0026228-T01-IM6	P-0026228	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		486	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.35	Stable	MSKCC	Matched	81	NO	37.9	2.6	59.9	YES	916997
P-0026237-T01-IM6	P-0026237	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	390	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.17	Stable	MSKCC	Matched	64	NO	44.1	3.5	69.1	YES	920112
P-0026256-T01-IM6	P-0026256	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		208	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	73	NO	37.9	2.6	59.9	YES	916416
P-0026316-T01-IM6	P-0026316	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		379	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	MSKCC	Matched	82	NO	54.1	4.4	79.3	YES	916902
P-0026355-T01-IM6	P-0026355	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		286	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.23	Stable	MSKCC	Matched	58	NO	25.2	1.8	41.8	YES	924712
P-0026369-T01-IM6	P-0026369	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		373	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.87	Stable	MSKCC	Matched	68	NO	13.1	0.9	20.6	NO	NA
P-0026377-T01-IM6	P-0026377	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	423	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	64	NO	13.1	0.9	20.6	YES	922314
P-0026395-T01-IM6	P-0026395	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		805	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.32	Stable	MSKCC	Matched	78	NO	25.2	1.8	41.8	YES	927045
P-0026409-T01-IM6	P-0026409	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6q15-22, 13q14-24, 16q, 17p, and 20q12.	1007	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	MSKCC	Matched	87	NO	54.1	4.4	79.3	YES	924669
P-0026447-T01-IM6	P-0026447	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gains on Chromosomes 7 and X.	762	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.90	Stable	MSKCC	Matched	63	NO	54.1	4.4	79.3	YES	922265
P-0026652-T01-IM6	P-0026652	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		916	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.16	Stable	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	929539
P-0026673-T01-IM6	P-0026673	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		484	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.24	Stable	MSKCC	Matched	42	NO	25.2	1.8	41.8	YES	934679
P-0026676-T01-IM6	P-0026676	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		469	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	68	NO	25.2	1.8	41.8	YES	933084
P-0026698-T01-IM6	P-0026698	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8 and Chromosome arm 1q. Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 13q12-14 and 16q22-23	855	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.65	Stable	MSKCC	Matched	67	NO	37.9	2.6	59.9	YES	922409
P-0026706-T01-IM6	P-0026706	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		813	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.68	Stable	MSKCC	Matched	61	NO	37.9	2.6	59.9	YES	933103
P-0026716-T01-IM6	P-0026716	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		803	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.41	Stable	MSKCC	Matched	58	NO	25.2	1.8	41.8	YES	934656
P-0026750-T01-IM6	P-0026750	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		930	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.19	Stable	MSKCC	Matched	66	NO	13.1	0.9	20.6	YES	936066
P-0026752-T01-IM6	P-0026752	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		775	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO	25.2	1.8	41.8	YES	934723
P-0026768-T01-IM6	P-0026768	Prostate Cancer	Metastasis	Tumor	Bladder Wall	Prostate	Prostate Adenocarcinoma	IMPACT468		494	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.85	Stable	MSKCC	Matched	72	NO	54.1	4.4	79.3	YES	935162
P-0026774-T01-IM6	P-0026774	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		652	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.15	Stable	MSKCC	Matched	65	NO	37.9	2.6	59.9	YES	935065
P-0026808-T01-IM6	P-0026808	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		823	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.20	Stable	MSKCC	Matched	66	NO	54.1	4.4	79.3	YES	937688
P-0026812-T01-IM6	P-0026812	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		735	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	83	NO	13.1	0.9	20.6	YES	937795
P-0026855-T01-IM6	P-0026855	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome.	1039	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.93	Stable	MSKCC	Matched	66	NO	54.1	4.4	79.3	YES	938970
P-0026861-T01-IM6	P-0026861	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		808	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.33	Stable	MSKCC	Matched	88	NO	54.1	4.4	79.3	YES	939202
P-0026871-T01-IM6	P-0026871	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		839	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.38	Stable	MSKCC	Matched	64	NO	85.9	9.7	96.5	YES	939205
P-0026872-T01-IM6	P-0026872	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations detected in the context of adequate tumor content by morphologic review. Silent mutations were identified. More comprehensive testing could be valuable.	618	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.15	Stable	MSKCC	Matched	64	NO				YES	939106
P-0026916-T01-IM6	P-0026916	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		642	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	MSKCC	Matched	65	NO	13.1	0.9	20.6	YES	940729
P-0027021-T01-IM6	P-0027021	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		793	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	53	NO	13.1	0.9	20.6	YES	928791
P-0027036-T01-IM6	P-0027036	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		740	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	66	NO	44.1	3.5	69.1	YES	949251
P-0027037-T01-IM6	P-0027037	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		490	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	58	NO	37.9	2.6	59.9	YES	949267
P-0027073-T01-IM6	P-0027073	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	528	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	74	NO	25.2	1.8	41.8	YES	946741
P-0027082-T01-IM6	P-0027082	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	712	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	65	NO	37.9	2.6	59.9	YES	946649
P-0027134-T01-IM6	P-0027134	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	427	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	56	NO	37.9	2.6	59.9	YES	949378
P-0027160-T01-IM6	P-0027160	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	418	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.39	Stable	MSKCC	Matched	72	NO	25.2	1.8	41.8	YES	949348
P-0027162-T01-IM6	P-0027162	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		815	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	MSKCC	Matched	79	NO	25.2	1.8	41.8	YES	949319
P-0027165-T01-IM6	P-0027165	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	630	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO	25.2	1.8	41.8	YES	949423
P-0027193-T01-IM6	P-0027193	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		822	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	66	YES	37.9	2.6	59.9	YES	956082
P-0027210-T01-IM6	P-0027210	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		652	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.15	Stable	MSKCC	Matched	77	NO	54.1	4.4	79.3	YES	954576
P-0027216-T01-IM6	P-0027216	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		666	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	75	NO	25.2	1.8	41.8	NO	NA
P-0027219-T01-IM6	P-0027219	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low sequencing depth of coverage of 183X, MSI and negative results should be interpreted with caution. Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	187	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.22	Stable	MSKCC	Matched	74	NO	37.9	2.6	59.9	YES	955350
P-0027245-T01-IM6	P-0027245	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		787	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.30	Stable	MSKCC	Matched	67	NO	44.1	3.5	69.1	YES	949229
P-0027272-T01-IM6	P-0027272	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative copy number results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Additional mutations and structural variants may not be detected due to low tumor content.	697	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	60	NO	25.2	1.8	41.8	YES	955598
P-0027293-T01-IM6	P-0027293	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		770	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	78	NO	54.1	4.4	79.3	YES	954675
P-0027453-T01-IM6	P-0027453	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		808	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	MSKCC	Matched	62	NO	13.1	0.9	20.6	YES	963271
P-0027454-T01-IM6	P-0027454	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		793	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	67	NO	25.2	1.8	41.8	YES	963211
P-0027466-T01-IM6	P-0027466	Prostate Cancer	Metastasis	Tumor	Colon	Prostate	Prostate Adenocarcinoma	IMPACT468		721	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	77	NO	54.1	4.4	79.3	YES	963248
P-0027471-T01-IM6	P-0027471	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	703	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO				YES	962035
P-0027526-T01-IM6	P-0027526	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		761	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	76	NO	44.1	3.5	69.1	YES	963097
P-0027593-T01-IM6	P-0027593	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	642	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	61	NO	13.1	0.9	20.6	YES	972243
P-0027635-T01-IM6	P-0027635	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	747	10	PRAD	NA	0.00	Do not report	MSKCC	Matched	66	NO				YES	968894
P-0027637-T01-IM6	P-0027637	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated. Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	230	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.63	Stable	MSKCC	Matched	58	NO	25.2	1.8	41.8	YES	963208
P-0027645-T01-IM6	P-0027645	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 10 (including PTEN), 11q21-24, and 17p (including TP53).	670	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	60	NO	13.1	0.9	20.6	YES	964571
P-0027711-T01-IM6	P-0027711	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q. Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 6q15-22.	654	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.72	Stable	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	968697
P-0027722-T01-IM6	P-0027722	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		492	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.75	Stable	MSKCC	Matched	72	NO	79.1	7.9	95.5	YES	971360
P-0027821-T01-IM6	P-0027821	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	586	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	73	NO				YES	973199
P-0027823-T01-IM6	P-0027823	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		959	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	72	NO	37.9	2.6	59.9	YES	972196
P-0027874-T01-IM6	P-0027874	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 3q22-28, 8q11-24.21 and 10q11-21. Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 10q, 17p and 17q11-21.31.	860	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.59	Stable	MSKCC	Matched	66	NO	37.9	2.6	59.9	YES	972194
P-0027921-T01-IM6	P-0027921	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		458	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO	25.2	1.8	41.8	YES	976598
P-0027923-T01-IM6	P-0027923	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	861	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	74	NO				YES	974507
P-0028000-T01-IM6	P-0028000	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	509	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	51	NO	25.2	1.8	41.8	YES	974461
P-0028053-T01-IM6	P-0028053	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	436	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	78	NO	13.1	0.9	20.6	YES	981071
P-0028071-T01-IM6	P-0028071	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468		669	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.50	Stable	MSKCC	Matched	75	NO	75.9	7.0	93.7	YES	979493
P-0028080-T01-IM6	P-0028080	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		742	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	79	NO				YES	996053
P-0028090-T01-IM6	P-0028090	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		809	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.01	Stable	MSKCC	Matched	83	NO	13.1	0.9	20.6	YES	980988
P-0028102-T01-IM6	P-0028102	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Allele specific copy number analysis by FACETS suggests homozygous deletion of RB1. Facets results are for investigational use only.	850	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	62	NO	44.1	3.5	69.1	YES	980466
P-0028160-T01-IM6	P-0028160	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		311	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.20	Stable	MSKCC	Matched	58	NO	63.5	5.3	87.8	YES	984843
P-0028163-T01-IM6	P-0028163	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		644	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	72	NO	44.1	3.5	69.1	YES	996055
P-0028167-T01-IM6	P-0028167	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		533	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	73	NO	44.1	3.5	69.1	YES	984875
P-0028306-T01-IM6	P-0028306	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		745	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.21	Stable	MSKCC	Matched	75	NO	63.5	5.3	87.8	YES	988571
P-0028351-T01-IM6	P-0028351	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Additional mutation may not be detected due to low tumor content.	711	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO	13.1	0.9	20.6	YES	992768
P-0028381-T01-IM6	P-0028381	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is limited by poor sample quality. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	288	20	PRAD	NA	4.40	Do not report	MSKCC	Matched	74	NO	37.9	2.6	59.9	YES	988521
P-0028430-T01-IM6	P-0028430	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		528	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	77	NO	25.2	1.8	41.8	YES	992859
P-0028450-T01-IM6	P-0028450	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		291	30	PRAD	NA	3.66	Do not report	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	992866
P-0028551-T01-IM6	P-0028551	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		893	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	77	NO	13.1	0.9	20.6	YES	996537
P-0028587-T01-IM6	P-0028587	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		357	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	48	NO	79.1	7.9	95.5	YES	996633
P-0028654-T01-IM6	P-0028654	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		611	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.11	Stable	MSKCC	Matched	63	NO	37.9	2.6	59.9	YES	999390
P-0028700-T01-IM6	P-0028700	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	660	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	66	NO	25.2	1.8	41.8	YES	1000561
P-0028741-T01-IM6	P-0028741	Prostate Cancer	Metastasis	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		540	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.29	Stable	MSKCC	Matched	90	NO	54.1	4.4	79.3	YES	999324
P-0028775-T01-IM6	P-0028775	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less). Negative copy number results as well as low (stable) MSI sensor scores, should be interpreted with caution. Additional mutations and structural variants may not be detected due to low tumor content.	440	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	73	NO	37.9	2.6	59.9	YES	1001943
P-0028784-T01-IM6	P-0028784	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		857	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.87	Stable	MSKCC	Matched	76	NO	25.2	1.8	41.8	YES	1006934
P-0029028-T01-IM6	P-0029028	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		780	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.54	Stable	MSKCC	Matched	75	NO	13.1	0.9	20.6	NO	NA
P-0029059-T01-IM6	P-0029059	Prostate Cancer	Metastasis	Tumor	Rib	Prostate	Prostate Adenocarcinoma	IMPACT468		610	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	70	YES	25.2	1.8	41.8	YES	1015885
P-0029105-T01-IM6	P-0029105	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		713	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.32	Stable	MSKCC	Matched	75	NO	25.2	1.8	41.8	YES	1017505
P-0029106-T01-IM6	P-0029106	Prostate Cancer	Metastasis	Tumor	lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468		886	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.11	Stable	MSKCC	Matched	74	NO	37.9	2.6	59.9	YES	1019432
P-0029127-T01-IM6	P-0029127	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		316	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.73	Stable	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	1015846
P-0029260-T01-IM6	P-0029260	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		416	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.99	Stable	MSKCC	Matched	75	NO	37.9	2.6	59.9	YES	1019219
P-0029284-T01-IM6	P-0029284	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		645	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.28	Stable	MSKCC	Matched	71	NO	63.5	5.3	87.8	YES	1017983
P-0029336-T01-IM6	P-0029336	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468		619	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	49	NO	63.5	5.3	87.8	YES	1018142
P-0029339-T01-IM6	P-0029339	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		699	90	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.62	Stable	MSKCC	Matched	74	NO	37.9	2.6	59.9	YES	1018145
P-0029405-T01-IM6	P-0029405	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		715	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	77	NO	25.2	1.8	41.8	YES	1021067
P-0029466-T01-IM6	P-0029466	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		670	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.24	Stable	MSKCC	Matched	69	NO	76.6	7	94.8	YES	1024800
P-0029508-T01-IM6	P-0029508	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		429	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	68	NO	44.1	3.5	69.1	YES	1026003
P-0029523-T01-IM6	P-0029523	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 8q and Chromosome 9.	477	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.45	Stable	MSKCC	Matched	85	NO	25.2	1.8	41.8	YES	1026084
P-0029563-T01-IM6	P-0029563	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		592	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	68	NO	37.9	2.6	59.9	YES	1026098
P-0029604-T01-IM6	P-0029604	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	822	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	67	NO	37.9	2.6	59.9	YES	1032748
P-0029659-T01-IM6	P-0029659	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.  Additional mutations may not be detected due to low tumor content.	1526	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.18	Stable	MSKCC	Matched	72	NO	13.1	0.9	20.6	YES	1033160
P-0029664-T01-IM6	P-0029664	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		466	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	72	NO	73.7	6.1	93.5	YES	1027676
P-0029728-T01-IM6	P-0029728	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		710	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	64	NO	54.1	4.4	79.3	YES	1032307
P-0029796-T01-IM6	P-0029796	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		561	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	52	NO	37.9	2.6	59.9	YES	1036844
P-0029809-T01-IM6	P-0029809	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		543	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO	25.2	1.8	41.8	YES	1042080
P-0029832-T01-IM6	P-0029832	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated. Evaluation of MSI status by alternate method is advised, if clinically indicated.	672	20	PRAD	NA	0.00	Do not report	MSKCC	Matched	57	NO				YES	1042045
P-0029837-T01-IM6	P-0029837	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	247	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	76	NO	25.2	1.8	41.8	YES	1042012
P-0029843-T01-IM6	P-0029843	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		343	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.52	Stable	MSKCC	Matched	88	YES	63.5	5.3	87.8	YES	1042084
P-0029852-T01-IM6	P-0029852	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	604	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	71	NO	37.9	2.6	59.9	YES	1039424
P-0030029-T01-IM6	P-0030029	Prostate Cancer	Metastasis	Tumor	Lymph node	Prostate	Prostate Adenocarcinoma	IMPACT468		528	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	MSKCC	Matched	65	NO	25.2	1.8	41.8	YES	1043981
P-0030109-T01-IM6	P-0030109	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		438	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	59	NO	25.2	1.8	41.8	YES	1039372
P-0030143-T01-IM6	P-0030143	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		307	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.20	Stable	MSKCC	Matched	69	NO	54.1	4.4	79.3	YES	1046642
P-0030162-T01-IM6	P-0030162	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	427	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	61	NO	37.9	2.6	59.9	YES	1044869
P-0030180-T01-IM6	P-0030180	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7 and Chromosome arm 8q.	516	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.30	Stable	MSKCC	Matched	65	NO	38.1	2.6	59.9	YES	1044842
P-0030184-T01-IM6	P-0030184	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		486	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	MSKCC	Matched	52	NO	37.9	2.6	59.9	YES	1044112
P-0030261-T01-IM6	P-0030261	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		510	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	75	NO	13.1	0.9	20.6	YES	1046358
P-0030288-T01-IM6	P-0030288	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		536	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.18	Stable	MSKCC	Matched	76	NO	37.9	2.6	59.9	YES	1051505
P-0030365-T01-IM6	P-0030365	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		281	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO	13.1	0.9	20.6	YES	1052962
P-0030381-T01-IM6	P-0030381	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p36, 5q11-22, 6q15-22, 13q and 16q.	594	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.38	Stable	MSKCC	Matched	66	NO	37.9	2.6	59.9	YES	1051734
P-0030410-T01-IM6	P-0030410	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		731	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.18	Stable	MSKCC	Matched	67	NO	37.9	2.6	59.9	YES	1052932
P-0030438-T01-IM6	P-0030438	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		412	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	58	NO	54.1	4.4	79.3	YES	1054365
P-0030445-T01-IM6	P-0030445	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	632	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	64	NO	25.2	1.8	41.8	YES	1016919
P-0030465-T01-IM6	P-0030465	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	554	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	68	NO	73.7	6.1	93.5	YES	1054243
P-0030521-T02-IM6	P-0030521	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	808	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.54	Stable	MSKCC	Matched	62	NO	73.6	6.1	92.7	YES	1576698
P-0030552-T01-IM6	P-0030552	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	348	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	65	NO	37.9	2.6	59.9	YES	1061527
P-0030580-T01-IM6	P-0030580	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		591	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.60	Stable	MSKCC	Matched	67	NO	25.2	1.8	41.8	YES	1056278
P-0030625-T01-IM6	P-0030625	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of multiple chromosome level losses and gains which include but are not limited to broad copy number gains on Chromosome arms 8p11 and 8q (including MYC) and losses on Chromosome arms 13q (including RB1), 16q, 17p (including TP53).	465	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	MSKCC	Matched	88	NO	54.1	4.4	79.3	YES	1056467
P-0030640-T01-IM6	P-0030640	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		584	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	MSKCC	Matched	61	NO	44.1	3.5	69.1	YES	1061505
P-0030717-T01-IM6	P-0030717	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		688	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.13	Stable	MSKCC	Matched	65	NO	37.9	2.6	59.9	YES	1061485
P-0030730-T01-IM6	P-0030730	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	515	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	75	NO	37.9	2.6	59.9	YES	1060086
P-0030736-T01-IM6	P-0030736	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		645	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO	37.9	2.6	59.9	YES	1061745
P-0030801-T01-IM6	P-0030801	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		811	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	MSKCC	Matched	58	NO	37.9	2.6	59.9	YES	1066803
P-0030845-T01-IM6	P-0030845	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		659	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	47	NO				YES	1066818
P-0030902-T01-IM6	P-0030902	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		597	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	68	NO	37.9	2.6	59.9	YES	1070820
P-0030943-T01-IM6	P-0030943	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		743	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.15	Stable	MSKCC	Matched	70	NO	53.0	4.4	77.2	YES	1074505
P-0030972-T01-IM6	P-0030972	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		575	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.11	Stable	MSKCC	Matched	60	NO	25.2	1.8	41.8	YES	1075494
P-0030976-T01-IM6	P-0030976	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 2q14-32, and 6q12-22.	364	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.48	Stable	MSKCC	Matched	69	NO	54.1	4.4	79.3	YES	1075609
P-0031008-T01-IM6	P-0031008	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		413	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.09	Stable	MSKCC	Matched	42	NO	13.8	0.9	21.8	YES	1075588
P-0031015-T01-IM6	P-0031015	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Note:  Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	233	20	PRAD	NA	4.71	Do not report	MSKCC	Matched	69	NO	NA	NA	NA	YES	1074777
P-0031062-T01-IM6	P-0031062	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of multiple chromosome arm level losses, including RB1 on Chromosome arm 13q.	804	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	56	NO	54.1	4.4	79.3	YES	1077077
P-0031135-T01-IM6	P-0031135	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		346	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.48	Stable	MSKCC	Matched	69	NO	82.2	8.8	96.1	YES	1081541
P-0031137-T01-IM6	P-0031137	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		564	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.76	Stable	MSKCC	Matched	70	NO	37.9	2.6	59.9	YES	1082635
P-0031270-T01-IM6	P-0031270	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	301	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.35	Stable	MSKCC	Matched	69	NO	63.5	5.3	87.8	YES	1082799
P-0031374-T01-IM6	P-0031374	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		674	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.10	Stable	MSKCC	Matched	74	NO	13.1	0.9	20.6	YES	1092563
P-0031392-T01-IM6	P-0031392	Prostate Cancer	Metastasis	Tumor	Retroperitoneum	Prostate	Prostate Adenocarcinoma	IMPACT468		723	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	78	NO	13.1	0.9	20.6	NO	NA
P-0031419-T01-IM6	P-0031419	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		756	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.29	Stable	MSKCC	Matched	65	NO	44.1	3.5	69.1	YES	1091852
P-0031426-T01-IM6	P-0031426	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		680	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.50	Stable	MSKCC	Matched	66	NO	44.1	3.5	69.1	YES	1091748
P-0031429-T01-IM6	P-0031429	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out.	255	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.37	Stable	MSKCC	Matched	55	NO	91	13.2	97.3	YES	1090291
P-0031536-T01-IM6	P-0031536	Prostate Cancer	Metastasis	Tumor	Brain	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	455	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.11	Stable	MSKCC	Matched	64	NO	25.2	1.8	41.8	YES	1093042
P-0031690-T01-IM6	P-0031690	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	535	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO	37.9	2.6	59.9	YES	1103571
P-0031712-T01-IM6	P-0031712	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		643	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.72	Stable	MSKCC	Matched	62	NO	44.1	3.5	69.1	YES	1106028
P-0031720-T01-IM6	P-0031720	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		607	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	MSKCC	Matched	66	NO	44.1	3.5	69.1	YES	1099643
P-0031769-T01-IM6	P-0031769	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		868	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	MSKCC	Matched	67	NO	25.2	1.8	41.8	YES	1105946
P-0031771-T01-IM6	P-0031771	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		615	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	63	NO	43.0	3.5	67.2	YES	1105952
P-0031808-T02-IM6	P-0031808	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome.	872	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.09	Stable	MSKCC	Matched	88	NO	38.1	2.6	59.9	YES	1514031
P-0031810-T01-IM6	P-0031810	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low sequencing depth of coverage of 181X, MSI results and negative results should be interpreted with caution.	181	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.62	Stable	MSKCC	Matched	69	NO	37.9	2.6	59.9	YES	1106081
P-0031812-T01-IM6	P-0031812	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		368	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.17	Stable	MSKCC	Matched	67	NO	13.1	0.9	20.6	YES	1108964
P-0031990-T01-IM6	P-0031990	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.  Additional mutations may not be detected due to low tumor content.	694	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO	44.1	3.5	69.1	YES	1116326
P-0031991-T01-IM6	P-0031991	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		699	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.56	Stable	MSKCC	Matched	>90	NO	13.1	0.9	20.6	YES	1116360
P-0032046-T01-IM6	P-0032046	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		418	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	67	NO	NA	NA	NA	YES	1113506
P-0032068-T01-IM6	P-0032068	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Allele specific copy number analysis by FACETS suggests loss of heterozygosity of KDR and KIT (4q12).  FACETS is for investigational use only.	547	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	51	NO	43.0	3.5	67.2	YES	1118903
P-0032080-T01-IM6	P-0032080	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		375	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	57	NO	13.1	0.9	20.6	YES	1116458
P-0032154-T01-IM6	P-0032154	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		436	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	76	NO	43.0	3.5	67.2	YES	1114047
P-0032194-T01-IM6	P-0032194	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		595	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.24	Stable	MSKCC	Matched	67	NO	63.5	5.3	87.8	YES	1119370
P-0032212-T01-IM6	P-0032212	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468		618	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	72	NO	37.9	2.6	59.9	YES	1118075
P-0032256-T01-IM6	P-0032256	Prostate Cancer	Metastasis	Tumor	Iliac Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		276	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.78	Stable	MSKCC	Matched	86	NO	54.1	4.4	79.3	YES	1124054
P-0032314-T01-IM6	P-0032314	Prostate Cancer	Metastasis	Tumor	Soft Tissue	Prostate	Prostate Adenocarcinoma	IMPACT468		630	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	78	NO	43.0	3.5	67.2	YES	1120544
P-0032352-T01-IM6	P-0032352	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		633	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	69	NO	13.1	0.9	20.6	YES	1126338
P-0032478-T01-IM6	P-0032478	Prostate Cancer	Metastasis	Tumor	Pelvis	Prostate	Prostate Adenocarcinoma	IMPACT468		341	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.26	Stable	MSKCC	Matched	67	NO	44.1	3.5	69.1	YES	1127972
P-0032480-T01-IM6	P-0032480	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		479	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	71	NO	63.5	5.3	87.8	YES	1128014
P-0032573-T01-IM6	P-0032573	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		598	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.27	Stable	MSKCC	Matched	75	NO	37.9	2.6	59.9	YES	1139037
P-0032601-T01-IM6	P-0032601	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		315	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.21	Stable	MSKCC	Matched	60	NO	25.2	1.8	41.8	YES	1136945
P-0032646-T01-IM6	P-0032646	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		425	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	74	NO	25.2	1.8	41.8	YES	1139125
P-0032651-T01-IM6	P-0032651	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		277	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.74	Stable	MSKCC	Matched	84	NO	37.9	2.6	59.9	YES	1138050
P-0032695-T01-IM6	P-0032695	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	479	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	54	NO	0.0	0.0	0.0	YES	1138978
P-0032757-T01-IM6	P-0032757	Prostate Cancer	Metastasis	Tumor	Bone	Prostate	Prostate Adenocarcinoma	IMPACT468		390	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	MSKCC	Matched	82	NO	73.7	6.1	93.5	YES	1138204
P-0032799-T01-IM6	P-0032799	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		372	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	MSKCC	Matched	60	NO	13.1	0.9	20.6	YES	1141434
P-0032801-T01-IM6	P-0032801	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q.	342	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.96	Stable	MSKCC	Matched	60	NO	37.9	2.6	59.9	YES	1141438
P-0032815-T01-IM6	P-0032815	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	341	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	MSKCC	Matched	69	NO	13.1	0.9	20.6	YES	1143295
P-0032868-T01-IM6	P-0032868	Prostate Cancer	Metastasis	Tumor	Pleura	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 2p22-23,13q14-34,17p13, 18q and 22q.	603	70	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.27	Stable	MSKCC	Matched	65	NO	25.2	1.8	41.8	YES	1139299
P-0032987-T01-IM6	P-0032987	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		381	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	70	NO	13.1	0.9	20.6	YES	1145519
P-0033007-T01-IM6	P-0033007	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Absence of any somatic mutations and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	487	10	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	76	NO	NA	NA	NA	YES	1148086
P-0033010-T01-IM6	P-0033010	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		346	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.24	Stable	MSKCC	Matched	66	NO	13.1	0.9	20.6	YES	1147146
P-0033076-T01-IM6	P-0033076	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		567	60	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.11	Stable	MSKCC	Matched	82	NO	25.2	1.8	41.8	YES	1147207
P-0033105-T01-IM6	P-0033105	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Low tumor content (approximately 20% or less).  Negative structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.  Additional mutations and copy number alterations may not be detected due to low tumor content.	541	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	73	NO	13.1	0.9	20.6	NO	NA
P-0033114-T01-IM6	P-0033114	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	210	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.20	Stable	MSKCC	Matched	68	NO	13.1	0.9	20.6	NO	NA
P-0033117-T01-IM6	P-0033117	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: No alterations identified in the context of adequate tumor content. Silent mutations identified were present in high percentage. More comprehensive testing could be valuable.	461	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	50	NO	NA	NA	NA	YES	1151541
P-0033135-T01-IM6	P-0033135	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		718	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	73	NO	44.1	3.5	69.1	YES	1144474
P-0033175-T01-IM6	P-0033175	Prostate Cancer	Metastasis	Tumor	Lung	Prostate	Prostate Adenocarcinoma	IMPACT468		704	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	76	NO	44.1	3.5	69.1	NO	NA
P-0033226-T01-IM6	P-0033226	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		264	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.39	Stable	MSKCC	Matched	68	NO	37.9	2.6	59.9	NO	NA
P-0033767-T01-IM6	P-0033767	Prostate Cancer	Metastasis	Tumor	Liver	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of a fragmented genome.	754	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	1.08	Stable	MSKCC	Matched	64	NO	54.1	4.4	79.3	NO	NA
P-0034039-T01-IM6	P-0034039	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		390	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	MSKCC	Matched	61	NO	63.5	5.3	87.8	NO	NA
P-0034378-T01-IM6	P-0034378	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		306	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.17	Stable	MSKCC	Matched	56	NO	63.5	5.3	87.8	NO	NA
P-0035824-T01-IM6	P-0035824	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		539	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	74	NO	37.9	2.6	59.9	YES	1307982
P-0036594-T01-IM6	P-0036594	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 6q and 13q.	537	80	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.15	Stable	MSKCC	Matched	76	NO	37.9	2.6	59.9	NO	NA
P-0036734-T01-IM6	P-0036734	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		322	20	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	62	NO	44.1	3.5	69.1	NO	NA
P-0037023-T01-IM6	P-0037023	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468	Note: Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	244	40	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	2.89	Stable	MSKCC	Matched	64	NO	25.2	1.8	41.8	NO	NA
P-0037421-T01-IM6	P-0037421	Prostate Cancer	Metastasis	Tumor	Lymph Node	Prostate	Prostate Adenocarcinoma	IMPACT468		498	50	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.20	Stable	MSKCC	Matched	72	NO	54.1	4.4	79.3	NO	NA
P-0038369-T01-IM6	P-0038369	Prostate Cancer	Primary	Tumor	Not Applicable	Prostate	Prostate Adenocarcinoma	IMPACT468		642	30	PRAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	MSKCC	Matched	70	NO	38.1	2.6	59.9	YES	1458261